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Myelination has been evolved in the vertebrate system as an essential mechanism to 
facilitate axonal signal transduction and provide trophic support for neurons. Formation and 
maintenance of myelin sheaths are tightly regulated throughout the development by diverse cell 
metabolic pathways. Consequently, the impairment of myelin homeostasis, for instance by an 
altered metabolism of myelinating glial cells, can lead to severe axonal degeneration. Inherited 
peripheral neuropathies such as the most commonly inherited Charcot-Marie-Tooth (CMT) 
diseases are a heterogeneous group of disorders, caused by mutations in more than 80 different 
genes. The demyelinating CMT-type 4B results from loss-of-function or missense mutations in 
myotubularin-related protein 2 (MTMR2), MTMR5 or MTMR13. These proteins belong to the 
family of MTMR phosphatidylinositol (PI) phosphatases that specifically hydrolyze the 
endomembrane signaling lipids PI(3)P and PI(3,5)P2 at the D-3 position. How dysregulated 
PI(3)-phosphate conversion in myelinating Schwann cells can lead to such a severely affected 
myelin homeostasis, as observed in the absence of CMT-associated MTMRs, is still elusive. 
Here, we show that the small GTPase Rab35, a critical regulator of endomembrane 
trafficking, interacts with CMT-associated MTMR lipid phosphatases. Rab35 binds and recruits 
the pseudophosphatases MTMR13 and MTMR5, and via these, also the active phosphatase 
MTMR2. In agreement with the critical involvement of these proteins in the myelin homeostasis 
of the peripheral nervous system (PNS), Schwann cell-specific Rab35 ablation results in severe 
peripheral demyelination in mice. Sciatic nerves of these animals are characterized by 
aberrantly myelinated fibers with Tomacula and myelin outfoldings. This progressive focal 
hypermyelination is accompanied by abnormally elevated activity of mTORC1, a central cell 
signaling hub that needs to be crucially balanced for proper myelination. Inhibiting mTORC1 
activity by pharmaceutical treatment of these mice using Rapamycin leads to a partial 
amelioration of the nerve morphology. Moreover, reduced myelin segment formation and 
myelin abnormalities in Rab35-depleted Schwann cells ex vivo, in Schwann cell and dorsal root 
ganglion neuron co-cultures, are rescued by Rapamycin application. These findings strongly 
indicate that mTORC1 hyperactivity contributes to the observed impairment of myelin 
homeostasis in conditional Rab35 knockout (KO) animals. 
Furthermore, the absence of Rab35 or the active phosphatase MTMR2, or both, result 
in elevated mTORC1 activity in different cultured cell types, including primary cells of the 
nervous system. This hyperactivity is displayed independently of receptor tyrosine kinase 





Rab35-depleted cells by overexpression of MTMR2, suggesting a sequential function of the 
small GTPase and active MTMR complexes in repressing mTORC1. In accordance with the 
lipid phosphatase activity of MTMR2, we further show that dysregulated PI(3)-phosphate 
levels in the absence of Rab35 are causative for the observed mTORC1 hyperactivation, and 
likely result from an impaired recruitment of MTMR complexes. Rab35-depleted cells display 
an accumulation of PI(3)P and likely its product, PI(3,5)P2. Importantly, pharmacological 
interference with VPS34-mediated PI(3)P synthesis restores physiological levels of mTORC1 
activity. We observe this mechanism in non-myelinating cells as well as in Schwann cells. 
Elevated mTORC1 activity and PI(3)P accumulation are accompanied by increased levels of 
the myelin protein P0 in differentiated Rab35 KO Schwann cells in culture. Importantly, 
P0-protein levels are reduced and comparable to WT levels upon pharmacological inhibition of 
mTORC1, VPS34, and especially the PI(3,5)P2-synthesizing enzyme PIKfyve. This suggests 
that PI(3,5)P2 is the critical lipid for mTORC1 activation in PNS myelinating glial cells and 
thus, provides a possible explanation for the crucial effect of the loss of MTMR proteins on 
myelin homeostasis. Moreover, our data indicate a similar role for Rab35 in myelinating glial 
cells of the central nervous system (CNS). 
Taken together, we could identify Rab35 as a novel critical regulator of both, myelin 
homeostasis and mTORC1 activity. We propose a mechanism in which Rab35 represses 
mTORC1 activity by the recruitment of PI(3)-phosphate-hydrolyzing MTMR complexes to 
lysosomal sites. These findings may have implications for a potential therapeutic treatment of 
CMT4B-patients by pharmaceutical mTORC1-inhibition, for instance with Rapamycin. 





Myelinisierung ist ein essenzieller Mechanismus innerhalb der evolutionären 
Entwicklung der Wirbeltiere, für die Beschleunigung der axonalen Signaltransduktion sowie 
die trophische Unterstützung von Neuronen. Formation und lebenslanger Erhalt der 
Myelinscheiden sind durch zahlreiche Zell-metabolische Stoffwechselwege streng reguliert. 
Beeinträchtigungen der Myelin Homöostase, die beispielsweise aus Abweichungen im 
Metabolismus von myelinisierenden Gliazellen resultieren, können somit zur schwerwiegenden 
Degeneration von Axonen führen. Vererbbare Neuropathien im peripheren Nervensystem 
(PNS), wie die am häufigsten vererbte Charcot-Marie-Tooth (CMT) Krankheit, sind eine 
heterogene Gruppe von Erkrankungen, die durch Mutationen in mehr als 80 verschiedenen 
Genen verursacht werden können. Der demyelinisierende CMT-Krankheitstyp 4B wird durch 
Genmutationen ausgelöst, die zum Verlust oder der Fehlfunktion von myotubularin-related 
protein 2 (MTMR2), MTMR5 oder MTMR13 führen. Diese Proteine gehören zur Gruppe der 
MTMR Phosphatidylinositol (PI) Phosphatasen, die spezifisch die endomembranen 
Signallipide PI(3)P und PI(3,5)P2 an der 3‘-Phosphatgruppe hydrolysieren. Unklar ist jedoch, 
wie sich eine Deregulation der Umsetzung der Lipide in myelinisierenden Schwann-Zellen in 
der Abwesenheit dieser MTMR Phosphatasen so schwerwiegend auf die Myelin Homöostase 
auswirken kann. 
In dieser Arbeit zeigen wir, dass Rab35, eine kleine GTPase, die in der Regulation des 
intrazellulären Membrantransports involviert ist, mit diesen CMT-assoziierten MTMR 
Lipidphosphatasen interagiert. Rab35 bindet und rekrutiert die Pseudophosphatasen MTMR13 
und MTMR5, und dadurch auch die mit ihnen im Komplex gebundene aktive Phosphatase 
MTMR2. Entsprechend der kritischen Rolle dieser Proteine in der Regulation der Myelin 
Homöostase im PNS, führt die Schwann-Zell-spezifische Ablation von Rab35 in vivo zu einer 
schweren Demyelinisierung des Ischias-Nervs in Mäusen. Die Tiere weisen 
aberrant-myelinisierte periphere Nervenfasern mit Tomacula und Myelinscheidenausfaltungen 
auf. Diese voranschreitende fokale Hypermyelinisierung ist begleitet von einer abnormal 
erhöhten Aktivität einer der zentralen Signalverschaltungskomplexe für die Regulation der 
Myelinscheidenformation, mTORC1, im Nervengewebe. Ein Entgegenwirken der mTORC1-
Hyperaktivität durch die pharmakologische Inhibierung mit Rapamyzin führt zu einer partiellen 
Verbesserung der Nervenmorphologie. Die chronische Applikation von Rapamyzin in Rab35-
depletierten Schwann-Zellen ex vivo behebt zudem die reduzierte Formation von 
Myelinsegmenten und -abberrationen in Co-Kulturen von Schwann-Zellen und dorsal root 




Aktivität in Schwann-Zellen zu der beeinträchtigten Myelin Homöostase in den konditionellen 
Rab35 knockout (KO) Tieren beiträgt.  
Des Weiteren führt die Depletion von Rab35, der aktiven Phosphatase MTMR2, oder 
beider Proteine zu erhöhter mTORC1-Aktivität in verschiedenen kultivierten Zelltypen, unter 
anderem auch in Primärzellen des Nervensystems. Dieser Effekt ist unabhängig von der 
Stimulation der mTORC1-aktivierenden Rezeptortyrosinkinasen sowie der daraus 
resultierenden AKT-Aktivierung. Interessanterweise kann eine physiologische mTORC1-
Aktivität durch Überexpression von MTMR2 in Rab35-depletierten Zellen wiederhergestellt 
werden. Dies lässt auf einen sequenziellen Ablauf der mTORC1-Repression durch die kleine 
GTPase und aktiven MTMR Komplexen schließen. Damit übereinstimmend haben wir 
festgestellt, dass eine fehlende Regulierung von PI(3)-Phosphaten in der Abwesenheit von 
Rab35 ursächlich für die beobachtete mTORC1-Hyperaktivität ist und vermutlich aus einer 
beeinträchtigten Rekrutierung von MTMR Komplexen resultiert. Kultivierte Zellen in denen 
die Expression von Rab35 gänzlich oder größtenteils unterdrückt wird, weisen eine 
Akkumulation von PI(3)P und möglicherweise auch von PI(3,5)P2 Lipiden auf. In diesen Zellen 
kann durch pharmakologische Unterbindung der PI(3)P Synthese durch Inhibierung von VPS34 
die mTORC1-Aktivität wieder auf physiologische Level reduziert werden. Diesen 
Mechanismus sehen wir sowohl in nicht-myelinisierenden als auch in Schwann-Zellen. Neben 
der mTORC1-Hyperaktivität und der Akkumulation von PI(3)P Lipiden weisen differenzierte 
Rab35 KO Schwann-Zellen in Kultur erhöhte Myelin Protein P0-Level auf. Diese können 
bemerkenswerterweise durch die chronische Applikation der Kulturen mit Inhibitoren gegen 
mTORC1, VPS34, und insbesondere gegen das PI(3,5)P2-synthetisierende Enzym, PIKfyve, 
wieder reduziert werden. Dies legt den Schluss nahe, dass PI(3,5)P2 das entscheidende 
mTORC1-aktivierende Lipid in den myelinisierenden Gliazellen des PNS‘ ist, und bietet somit 
eine mögliche Erklärung für die Auswirkung des Verlustes von MTMR Proteinen auf die 
Myelin Homöostase. Unsere Daten weisen zudem darauf hin, dass Rab35 eine ähnliche 
Funktion in Oligodendrozyten, den myelinisierenden Zellen des zentralen Nervensystems 
übernimmt. 
Zusammenfassend identifizieren unsere Ergebnisse Rab35 als bisher unentdeckten 
Regulator der Myelinscheidenformation im PNS, sowie als Repressor von mTORC1. Wir 
vermuten, dass Rab35 die Aktivität von mTORC1 durch die Rekrutierung von MTMR 
Phosphatasen zu Lysosomen unterdrückt. Diese Ergebnisse deuten darauf hin, dass die 
therapeutische Behandlung mit mTORC1-inhibierenden Pharmaka wie Rapamyzin zu einer 
Verbesserung des Krankheitsverlaufs von CMT4B Patienten führen könnte.  





1.1 Myelination of the vertebrate nervous system 
The electrical insulation of neuronal axons by compacted glial membrane wrapping 
appeared for the first time in evolution approximately 425 Mio years ago in placoderms. 
Myelination is one of the crucial acquisitions that underly the potential of higher organisms to 
develop large and complex nervous systems by enabling rapid and efficient nerve conduction 
in small diameter axons (Zalc, 2008; 2016). “Myelin” originates from the greek term of marrow 
(“myelos”) and was first coined by Rudolf Virchow (Virchow, 1854). The vertebrate nervous 
system is composed of the central nervous system (CNS), including spinal cord and brain, and 
the peripheral nervous system (PNS) with its nerves that connect the CNS with organs and 
limbs. The CNS is further subdivided into the grey and white matter, whereas the latter contains 
almost exclusively myelinated fibers with a dry weight myelin proportion of 50 - 60 % (Morell 
and Norton, 1980). In contrast, peripheral nerves contain bundles of small diameter, non-
myelinated and large, myelinated axons in a ratio of 4 to 1 (Voyvodic et al., 1989; Griffin and 
Thompson, 2008). The axonal diameter is a key determinant for and directly proportional to the 
signal conduction velocity (Rushton, 1951; Waxman, 1980). In invertebrates, long fibers 
require a large diameter to transmit signals with a sufficient speed (Young, 1938). Myelination 
of vertebrate axons circumvents the requirement of large fiber surfaces by preventing the loss 
of charge, reducing membrane capacitance during signal propagation, and providing trophic 
support for axonal integrity (Nave, 2010). The extent of myelination is tightly regulated and 
adapted to the axonal diameter, represented by a constant g-ratio. It is defined as the axon 
diameter divided by the total fiber diameter, and between 0.6 - 0.7 for myelinated fibers in PNS 
and CNS. The g-ratio increases slightly with age whereas significant deviations indicate 
pathological conditions (Rushton, 1951; Berthold et al., 1983; Friede and Beuche, 1985; Kidd 
et al., 2013).   
 
1.2 Myelinating glial cells  
Oligodendrocytes (OLs) and Schwann cells (SCs) myelinate axons of the CNS and PNS, 
respectively. They are presumed to be evolutionarily developed from a common progenitor that 
might descendant from the invertebrate ensheathing glial cells (Zalc et al., 2008; 2016). 
Nevertheless, their cell morphology is quite distinct, especially in the mature myelinating stage 
(Fig. 1-1). Multibranching OLs produce up to 40 myelin segments on multiple axons by the 
sequential extension of axon-contacting filopodia, followed by lamellopodial wrapping 





of their whole cell body (Kidd et al., 2013). In addition, SCs origin from neural crest cells, 
whereas OLs are derived from neuroepithelial cells (Jessen et al., 1994; Rowitch, 2004). 
Proliferating oligodendrocyte precursor cells (OPCs) migrate to their destined localization into 
future white matter tracts of the CNS with regulatory contributions of extrinsic signals from 
neurons and other glial cells of the developing brain (Rowitch, 2004). In peripheral nerves, SC 
precursors co-migrate with growing axons and their survival and differentiation depend on 
axonal signals (Jessen & Mirsky, 2005; Nave and Salzer, 2006).   
 
In the human brain most myelin sheaths are formed during the first year, but their 
development is not completed before the age of 20 (Fields, 2008). Bipolar OPCs are already 
observed at embryonic day (E) 9.5 in the mouse telencephalon, shortly after neuronal 
specification (Timsit et al., 1995; Poncet et al., 1996; Perez-Villegas et al., 1999). SC 
precursors are generated in rodent nerves at E12-15. Immature SCs start to segregate axon 
bundles at E13-17. Postnatally, immature SCs perform axonal sorting, and eventually 
differentiate into mature pro- and thus myelinating SCs or non-myelinating Remak bundle 
forming cells (Jessen et al., 1994; Dong et al., 1995; Jessen and Mirsky, 2005). Similar to post-
mitotic mature OLs, differentiated SCs exit from the cell cycle. However, upon nerve injury 
SCs can re-enter the cell cycle by dedifferentiation of mature into immature SCs (Jessen and 
Mirsky, 2005). Maturation and differentiation within both lineages require complex 
morphogenetic changes and thus, a tight regulation of the gene expression pattern.  
OPCs are characterized by expression of the receptor tyrosine kinase PDGFRα (Platelet 
derived growth factor receptor) and the chondroitin sulphate proteoglycan NG2 (neural glial 
antigen 2), regulated by the transcription factors Olig-1 and Olig-2 (Stallcup and Beasley, 1987; 
Figure 1-1: Myelin segment formation 
in the CNS and PNS. (a) 
Oligodendrocytes in the CNS form 
internodes on different axons by several 
filopodial extensions. Perinodal 
astrocytes with so far unknown function 
contact the axon in nodal regions. (b) 
Schwann cells in the PNS form each one 
segment only and a surrounding basal 








Pringle et al., 1992; Wegner, 2008). Upon differentiation into late progenitors and pro-
myelinating OLs, O4-reactive glycoproteins and galactocerebrosides (GalC) are upregulated, 
whereas NG2- and PDGFRα-expression is lost (Bansal et al. 1992; Barateiro and Fernandes 
2014). Myelination induction in mature OLs is supposed to be controlled by the transcription 
factor MyRF (myelin regulatory factor) that binds to myelin protein and lipid synthesis genes 
(Bujalka et al., 2013). During the transition to myelinating OLs, major myelin components such 
as the myelin-associated glycoprotein (MAG), 2′,3′-cyclic nucleotide 3′-phosphodiesterase 
(CNPase), as well as myelin basic protein (MBP) and proteolipid protein (PLP) are upregulated 
(Fig. 1-2a) (McMorris, 1984; Verity and Campagnoni 1988; Miron and Kuhlmann, 2011). A 
distinct proportion of OPCs with around 5 to 8 % of all glial cells remain in the adult brain as 
precursors for myelin remodeling (Dawson et al., 2000; Young et al., 2013).  
 
Figure 1-2: Lineage progression of myelinating glial cells. (a) PDGFRα/NG2+ OPCs are derived from 
neuroepithelial cells and differentiate into O4/GalC+ immature and eventually myelinating oligodendrocytes 
(OL) that express major myelin components. Modified from (Armada-Moreira et al., 2015). (b) Schwann 
cell precursors assemble with axons via nerve CAM (N-CAM) and ErbB2/B3 paracrine signaling and 
differentiate into immature O4+ SCs. The pro-myelin stage is marked by upregulation of transcription factors 
for myelin protein- and lipid-synthesis, and downregulation of cell adhesion molecules (N-CAM). Modified 
from (Jessen and Mirsky, 2019). green – selected set of proteins expressed in each stage; italic – selected 







Proteins mainly expressed in immature SCs and downregulated upon differentiation, 
include the low-affinity neurotrophin receptor p75NTR, and the transcription factors c-Jun and 
Sry box protein (Sox)-2, regulated by cAMP-signaling (Scherer et al., 1994; Parkinson et al., 
2004; 2008). The EGF-like receptors, ErbB2 and -B3, and Sox10 are expressed throughout all 
lineage stages, and are required for proliferation, differentiation and myelination (Kim et al., 
1997). Cell cycle exit is mediated by the cyclin-dependent kinase inhibitor p27(Kip1), which is 
upregulated by the master transcription factor for differentiation into myelinating SCs, the zinc 
finger protein KROX20/Egr2 (Zorick et al., 1999; Parkinson et al., 2004). KROX20 is 
repressed in immature SCs by Sox-2 and transcriptionally upregulated in the pro-myelinating 
stage by POU domain transcription factors, Sox10 and NFAT (nuclear factor of activated T 
cells) (Topilko et al., 1994; Jaegle et al, 2003; Le et al., 2005; Ghislain and Charnay, 2006; Kao 
et al., 2009; Jang et al., 2010). Following differentiation initiation, myelin-associated proteins 
such as the scaffolding protein periaxin, the nuclear factor-κB, and the myelin compaction 
proteins, myelin protein 0 (P0) and MBP are expressed (Lemke and Chao, 1988; Morgan et al., 
1991; Parkinson et al., 2003; Patzig et al., 2011; Yoon et al., 2008). Lipid synthesis is induced 
by upregulation of the sterol regulatory element-binding protein (SREBP) transcription factors 
(Camargo et al., 2009). In contrast, the expression of cell adhesion molecules (CAM) is 
downregulated upon differentiation into myelinating but not in non-myelinating mature SCs 
(Jessen et al., 1987) (Fig. 1-2b).  
 
1.3 The function of myelination 
The concentrical wrapping and subsequent compaction of several layers of glial 
membrane around axons fulfills essential functions in the facilitation of nerve conductance. 
Myelin segments cover around 99 % of the axonal surface. These internodes are regularly 
spaced and separated by small gaps of around 1 µm, the nodes of Ranvier (Ranvier, 1871; Salzer 
et al., 2015). The axon is electrically insulated in internode regions and almost devoid of ion 
channels, whereas voltage-gated sodium channels (Nav1.6 and Nav1.3) are concentrated in the 
nodes (Kordeli et al., 1990; Rasband et al., 1999a). Voltage-gated potassium channels (Kv1.1 
and Kv1.3) are clustered in a region between node and paranode, the juxtaparanode, and thereby 
electrically separated from Nav-channels (Chiu and Ritchie, 1984; Rasband et al., 1999b). The 
sodium channel density is around six times higher in the nodes of myelinated fibers than on 
surfaces of non-myelinated axons (Pellegrino et al., 1984; Black et al., 1990). Thus, action 
potentials that are propagated continuously along the latter, are generated in the nodal regions 
of myelinated axons only. This saltatory conduction (latin: saltare – jump) allows for fast signal 




propagation with up to 150 m/s compared to a maximum of 10 m/s in unmyelinated axons (; 
Ritchie, 1982; Purves et al., 2001). As concluded from theoretical models, the internode length 
is adapted to an optimal conduction velocity and correlates almost linearly with the axonal 
diameter (Waxman, 1980; Murray and Blakemore, 1980; Hildebrand et al., 1993; Simpson et 
al. 2013). In addition, the lamellae number of internodes, which corresponds to the myelin 
thickness, is strongly correlated to the axonal diameter as well (Hildebrand and Hahn, 1978). 
Notably, saltatory conduction requires less energy than continuous AP generation (Harris and 
Atwell, 2012; Waxman et al., 2006). 
The axon length is not only critical for signal transduction speed but also for the 
energy-requiring axonal transport of vesicular cargo and molecules, which maintain axonal and 
synaptic integrity (Roy et al., 2005). In agreement, the loss of myelin compaction proteins 
results in early defects in the anterograde and retrograde axonal transport in vivo (Lappe-Siefke 
et al., 2003; Edgar et al., 2004). In the CNS, monocarboxylate transporters that transfer 
pyruvate and lactate are located in myelin sheaths (MCT1) and the underlying axolemma 
(MCT2) (Rinholm et al., 2011). Downregulation of MCT1 expression results in a severe 
progressive neurodegeneration in the brain, but also in peripheral motor neurons, which is 
rescued by the addition of free lactate (Lee et al., 2012). Trophic support of axons is presumably 
also enabled by the physical protection of ensheathed axon from activated autoreactive T cells 
(Neumann et al., 2002), the secretion of stress-protective proteins (Krämer-Albers et al., 2007) 
and by the production of neurotrophic factors such as the glial cell-derived neurotrophic factor 
(GDNF) (Wilkins et al., 2003). In addition, SCs transfer mRNA and ribosomes to axons (Court 
et al. 2008; 2011a; Sotelo et al. 2013). Moreover, in contrast to CNS axons, peripheral nerve 
fibers are capable to regenerate after axon injury, greatly supported by SCs. Dedifferentiated 
SCs perform myelin breakdown to clear the injury sites and support axonal regeneration and 
neuronal survival before eventual remyelination (Allen and Barres, 2009; Arthur-Farraj et al., 
2012).  
 
1.4 Myelin structure  
In peripheral nerves, all axons are ensheathed by SCs and arranged within fascicles prior 
to myelination. This process of radial sorting is performed by pro-myelinating SCs that already 
attach to axons as precursor cells. They radially form bundles with subsequent separation and 
association in a 1:1 ratio with large-diameter axons for subsequent myelination. Alternatively, 
several small diameter, mainly sensory axons are segregated and ensheathed as ‘Remak 





than 1 µm in the PNS, and minimal 0.2 µm to 0.8 µm in the CNS become myelinated (Rushton, 
1951; Waxman and Bennett, 1972; Remahl and Hildebrand, 1982; Peters et al., 1991). The 
ultrastructure and qualitative lipid composition of CNS and PNS myelin sheaths is similar 
(Werner and Nave, 2005; Chrast et al., 2011). In accordance, fibers that span through the CNS 
and PNS throughout their development get sequentially myelinated by both cell types (Zalc et 
al., 2016). Nevertheless, the protein composition of CNS and PNS myelin partially differs. 
Myelin basic protein (MBP) is one of the most abundant proteins with 8 % in both, CNS and 
PNS myelin, whereas the most abundant compaction proteins are proteolipid protein (PLP) or 
myelin protein 0 (P0), respectively, making up around 20 % of total myelin protein (Jahn et al., 
2009; Patzig et al., 2011). Interestingly, P0 is the major PNS and CNS myelin protein in fish, 
implicating that P0 was replaced by PLP in the CNS just with the amphibian evolution (Patzig 
et al., 2016; Zalc et al., 2016).  
Compacted myelin membrane layers comprise a high lipid content of at least 70 % of 
dry weight, enriched in galactosphingolipids, saturated long-chain fatty acids and especially 
cholesterol with more than 25 % of total lipid (Norton and Poduslo, 1973; Baumann and Pham-
Dinh, 2001; Saher and Simons, 2010). During radial myelin growth, the innermost myelin layer 
spirally expands around the axon underneath the previously formed membrane layers with 
simultaneous longitudinal extension to the future node of Ranvier (Bunge et al., 1989; Asou et 
al., 1995). Conversely, the compaction of the sheaths starts at the outermost layer of already 
deposited myelin. This process includes tight apposition of membrane layers and extrusion of 
the cytoplasmic content. The bilipid layers of compact myelin are interconnected by mainly 
low molecular weight proteins, characterized by a slow turn-over rate (Toyama et al., 2013). 
For instance, MBP connects the cytoplasmic leaflets of two opposing membranes by 
oligomerization into a cohesive protein meshwork (Readhead et al., 1987; Uschkureit et al., 
2000; Kidd et al., 2013). Compaction at extracellular leaflets is performed by the membrane 
residing PLP and its splice isoform DM20 or P0 protein and peripheral myelin protein 22 
(PMP22), in the CNS and PNS, respectively, through interactions between their extracellular 
domains (Stoffel et al., 1984; Filbin et al., 1990; Martini et al., 1995; Shapiro et al., 1996; 
Möbius et al., 2008). This process includes expression downregulation and extrusion of large, 
negatively charged glycoproteins from these membrane areas (Aggarwal et al., 2011; Bakhti et 
al., 2013). The directionality of compaction is mediated by compaction antagonists such as the 
CNPase, which maintains the separation of single membrane layers (Gravel et al., 1996; Yin et 
al., 1997; Snaidero et al., 2014). A function of CNPase-mediated cyclic adenosine 
monophosphate (cAMP) conversion is so far not linked to this process. These non-compacted 




regions are required for ongoing myelin growth. Additional myelin-associated proteins such as 
MAG, MOG or PMP2, as well as Claudin-11, the depolymerization of F-actin and the 
membrane lipid composition presumably contribute to compaction and stability maintenance 
of myelin membranes (Chow et al., 2005; Majava et al., 2010; Aggarwal et al., 2011; 2013; 
Zalc et al., 2016). Interestingly, myelin proteins are distinctively synthesized and delivered to 
the nascent myelin sheath. MBP mRNA is transported and locally translated at glial-axonal 
contact sites. The synthesized protein subsequently diffuses back and starts to compact the outer 
myelin layers (Wake et al., 2011; Kidd et al., 2013). In contrast, PLP and the non-compaction 
protein MAG are synthesized in the endoplasmatic reticulum. After initial transport and 
incorporation into the OL cell body membrane, both proteins are internalized by endocytosis 
and targeted to late endosomes/lysosomes for subsequent delivery into the myelin sheaths 
(Simmons and Trajkovic, 2006; Winterstein et al., 2008; Mironova et al., 2016). 
The myelinated fiber is dual polarized, in radially and longitudinally distinct 
compartments (Fig. 1-3). Radial polarity spans from the abaxonal to the adaxonal membrane 
via the compacted myelin sheath. In Schwann cell-myelinated fibers, the abaxonal compartment 
is surrounded by a basal lamina and contains the nucleus. It is interrupted by periodic 
appositions, enriched in a periaxin-dystroglycan complex which connects cellular cytoskeleton 
and extracellular matrix (ECM) proteins (Sherman et al., 2012a). They delineate the cajal 
bands, cytoplasmic channels that contain ß1-integrins, and cytoskeletal proteins for interaction 
with the basal lamina (Court et al., 2004; 2011b). The compacted myelin region is interspaced 
by Schmidt-Lantermann-incisures (SLI) that retain cytoplasm and are coupled by gap junctions 
for intrasheath transport. Interconnected cytoplasmic pockets with active diffusion are also 
observed in CNS myelin (Velumian et al. 2011). The myelinic channel network provides a path 
for the helical transport of membrane, proteins and RNA, from the glia cytoplasm to the leading 
edge of myelin growth at the inner tongue and the lateral expansions. Most channels partially 
and gradually disappear when myelination is terminated. The lateral edges and SLIs remain 
open, presumably for postnatal myelin remodeling, trophic support of neurons and cross-
signaling with the axon (Berthold and Nilsson, 2002; Snaidero et al., 2014). The innermost, 
non-compacted myelin layer is connected to the axolemma through the periaxonal space by 
glial and axonal adhesion molecules such as CADM1-4 (Maurel et al., 2007; Spiegel et al., 
2007). In addition, glial receptors and their cognate axonal ligands interact through this space.  
The adaxonal site is longitudinally subdivided into nodal, paranodal, juxtaparanodal and 
internodal regions. Nodes of Ranvier are maintained by a meshwork of axonal and glial 





voltage-gated channels are anchored to the axonal cytoskeleton by AnkyrinG and ß-IV spectrins 
(Kordeli et al., 1995; Davis et al., 1996; Berghs et al., 2000; Eshed et al., 2005), presumably 
promoted by perinodal astrocytes or SC microvilli which flank CNS and PNS nodal regions, 
respectively (Saito et al., 2003).The paranodal regions are composed of closely apposed glial 
membrane loops which retain cytoplasm and represent the lateral growth edges of each myelin 
layer. Each loop contacts the axon by autotypic junctional complexes of adherens, tight and gap 
junctions (Rosenbluth, 2009; Snaidero et al., 2014), and electrically separate the juxta-
paranodal region with its axonal Kv1
+-channel clusters (Chiu and Ritchie, 1984; Rasband et al., 
1999b). Formation and maintenance of these compartments is actin- and myosin-dependent 
(Trapp et al., 1989; Fernandez-Valle et al. 1997; Wang et al. 2008).  
 
1.5 Cell signaling pathways in myelination 
Several extrinsic and intrinsic factors are transduced by canonical cell signaling 
pathways in myelinating glial cells. These are partially distinct in the different lineage stages 
and regulate the transcriptional machinery during proliferation, migration and maturation, as 
well as myelination induction, maintenance and remodeling. The basal lamina is crucial for SC 
cell polarity establishment and abaxonal membrane organization (Bunge et al., 1982; 1986; 
Court et al., 2011b). Autocrine signaling between laminins or collagens with their cognate 
Figure 1-3: Ultrastructure of a myelinated PNS fiber. Radial polarization: adaxonal membrane, 
compacted sheath, abaxonal membrane; Longitudinal polarization: Node, SC microvilli, paranodal loops, 
juxtaparanode region, internode (myelin segment); (SN) - Schwann cell nucleus; (SLI) - Schmidt-
Lantermann-Inscisure. Taken from (Salzer, 2015). 




receptors at the abaxonal membrane such as ß-integrins, activate cAMP-PKA (Protein kinase 
A) and class I phosphoinositide-3 kinase (PI3K) signaling. These pathways regulate the 
transcription of several proteins via POU-domain transcription factors and KROX20 (Howe 
and McCarthy 2000; Chernousov et al. 2008; Monk et al., 2009; Glenn and Talbot, 2013a; 
Petersen et al., 2015). In addition, downstream, the cytoskeleton-regulating proteins Rac1 and 
CDC42 are essential for axonal sorting and ensheathment (Bacon et al., 2007; Benninger et al., 
2007; Nodari et al., 2007; Chernousov et al. 2008). The formation of the basal lamina starts 
already in the pro-myelinating stage, and is likely guided by axonal signals (Bunge et al. 1982) 
In turn, axonal regeneration after injury is supported by upregulation of integrins (Salzer, 2015; 
Chang et al., 2018). In contrast to the great loss of OLs upon axonal injury, SCs ensure their 
survival by activating autocrine circuits, involving PDGF, insulin growth factor (IGF)-1 and 
neurotrophin (NT)-3 signaling (Ludwin, 1990; Jessen and Mirsky, 1999).  
Proper myelination depends to a large extent on the synergistic relationship between 
neurons and myelinating glial cells (Rushton, 1951; Matthews, 1968; Murray and Blakemore, 
1980; Waxmann, 1997). Already the maturation and proliferation of SC precursors and 
immature SCs is promoted by axonally-anchored neural cell recognition molecule-activated 
Notch1 and TGFß (transforming growth factor ß)-activated JNK (c-Jun N-terminal kinase) 
signaling with its terminal component, the transcription factor c-Jun (Hu et al., 2003; Parkinson 
et al., 2004). Both pathways are downregulated by KROX20 during myelination induction. A 
key juxtacrine signaling pathway is the activation of the adaxonal residing ErbB2/B3 homo- or 
heterodimer receptor tyrosine kinases (RTK) by the axonal transmembrane ligand NRG1-
typeIII (Brinkmann et al., 2008; Newbern and Birchmeier, 2010). In the PNS, NRG1-III 
represents the master growth factor for SC proliferation, axonal ensheathment, and myelin 
thickness (Chen et al., 1994; Morrissey et al., 1995; Michailov et al., 2004; Ogata et al., 2004; 
Taveggia et al., 2005). This multifunctional outcome is supposed to be achieved by cAMP-
mediated modulation of ErbB2/B3 signaling. Both, NRG1-III and cAMP, but not NRG1-III 
alone, are required to induce myelination in in vitro SC mono-cultures (Arthur-Farraj et al. 
2011). Axonal NRG1-III expression levels positively correlate with the myelin thickness and 
might even define the axonal fate for non- or myelinating ensheathment: Overexpression of 
NRG1-III leads to excessive myelination of large diameter axons, and even de novo myelination 
of the usually just ensheathed sympathetic axons (Michailov et al., 2004; Taveggia et al., 2005). 
Its genetic inactivation results in reduced myelin thickness and thus, hypomyelination of the 
PNS (Michailov et al. 2004; Brinkmann et al., 2008). In oligodendrocytes, expression of the 





induction is regulated by a set of different growth factors (Raff et al., 1988; Pringle et al., 1989; 
Fruttiger et al., 2000; Hu et al., 2012). For instance, Fibroblast Growth Factor (FGF) signaling 
plays a major role in mature OLs and promotes myelination (Carson et al., 1993; Furusho et 
al., 2012). In some CNS areas, NRG-overexpression results in an increased myelin thickness 
(hypermyelination) as well. Unlike the PNS, depleting NRG1 protein levels has not an overall 
CNS hypomyelination effect (Brinkmann et al., 2008; Taveggia et al., 2008).  
Transmembrane NRG1 proteins are cleaved by metalloproteases (Falls, 2003). Its 
cleavage by the α -secretase ADAM17/TACE results in inactivation whereas cleavage by the 
ß-secretase BACE1 reveals the RTK-ligand EGF (epidermal growth factor)-like domain. Thus, 
inactivation of either enzyme in mice results in PNS hyper- or hypomyelination, respectively 
(Hu et al., 2006; Willem et al., 2006; La Marca et al., 2011). NRG1 typeI and -typeII are 
released from the membrane by BACE1-cleavage and act as paracrine signals. In contrast, the 
major PNS-neuronally expressed -typeIII remains tethered to the axonal surface and activates 
ErbB2/B3 as a juxtacrine signal (Meyer et al., 1997; Taveggia et al., 2005). FGF receptors, 
PDGFRα and ErbB2/B3 are RTKs and activate PI3K/AKT, MAPK (mitogen-activated protein 
kinases MEK and ERK) and PLCy (phospholipase C) pathways, which are involved in the 
regulation of myelination in PNS and/ or CNS (Figure 1-4). In SCs, PLCy-mediated activation 
of cytosolic NFAT proteins by calcineurin induces gene transcription for axonal sorting and 
ensheathment and promotes myelination by KROX20 activation (Kao et al., 2009). PI3K/AKT 
and MEK/ERK signaling display crosstalk, for instance on the activation of mTORC1, and 
defects in either pathway lead to profound myelin impairments in vivo, reminiscent of common 
pathological features (Newbern et al., 2011; Norrmén and Suter, 2013; Furusho et al., 2017). 
Figure 1-4: Signaling pathways that control myelination in Schwann cells. (a) Electron micrograph of a 
myelinated axon in the mouse peripheral sciatic nerve, surrounded by compacted myelin sheath and Schwann 




cell cytoplasm. (b) Schwann cell myelination is regulated by different canonical pathways. It is activated 
upon (juxta-) paracrine signaling, either from the basal lamina or from axonal Neuregulin (NRG1) via glial 
receptor tyrosine kinases ErbB2/B3. Downstream, activation of PI3K/AKT or MAPK/ERK translates myelin 
promoting cues into the transcriptional activation of myelin synthesis. Rac1 and CDC42 regulate cytoskeletal 
adaptions. Taken from (Norrmén and Suter, 2013). 
 
1.5.1 mTORC1 is a central regulator of myelination 
Cells must adapt to different environmental conditions in order to ensure their survival 
by a tightly regulated metabolism. The serine/ threonine kinase mTOR (mechanistic target of 
rapamycin) is a key regulator in this process. External stimuli, such as mitogens, growth factors 
and amino acids are translated by different signaling cascades from the cell environment and 
converge at the mTOR complex 1 (mTORC1). In nutrient-rich environments mTORC1 is 
activated and promotes the synthesis of proteins, lipids and nucleotides and thereby cell growth. 
Under conditions of constrained nutrients, low oxygen or reduced energy levels, mTORC1 is 
inactivated and the minimal requirements for cell survival are achieved by upregulation of 
(macro-)autophagy, by which molecules from the cell interior are recycled. This pathway is 
conserved from yeast to human (Tatebe and Shiozaki, 2017). Higher eukaryotes contain one 
highly conserved gene for the kinase, which is present in two complexes, mTORC1 and 
mTORC2 (Sabatini et al., 1994). Raptor and the rapamycin-sensitive peptidyl-prolyl-isomerase 
FKBP12 are mTORC1 core components (Sabatini et al., 1994; Kim et al., 2002a; 2003a). 
mTORC2 includes Rictor and mSin1 (Sarbassov et al., 2004; Yang et al., 2006). mLST8 is a 
component of both complexes. In addition, PRAS40 and DEPTOR are mTORC-associated 
proteins (Sancak et al., 2007; Peterson et al., 2009).  
 
1.5.1.1 Canonical pathways that regulate mTORC1 activity 
Mitogens and growth factors, such as EGF, PDGF or IGF are sensed by RTKs at the 
plasma membrane (PM). Dimerization and autophosphorylation of the transmembrane 
receptors upon ligand binding, recruits phosphatidylinositol 3’-kinase class І (PI3K) which 
phosphorylates phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2] at the D-3 position. The 
corresponding synthesis of PI-3,4,5-trisphosphate [PI(3,4,5)P3] leads to PM-recruitment of 
PDK1 (3-phosphoinositide-dependent kinase 1) and the AGC serine/threonine kinase AKT1 
(Ak strain transforming 1) (Stephens et al., 1998; Liu et al., 2015a). In addition, the PM-
residing mTORC2 complex is activated (Ebner et al., 2017). PDK1 and mTORC2 activate AKT 
through phosphorylation at Threonin-308 and Serine-478, respectively (Sarbassov et al., 2005). 
Simultaneously, the dual protein and lipid phosphatase and tensin homolog on chromosome 10 





PI(4,5)P2 (Shenoy et al., 2012). Activated AKT phosphorylates, among several proteins 
involved in cellular pathways, the heterotrimeric tuberous sclerosis complex (TSC) component 
TSC2. It is associated in a complex with TSC1 and TBC1D7 and functions as a GAP (GTPase 
activating protein) for the small GTPase Rheb (Inoki et al., 2002). Phosphorylated TSCs 
subsequently dissociate from lysosomes and allow for Rheb-mediated facilitation of mTORC1 
activity (Sancak et al., 2010; Demetriades et al., 2014; Menon et al., 2014). In addition, RTK-
activation results in phosphorylation of the MAPK/ERK kinase (MEK) by the Raf kinase 
(Avruch et al., 2001; Zarich et al., 2006). Thereby activated ERK (extracellular signal-regulated 
kinase) inactivates TSC2 and Raptor by phosphorylation (Nishida and Gotoh, 1993; Ma et al., 
2005; Carriere et al., 2010). In contrast, AMP-activated protein kinase (AMPK) is activated by 
glucose deprivation or phosphorylation by LKB1 (liver kinase B1) during hypoxia or upon 
energy stress. The latter also activates REDD1 (regulated in DNA damage and development 1), 
and both, AMPK and REDD1 inhibit mTORC1 through activation of the TSC complex 
(Schneider et al., 2008; Mihaylova and Shaw, 2011; Han et al., 2015a).  
Amino acid (aa) stimulation is crucial for the recruitment of mTORC1 to late 
endosomol/ lysosomal (LE/ Lys) membranes through the heterodimer of four Ras-related 
GTPases (Rag) A to D (Sancak et al., 2010). GTP-bound RagA or -B form active complexes 
with GDP-bound RagC or –D, that directly bind the mTORC1-component Raptor (Sancak et 
al., 2008). Rags are activated by the lysosomal residing pentameric Ragulator complex that 
functions as a GEF (guanine nucleotide exchange factor) for RagA/B, and inhibited by the GAP 
complex GATOR1 (Sancak et al., 2008; 2010; Bar-Peled et al., 2012;). The availability of aa 
is translated to mTORC1 by cytosolic sensors (Sestrin2, Castor1 and Samtor) which inhibit the 
Rag-GAP complex GATOR1 at the lysosomal compartment directly or indirectly, and thereby 
enable the activation of the Rag pentamer (Bar-Peled et al., 2013; Wolfson et al., 2015; 2017; 
Chantranupong et al., 2016; Gu et al., 2017). These sensors are activated upon aa-import by 
membrane residing aa-transporters or lysosomal aa-export upon protein degradation (Taylor et 
al., 2013). In addition, the lysosomal residing amino acid exporter SLC38A9 displays a 
conformational change upon arginine sensing that results in a weaker interaction with Ragulator 
and thus, increases the GEF-activity of the latter (Zoncu et al., 2011; Bar-Peled et al., 2012; 
Wang et al., 2015; Rebsamen et al., 2015).  
 
1.5.1.2 Regulation of mTORC1 activity by PI(3)-phosphates 
The major PI(3)P synthesizing enzyme class III PI3 Kinase VPS34 (vacuolar protein 
sorting complex 34), which produces around 65 % of cellular PI(3)P (Volinia et al., 1995; 




Devereaux et al., 2013) is strongly implicated in mTORC1 activation. Overexpression or 
siRNA-mediated depletion of VPS34 results in TSC-independent increased or reduced 
mTORC1 activity, respectively. In turn, increased VPS34 activity was observed upon amino 
acid stimulation or glucose-mediated inhibition of AMPK (Byfield et al., 2005; Nobukuni et 
al., 2005). In mouse fibroblasts (MEF) from VPS34 knockout (KO) animals, aa-stimulated 
mTORC1 activity is markedly decreased (Jaber et al., 2012). This mechanism might be 
mediated by the PI3P-dependent lysosomal translocation and activation of Phoshpolipase D 
(PLD) (Yoon et al., 2011). PLD hydrolizes phosphatidylcholine (PC) to phosphatic acid (PA). 
This is presumed to facilitate the recruitment of mTORC1 through binding of FKBP12 to PA 
(Fang et al., 2001; 2003; Xu et al., 2011; Yoon et al., 2011). In addition, the intracellular leucyl-
tRNA synthetase (LRS), which activates mTORC1 through its GAP activity towards RagC/D, 
directly binds to and activates VPS34 (Han et al., 2012; Yoon et al., 2016). VPS34 is only 
functional as a heterodimer with its myristorylated regulatory subunit p150 (VPS15), a 
threonine/serine kinase that modulates the activity of VPS34 (Panaretou et al., 1997). This 
dimer forms the core of two complexes: Autophagic VPS34 complex Ӏ (VPS34, VPS15, 
Beclin1/ATG6 , ATG14L and NRBF2) and endosomal VPS34-complex II (VPS34, VPS15, 
Beclin1 and UVRAG) (Cao et al., 2014). Under low energy conditions or upon glucose 
starvation when mTORC1 is downregulated, AMPK-mediated phosphorylation inhibits the 
endosomal VPS34-complex II as well (Kim et al., 2013a). Lysosomal PI(3)P is also reported 
as a recruitment factor for the Kinesin-1-, Protrudin- and FYCO1-machinery which mediates 
lysosomal positioning. In this process lysosomes are translocated to the cell periphery upon 
amino acid stimulation (Wullschleger et al., 2006; Korolchuk et al., 2011; Raiborg et al., 2015; 
Hong et al., 2017). PI(3,5)P2, the product of PI(3)P phosphorylation at the D-5 position by 
PI(3)-phosphate 5-kinase type III PIKfyve (Fab1 in yeast), is directly linked to mTORC1 
activation as well (Sbrissa et al., 1999; Zolov et al., 2012; Bridges et al., 2012). PIKfyve-
depleted adipocytes display decreased mTORC1 activity upon amino acid and insulin 
stimulation, but independent of AKT activation. In addition, elevated mTORC1 activity was 
observed when cells were directly supplemented with PI(3,5)P2. As causative, the authors 
identified PI(3,5)P2-mediated recruitment of Raptor (Bridges et al., 2012). This finding was 
later confirmed in yeast for the Raptor-homologue Kog1 (Jin et al., 2014). PIKfyve is associated 
in a complex with the PI(3,5)P2 D-5-phosphatase Fig4 (Vac7 in yeast), scaffolded by Vac14 
(Jin et al., 2008; McCartney et al., 2014). Disruption of the complex by removing either of the 
components results in decreased cellular PI(3,5)P2 levels (Mironova et al., 2016). This approach 





mTORC1. In addition, the authors reported a PI(3,5)P2-dependent recruitment of the mTORC1 
target Sch9, the yeast homologue of the serine/threonine protein kinase p70 S6 Kinase 1 (S6K) 
(Jin et al., 2014). Conversely, PI(3,4)P2, synthesized by the late endosomal/ lysosomal class II 
PI3-kinase type C2ß has been shown to locally repress mTORC1 activity in response to growth 
factor starvation (Marat et al., 2017). 
 
1.5.1.3 mTORC1 controls the metabolic switch of cells  
The activation status of mTORC1 represents the main switch between anabolism and 
catabolism of the cell (Fig. 1-5). Upon activation, mTORC1 phosphorylates the eukaryotic 
translation initiating factor (eIF) 4E-binding protein 1 (4E-BP1) and S6K (Threonine-389). The 
complex thereby activates global mRNA translation, and especially translation of the highly 
eIF4E-sensitive transcripts, which encode for proliferation- and cell survival-regulatory 
proteins (Gingras et al., 1999; Holz et al., 2005; Csibi et al., 2014; Nandagopal and Roux, 
2015). The translation of 5’-terminal oligopyrimidine (TOP) mRNAs is specifically dependent 
in an all-or-none fashion on mTORC1 activity. These mRNAs encode ribosomal proteins, 
elongation factors and polypyrimidines (Jefferies et al., 1994; Avni et al., 1997; Meyuhas, 
2000). In addition, S6K phosphorylates the 40s ribosomal protein S6 (S6), which is especially 
involved in the translation of cell size-regulating genes (Fumagalli and Thomas, 2000; 
Ruvinsky et al., 2005). SREBPs are important transcription factors for lipid, fatty acid and 
cholesterol synthesis, and activated by mTORC1-dependent phosphorylation of S6K and lipin1 
(Porstmann et al., 2008; Düvel et al., 2010; Li et al., 2010; Peterson et al., 2011). mTORC1 
also promotes trafficking and maturation of SREBPs by phosphorylation of the SREBP-
inhibitor CRTC2 (Han et al., 2015b). Simultaneously, mTORC1 inhibits autophagy by 
phosphorylation of the autophagy-initiation complex ULK1/Atg13/FIP200 (Hosokawa et al., 
2009; Jung et al., 2009). Moreover, the phosphorylation of TFEB (transcription factor EB), a 
master regulator of gene expression for lysosomal and autophagosomal proteins, prevents its 
translocation to the nucleus (Settembre et al., 2011; Martina et al., 2012).  
Finally, mTORC1 elicits negative feedback loops that ensure its transient activation. 
S6K directly inhibits the mTORC2 components Rictor and mSin1 by phosphorylation (Julien 
et al., 2010; Liu et al., 2013). S6K and growth factor receptor bound protein 10 (Grb10) inhibit 
the interaction of insulin receptor substrate 1 (IRS1) with the insulin receptor (IR) upstream of 
mTORC1 (Harrington et al., 2004; Hsu et al., 2011). In contrast, S6K promotes mTORC1 
activity by phosphorylation at Serin-2448 in a positive feedback loop (Chiang and Abraham, 
2005; Copp et al., 2009; Rosner et al., 2010).  





Figure 1-5: Regulation of mTORC1 activity. mTORC1 is recruited to lysosomes upon amino acid 
stimulation by Rag-complexes. Its activity is facilitated by growth factor stimulation via PI3K/AKT or 
MAPK/ERK. The complex promotes synthesis of lipids and proteins and thus cell growth. Under conditions 
of growth factor or amino acid deprivation, mTORC1 activity is downregulated by TSC complexes. During 
hypoxia or energy depletion, AMPK and REDD1 mediate mTORC1 inhibition and thus promote autophagy 
and lysosomal biogenesis. LE/Lys – late endosomal/ lysosomal compartment. Modified from (Kim et al., 
2013b). 
 
1.5.1.4 Altered mTORC1 activity leads to impaired myelin homeostasis  
The first indications for an essential regulation of the myelin homeostasis by mTORC1 
were just reported around one decade ago. Overactivation of PI3K/AKT in OLs by expression 
of constitutively active AKT(CA) or depletion of PTEN in vivo, results in radial 
hypermyelination, thus an increase in the myelin sheath thickness in the CNS (Flores et al., 
2008; Goebbels et al., 2010). In the transgenic AKT(CA) mice, this phenotype, accompanied 
by an increase in myelin protein levels, was traced back to elevated mTORC1 activity as the 
only altered AKT-target in these mutants, and was ameliorated by Rapamycin-mediated 
mTORC1 inhibition (Narayanan et al., 2009). In turn, application of rapamycin or knockdown 
of mTOR in OL cultures leads to reduced myelination in vitro (Tyler et al., 2009). In vivo, 
Rapamycin treatment results in an altered expression of a cohort of transcripts, including 
transcription factors for differentiation, myelin lipid synthesis enzymes and major myelin 





phosphorylation site S-2448, positively correlates with the extent of CNS myelination in vivo 
(Tyler et al., 2009). In the PNS, mTORC1 activation is mainly observed downstream to 
adaxonal NRG1-ErbB2/B3 signaling (Heller et al., 2014). In contrast to the CNS, the first 
studies that investigated knockout of PTEN in SCs in vivo reported radial hypermyelination for 
small diameter (< 2 µm) fibers only (Goebbels et al., 2010; 2012). In addition, and more 
pronounced than in the CNS, aberrantly myelinated nerve fibers were observed. These fibers 
were characterized by focal sausage-like thickening of the myelin sheath (‘tomacula’) and 
myelin outfoldings at paranodal regions. These features, referred to as focal hypermyelination, 
could be rescued by rapamycin treatment as well (Goebbels et al., 2012). The authors claimed 
striking similarities of the myelin morphology to two forms of human neuropathies with focal 
hypermyelination, Charcot-Marie-Tooth (CMT) disease type 4B and Hereditary Neuropathy 
with liability to pressure palsies (HNPP). In turn, the depletion of mTOR in vivo causes 
hypomyelination in the CNS as well as in the PNS (Sherman et al., 2012b; Wahl et al., 2014). 
In three independent following studies, the crucial involvement of mTORC1 in myelination, 
with only minor contribution of mTORC2, was revealed by the specific ablation of Rictor or 
Raptor in vivo (Bercury et al., 2014; Lebrun-Julien et al., 2014; Norrmén et al., 2014). 
Transgenic mice depleted of Raptor display severe hypomyelination in CNS and PNS. 
Furthermore, lower levels of SREBPs and their targets, the fatty acid synthase, stearolyl-CoA 
desaturase-1, 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) and 
isopentenyldiphosphate delta isomerase 1(IDI1) were observed. In addition, Raptor depletion 
results in reduced levels of cholestorol, nonessential fatty acids, phosphatidylcholine, ceramide, 
sphingomyelin, glycosylceramide, phosphatidylethanolamine and phosphatidylinositol, in the 
spinal cord and sciatic nerves (Lebrun-Julien et al., 2014; Norrmén et al., 2014). These findings 
revealed mTORC1 as crucially implicated in the regulation of the myelin lipid production in 
both, the CNS and PNS (Lebrun-Julien et al., 2014; Norrmén et al., 2014). Furthermore, the 
expression of major myelin proteins is markedly downregulated in these mice. Raptor depletion 
in the CNS results in a reduction of mRNA and protein levels of MAG, MOG, PLP and CNP 
(Bercury et al., 2014; Lebrun-Julien et al., 2014). For MBP, mainly protein levels are reduced, 
suggesting a distinct effect on MBP translation. In the PNS, reduced MBP and P0 protein but 
not MAG protein levels were reported (Norrmén et al., 2014). 
Most recent studies indicate a more complex function of mTORC1 in the PNS than 
promoting myelinogenesis only. Hyperactivation of mTORC1 is observed to have dosage- and 
time-dependent effects (Beirowski et al., 2017; Figlia et al., 2017; Jiang et al., 2018). In the 
PNS, strong hyperactivation of mTORC1 in TSC2 KOSC mice results in hypo- instead of 




hypermyelination. In contrast, TSC1 KOSC mice display an initial delay in the myelination 
onset, followed by focal hypermyelination of PNS fibers (Beirowski et al., 2017). mTORC1 
activity is more modestly increased upon TSC1 depletion, due to destabilized but not abolished 
TSC2 GAP activity (Zeng et al., 2011). Thus, this contrasting outcome was interpreted as a 
dosage-dependent effect, resulting from the promoting function of mTORC1 in the proliferation 
of precursor and immature Schwann cells. The complex inhibits the cell cycle exit in different 
cell types by the indirect repression of the cyclin dependent kinase (CdK)-inhibitor p27kip1 
(Hong et al., 2008; Ji et al., 2012; Ke et al., 2016; Beirowski et al., 2017). In agreement with a 
thus presumed time-dependent effect of mTORC1 elevation, the early ablation of TSC1 KOSC 
using a Desert hedge hoc (Dhh)-controlled Cre recombinase (Jiang et al., 2018) instead of a P0-
controlled one (Beirowski et al., 2017), expressed at E12 and E13.5, respectively, leads to 
sustained hypomyelination similar to TSC2 KOSC nerves. The authors also observed an 
upregulation of the polo-like kinase (PLK) that promotes the G2/M transition during cell cycle 
progression (Jiang et al., 2018). In addition, mTORC1 was reported to indirectly inhibit 
KROX20 through S6K and thereby the onset of myelination, thus mTORC1 activity needs to 
be repressed in promyelinating Schwann cells to allow for proper myelination (Figlia et al., 
2017). In turn, the SC-specific conditional ablation of PTEN or TSC1 in adult mice using 
tamoxifen induction, causes not only focal but also radial hypermyelination (Figlia et al., 2017; 
Jiang et al., 2018), reminiscent of the myelin promoting function of mTORC1 observed in the 
CNS. Why elevated mTORC1 activity leads to focal hypermyelination is equally unknown as 
the underlying molecular mechanisms of the formation of these aberrant myelin features. 
mTORC1-independent targets downstream to PTEN and AKT, such as PI(3,4,5)P3 or Rac1, 
respectively, are suggested to contribute to radial hypermyelination (Goebbels et al., 2012; 
Snaidero et al., 2014; Domenech-Estevez et al., 2016). In the CNS, mTORC1 activation 
mediated by MAPK/ERK signaling downstream of fibroblast growth factor receptor 2 
(FGFR2), was recently postulated to increase myelin thickness independent of the PI3K/AKT 
pathway (Ishii et al., 2013; Furusho et al., 2017). In the PNS, ERK overactivation results not 
only in mTORC1 hyperactivation and focal hypermyelination but also radial hypermyelination, 
which was partially assigned to mTORC1 independent targets of ERK (Sheean et al., 2014).  
 
1.6 Myelin in pathological conditions 
Impaired myelin homeostasis in the CNS leads to common neurodegenerative diseases 
such as Multiple Sclerosis and leukodystrophies, but also to psychiatric disorders as 





proteins are associated with the heterogeneous group of inherited neuropathies including 
Charcot-Marie tooth disease (CMT) (Berger et al., 2006a; Pareyson et al., 2017). CMT diseases 
result from mutations in more than 80 different genes known to date, and represent the most 
commonly inherited neuropathy with a current estimation of 10 to 28 affected individuals per 
100.000 (Skre, 1974; Saporta et al., 2014; Pareyson et al., 2017). These neuropathies mostly 
result in neuronal degeneration and are characterized by progressive muscle weakness and 
atrophy of the distal extremities, often accompanied by a sensory loss (Berger et al., 2006a; 
Saporta et al., 2014). According to the classical system, CMT disease types are categorized 
depending on the primarily affected cell type into demyelinating (type I; CMT1-like) or axonal 
(type II; CMT2-like) neuropathies, with nerve conduction velocity (NCVs) below or above 38 
m/s, respectively (Reilly et al., 2011). Autosomal dominant demyelinating CMT1 subtypes 
result from gene duplications of the myelin protein PMP22 (CMT1A), or mutations in the 
myelin compaction protein P0 (CMT1B), the transcription factor KROX20 (CMT1D) or the 
X-linked gap junction beta-1 gene/Connexin32 (GJB1; CMTX1) (Warner et al., 1998; Pareyson 
et al., 2017). The CMT4 subgroup comprises demyelinating neuropathies that are inherited in 
an autosomal recessive fashion and characterized by an early onset during childhood (Baets et 
al., 2011). These types are caused by mutations in the scaffolding protein Periaxin (CMT4F), 
the adaptor protein SH3TC2 (SH3 Domain And Tetratricopeptide Repeats 2; CMT4C), the 
CDC42-GEF Frabin/FDG4 (CMT4H) or MTMR proteins (CMT4B) (Harding and Thomas, 
1980; Baets et al., 2011; El-Abassi et al., 2014). Myelin outfoldings are a hallmark of CMT4B, 
but can also be observed in CMT4F and CMT4H, as well as in HNPP, caused by haplo-
insufficiency of PMP22 (Adlkofer et al, 1997; Guilbot et al., 2001; Azzedine et al., 2003; 
Senderek et al., 2003; Nave et al., 2007; Stendel et al., 2007; Nakhro et al. 2013). The 
appearance of myelin outfoldings is also reported from young animals as part of the developing 
sheath formation in CNS and PNS, but the underlying molecular mechanism remains elusive 
(Berthold and Nilsson, 2002; Bolino et al., 2004; Goebbels et al., 2012). Interestingly, different 
CMT-disease subtypes are caused by mutations in genes that are associated with PIs, the major 
signaling lipids of endomembrane trafficking. Mutations in the lipid-binding PH (pleckstrin 
homology) domain of the fission GTPase Dynamin-2 underly dominant intermediate CMT (DI-
CMT), and the CMT4H-related GEF Frabin also harbors PH- and FYVE-lipid binding domains 
(McNiven, 2005; Zuchner et al., 2005; Delague et al., 2007; Stendel et al., 2007). Intriguingly, 
CMT4B and CMT4J are caused by mutations in enzymes that are directly implicated in PI(3)-
phosphate lipid conversion, suggesting a significant role of the signaling lipids PI(3)P, 
PI(3,5)P2 and presumably also PI(5)P in myelination and axonal maintenance (Fig. 1-6) (Suter, 




2007; Vaccari et al., 2011; Mironova et al., 2016). Loss of function mutations in the PI(3,5)P2 
5-phosphatase Fig4/Sac3 results primarily in axonal degeneration in both, PNS and CNS, but 
is accompanied by thinly myelinated fibers (Chow et al., 2007; Sbrissa et al., 2007). CMT4B 
comprises three disorder subtypes that are caused by mutations in myotubularin-related PI 
phosphatase (MTMR)-proteins, that specifically hydrolyze PI(3)P and PI(3,5)P2 at the D-3 
position (Senderek et al., 2003; Nakhro et al., 2013; Bolino et al., 2014).  
 
 
1.6.1 Myotubularins are crucially involved in myelination 
1.6.1.1 The family of myotubularin-related lipid phosphatases 
Myotubularin-related lipid phosphatases (MTMRs) are a conserved family of multi-domain 
proteins that dephosphorylate the phosphatidylinositol ring of PI-phosphates at the D-3 position 
with a specificity towards PI(3)P and PI(3,5)P2 in vitro (Blondeau et al., 2000; Taylor et al., 
2000; Schaletzky et al., 2003; Tronchére et al., 2004). In human, the family includes fifteen 
members: myotubularin 1 (MTM1) and MTMR1 to MTMR14. Nine of these, MTM1, MTMR1 
to -R4 and MTMR6 to -R8 as well as MTMR14/JUMPY, contain a catalytically active protein 
tyrosine phosphatase (PTP) domain, characterized by an invariant PTP active site motif C(X)5R 
(Alonso et al., 2004). MTMR5(Sbf1), -R9 and -R10 to -R13(Sbf2) are pseudophosphatases that 
contain an inactive PTP domain with substitutions of the conserved cysteine and arginine 
residues in its catalytic site (Robinson and Dixon, 2006).  
Except for MTMR14, all family members contain a PH -glucosyltransferase, Rab-like 
GTPase activator and myotubularin (PH-GRAM) domain and a coiled-coil (CC) region, N-
terminal and C-terminal to the PTP-domain, respectively (Figure 1-7). The PH-GRAM domain 
mediates binding to PI(3,5)P2 and PI(5)P in vitro (Berger et al., 2003; Schaletzky et al., 2003; 
Tsujita et al., 2004), while the CC region is required for homo- and hetero-oligomerization 
(Berger et al., 2006b; Zou et al., 2009; 2012). Additional domains are found in closely related 
MTMRs, such as a C-terminal PDZ (protein-binding PSD95, Dlg-1, Zo-1)-domain in MTM1, 
Figure 1-6: Interconversion of PI(3)P, 
PI(3,5)P2 and PI(5)P. PI(3)P is synthesized 
from PI by class II and III PI-3 Kinases. It 
serves as the only known precursor for 
PI(3,5)P2 production by PIKfyve, which is 
associated in a complex with the 5‘-
phosphatase Fig4. MTMR proteins are 3‘-
phosphatases with a preference for PI(3)P 
and PI(3,5)P2. PI – phosphatidylinositol. 
Modified from (Di Paolo and De Camilli, 





-R1 and –R2, a FYVE (Fab1, YO1B, Vac and EEA1) in MTMR3 and -R4, or PH and DENN 
(differentially expressed in neoplastic versus normal cells) domains in MTMR5 and -R13 
(Isakoff et al., 1998; Lorenzo et al., 2005; Berger et al., 2006b). MTMR pseudophosphatases 
have a main function in the recruitment and activity modulation of active MTMR phosphatases. 
The complex formation between an inactive and an active MTMR is mediated by the CC region 
(Berger et al., 2006b), and results in increased catalytic activity, elevated substrate specificity 
and altered localization of the latter. This is reported for MTMR6, –R7, and –R8, each forming 
a complex with MTMR9 (Mochizuki and Majerus, 2003; Zou et al., 2009, 2012), MTM1 that 
oligomerizes with MTMR12 (Caldwell et al., 1991), and MTMR2 which associates with 
MTMR5 or MTMR13 (Kim et al., 2003b; Berger et al., 2006b). 
 
Figure 1-7: Myotubularin-related (MTMR) protein domain structures. PH – pleckstrin homology; 
GRAM - glycosyltransferase, Rab-like GTPase activator and myotubularin; PTP – protein tyrosine 
phosphatase; CC – coiled-coil region; PDZ-BD - PSD-95/Dlg-1/ZO1-binding domain; DENN - differentially 
expressed in neoplastic versus normal cells; FYVE - Fab1, YOTB, Vac1, EEA1 domain. Taken from (Bolis 
et al., 2007).  
 
As regulators of the signaling PI lipids which serve as hallmarks of intracellular membrane 
identities, MTMR proteins are mainly involved in endomembrane trafficking. Despite of their 
common substrate specificity towards PI(3)P and PI(3,5)P2, some members are reported to 
regulate the lipid pool on distinct compartments (Fig. 1-8). PI(3)P and PI(3,5)P2 are sequential 
key players of the endo-lysosomal pathway. PI(3)P, mainly generated by VPS34 with 
contributions of class II PI3K, is the major lipid at early or recycling endosomal membranes, 




where endocytosed cargo is sorted, either for recycling back to the plasma membrane or into 
the lysosomal pathway for degradation (Mayinger, 2012). PI(3)P-dependent formation of and 
cargo sorting into intraluminal vesicles (ILV), as well as the partial conversion of PI(3)P into 
PI(3,5)P2 mediated by PIKfyve, is required for the maturation of endosomes into late endosomal 
multi-vesicular bodies (MVBs) and their eventual fusion with lysosomes (Raiborg et al., 2013; 
Sbrissa et al., 1999; Zolov et al., 2012). In addition, PI(3)P is synthesized on autophagosomal 
membranes and crucial for their maturation and eventual fusion with lysosomes (Taguchi-
Atarashi et al., 2010; Cebollero et al., 2012; Wu et al., 2014).  
Figure 1-8: PI(3)-phosphates and metabolizing enzymes in endomembrane trafficking. 
Schematic overview of the localization of PI(3)-phosphates (rectangle) and their converting phosphatases 
(oval) and kinases (rounded rectangle). PI(3,4,5)P3 is produced upon RTK-activation at the plasma 
membrane. Receptors or other cargo are internalized in endocytic compartments whose maturation and fusion 
with endosomes requires the conversion from plasma membranous PI(3,4)P2 into PI(3)P. Upon endosomal 
sorting, receptors are either recycled back to the PM after ligand dissociation, as the transferrin receptor 
(TfR), or directed into the lysosomal degradation pathway, as the EGF receptor (EGFR). PI(3)P is partially 
converted into PI(3,5)P2 by PIKfyve during the maturation of early into late endosomal MVBs and their 
eventual fusion with lysosomes. PI(3)P production is also required for the formation and maturation of 
autophagosomes, which eventually fuse with lysosomes, and trafficking from and to the trans-golgi network. 
MVB – multi vesicular body; CCV/ CCP – Clathrin-coated vesicle/ pit. Modified from (Marat and Haucke, 





MTM1 and MTMR4 are observed on early and recycling endosomes (Lorenzo et al., 
2006; Cao et al., 2007; Naughtin et al., 2010; Ketel et al., 2017), MTMR2 and -R5 on late 
endosomes (Berger et al., 2003; Kim et al., 2003b). MTMR14 and MTMR3 localize to 
autophagosomal structures (Vergne et al., 2009; Taguchi-Atarashi et al., 2010) and MTMR7 
partially to golgi-like granules (Mochizuki and Majerus, 2003). The complex MTMR6/-R9 acts 
in negative regulation of apoptosis by controlling PI(3,5)P2 levels, while the MTMR8/-R9 
complex is a negative regulator of autophagy by dephosphorylation of PI(3)P (Zou et al., 2009; 
2012). MTM1 and MTMR2 are observed to act sequentially in the endolysosomal system. 
MTM1 hydrolizes PI(3)P at early endosomes (Rab5-positive), MTMR2 at late endosomes 
(Rab7-positive) (Cao et al., 2007, 2008). Finally, though MTMRs are ubiquitously expressed 
(Laporte et al., 1998), a distinct tissue enrichment is observed for some family members. A 2.4 
kbp MTM1 transcript is found in muscle tissue and testis only, and its loss results in the severe 
muscle disease X-linked centronuclear myopathy (XLCNM) (Laporte et al., 1996; 1998; Tosch 
et al., 2006). MTMR2 enrichment in neurons and Schwann cells was reported, and its mutations 
result in the severe neuropathy CMT4B1 (Berger et al., 2002; Bolino et al., 2002; 2004).  
 
1.6.1.2 CMT-associated MTMRs 
Mutations in MTMR2 or its alternating complex partners MTMR13 and MTMR5 cause 
CMT4B1, -B2 or –B3, respectively. The common pathology in human patients is a severe 
demyelinating peripheral neuropathy with an early onset during childhood. It is caused by 
defects in the Schwann cell myelin homeostasis and characterized by focally folded myelin 
sheaths at paranodal regions (Senderek et al., 2003, Bolino et al., 2004; Nakhro et al., 2013). 
Death can occur already in the fourth to fifth decade mainly due to respiratory failure (Quattrone 
et al., 1996). In addition, azoospermia is found in CMT4B3 patients and one -B1 case, as well 
as in the corresponding mouse models (Firestein et al., 2002; Laporte et al., 2003; Bolino et al., 
2004; Bohlega et al., 2011), and glaucoma in 50 % of all CMT4B2 and -B3 cases (Bird, 1998; 
Hirano et al., 2004). In CMT4B3 patients, impairments of the CNS, such as cerebellar or brain 
atrophies, cognitive defects or intellectual disabilities are reported. Finally, MTMR5 mutations 
can also lead to axonal neuropathy and the fork and bracket syndrome, characterized by 
degenerated fiber bundles in facial and oculomotoric nerves (Alazami et al., 2014; Romani et 
al., 2016; Manole et al., 2017).  
MTMR proteins are highly conserved. Human and mice homologues confer sequence 
identities greater than 90 %. In accordance, MTMR2 and MTMR13 KO mice display a 
demyelinating neuropathy, though in a milder form than humans, with a late axonal loss (Bolino 




et al., 2004; Tersar et al., 2007; Ng et al., 2013). MTMR5 KO mice are characterized by 
azoospermia only (Firestein et al., 2002). MTMR2 is the closest related to the active 
phosphatases MTMR1 and MTM1, with a sequence identity of 69.7 % and 63.4 %, 
respectively. MTMR13 and MTMR5 are most closely related with 59 % sequence identity. 
Similar to MTM1 in XLCNM, MTMR2 disease-related truncation or missense mutations are 
mainly located in evolutionary highly conserved residues in the PTP- and PH-GRAM domain, 
thus abolishing specifically the phosphatase activity and the presumed ability to bind to lipids 
(Laporte et al., 1997; 1998; Taylor et al., 2000; Berger et al., 2002; Tsujita et al., 2004; 
Goryunov et al., 2008). In accordance, disrupting the complex Fig4-Vac14-PIKfyve, which 
leads to reduced levels of PI(3,5)P2, can ameliorate the phenotype of MTMR2 loss. Fig4 
heterozygosity rescues myelin outfoldings in MTMR2 KO mouse in vivo, and PIKfyve 
depletion rescues myelin outfoldings in vitro (Vaccari et al., 2011). Reports about the 
endogeneous localization of MTMRs are rare due to the limited availability of functional 
antibodies. MTMR2 was detected in the cytosol of neurons, axons and in Schwann cell 
cytoplasm, such as the SC perinuclear region, paranodes and SLIs. Here, it is partially localized 
to punctate, presumably endo-/ lysosomal structures (Previtali et al., 2003; 2007; Ng et al., 
2013). Despite of the general lipid binding ability of MTMR2 by its PH-GRAM domain, its 
recruitment to endomembranes is rather not constitutive but regulated, for instance by complex 
formation. Upon overexpression, MTMR2 is diffusively localized in the cytoplasm, with partial 
enrichment in the perinuclear region. The latter is more frequently observed upon co-expression 
with MTMR5 or MTMR13 (Laporte et al., 2002; Berger et al., 2003; Kim et al., 2002b; 2003b; 
Robinson and Dixon, 2006). Despite both pseudophosphatases contain the additional lipid-
binding PH-domain at the C-terminus, it was shown to be dispensable for the membrane 
association of MTMR5 (Kim et al., 2003b). Instead, in membrane fractionation experiments 
the inactive PTP domain was sufficient to associate MTMR13 with membrane fractions 
(Robinson and Dixon, 2006). In addition, delocalization of MTMR2 from the cytoplasm 
towards vacuolar membranes was observed upon hypoosmotic shock in COS7 cells, a condition 
in which PI(3,5)P2 levels are increased (Berger et al., 2003). However, MTMR2 is also reported 
to regulate a late endosomal PI(3)P pool (Cao et al., 2008). In vitro experiments showed that 
complex formation with MTMR2 results in a 4.6-fold increase of its specificity towards PI(3)P 
and 3.4-fold towards PI(3,5)P2 when MTMR5 is bound (Kim et al., 2003b), or a 10-fold 
increase to PI(3)P and 25-fold to PI(3,5)P2 when MTMR13 is bound (Berger et al., 2006b). 
Furthermore, a strong interdependence between MTMR2 and MTMR13 is observed in vivo, in 





al., 2009; 2012; Gupta et al., 2013; Ng et al., 2013). A functional interaction of the complex 
partners was recently demonstrated in D. melanogaster. Sbf, the fly homologue of MTMR5 and 
MTMR13, recruits mtm, the single homologue of mammalian MTM1, MTMR1 and -R2, to 
regulate a class II PI-3 Kinase (PI3KC2)-dependent PI(3)P pool during endosomal trafficking 
and macrophage protrusion formation (Velichkova et al., 2010; Jean et al., 2012). The latter 
process also implies Rab21 recruitment and activation by Sbf via its N-terminal DENN domain 
(Jean et al., 2012). This interaction, as demonstrated later by the same group also in human 
cells, mediates autophagosome to lysosome fusion (Jean et al., 2015). In a screen for potential 
Rab-protein interactors in D. melanogaster, Sbf was detected in association with another small 
GTPase, Rab35 (Gillingham et al., 2014).  
In neuronal postsynapses, MTMR2 was reported to interact with PSD95 via its PDZ 
domain and represses endocytosis of the AMPA-receptor subunit GluA2 (Lee et al., 2010). In 
axons, MTMR2 interacts with the axonal neurofilament light chain (NF-L), a protein that causes 
the axonal neuropathy CMT2E (Previtali et al., 2003). Though no changes in NF-L protein 
levels could be observed in CMT4B patients, this interaction might contribute to the severe 
axonal loss in humans (Previtali et al., 2003). Electron microscopic analysis of MTMR2 and 
MTMR13 KO mice nerve fibers reveal intact adherens junctions at paranodal loops as well as 
functional axo-glial junctions between neuronal axolemma and Schwann cell membrane 
(Bolino et al., 2004; Robinson et al., 2008). MTMR2-mediated repression of membrane 
addition through its interaction with the scaffolding protein Dlg-1 (discs large homolog 1) was 
recently proposed to underly the CMT4B phenotype (Bolis et al., 2005; 2009). Dlg-1 belongs 
to the MAGUK family (membrane-associated guanylate kinase-like) and links transmembrane 
proteins with the intracellular cytoskeleton. It is located at paranodal loops and SLIs in Schwann 
cells (Bolino et al., 2004; Bolis et al., 2005; 2009). Interestingly, Dlg-1 also activates PTEN in 
SCs, which represses PI3K/AKT activity and thereby excessive myelin growth (Cotter et al., 
2010). In contrast to this indirect connection to PTEN, overexpression of MTMR2 was recently 
reported to lead to sustained AKT or ERK activation (Berger et al., 2011; Franklin et al., 2011). 
Nevertheless, MTMR2 or MTMR13 KO mice do not display altered levels of either 
phosphorylated AKT or ERK (Ng et al., 2013; Bolino et al., 2016). Despite of that, myelin 
outfoldings in the absence of MTMR2 could be ameliorated in vitro and in vivo by 
downregulation of Nrg1-III/ErbB receptor signaling through facilitation of the inactivating α-
secretase TACE (Bolino et al., 2016). However, the underlying molecular mechanism is not 
elucidated so far. 
 




1.7 The small GTPase Rab35 is implicated in myelination 
Rab (Ras-related protein in brain; Touchot et al. 1987) GTPases (GTP hydrolases) make 
up the largest branch of small monomeric GTPases of the Ras superfamily, besides the Ras, 
Rho, Arf and Ran subfamilies, with 11 different proteins identified in yeast and more than 60 
Rabs that are encoded in the human genome (Klöpper et al., 2012). Similar to PIs, they represent 
essential molecular switches in intracellular membrane trafficking and vesicular transport by 
serving as a platform for effector proteins involved in membrane tethering, fusion, fission and 
cell signaling (Zerial and McBride; 2001; Rink et al., 2005; Grosshans et al., 2006). Rab 
GTPases are characterized by a prenylated C-terminal amphipathic helix, which is inserted into 
the bilipid layers of membranes upon activation (Ghomashchi et al., 1995). Inactive, guanosine 
nucleotide diphosphate (GDP)-bound Rab proteins are kept soluble in the cytosol by Rab-GDP 
dissociation inhibitors (Rab-GDIs). Their recruitment to the respective membrane compartment 
is mediated by Guanine nucleotide exchange factors (GEFs). These enzymes facilitate the 
replacement of GDP for guanosine triphosphate (GTP) in the Ras-typical globular domain, 
which induces a conformational change. Thereby, the disordered switch I and II regions become 
stabilized and highly organized, and thus, allow for interaction and recruitment of effector 
proteins (Barr and Lambright, 2010; Blümer et al., 2013). Eventually, GTPase activating 
proteins (GAPs) promote the Rab-catalytic activity to hydrolyze GTP, which results in Rab 
protein inactivation and is followed by its GDI-mediated membrane dissociation (Fig. 1-9) 
(Milburn et al., 1990; Sasaki et al., 1990; Pylypenko et al., 2006; Wu et al., 2007; Wittinghofer 
and Vetter, 2011). Rab GAPs and GEFs are characterized by TBC (Tre2/Bub2/Cdc16) and 
DENN-domains, respectively (Barr and Lambright, 2010; Yoshimura et al., 2010).  
 
Rab35, or Rab1C due to its highest sequence homology to Rab1A and B, is 
phylogenetically highly conserved throughout metazoans (Pereira et al., 2001; Klöpper et al., 
Figure 1-9: Activity cycle of small 
GTPases. Small GTPases as Rab proteins 
cycle between an active, GTP-bound and an 
inactive, GDP-bound form. GAPs facilitate 
the GTPase activity whereas GEFs mediate 
the dissociation of GDP and its exchange 
for GTP. Inactive GTPases are sequestered 
in the cytosol by GDIs. Active GTPases can 
insert their amphipathic C-terminus into 
bilipid layers of membranes, and recruit and 





2012). It is reported to localize mainly at the plasma membrane, endocytic vesicles and 
endosomal membranes, but has also been detected recently on late endosomal/ lysosomal 
compartments (Hsu et al., 2010; Wheeler et al., 2015). Rab35 has an established role in the 
endosomal recycling of different receptors and cell surface proteins to the plasma membrane, 
such as cadherins, MHC (major histocompatibility complex class I and II), transferrin or T-cell 
receptors, the Ca2+-activated potassium channel KCa2.3 or the glucose transporter GLUT4 in 
adipocytes (Patino-Lopez et al., 2008; Walseng et al., 2008; Gao et al., 2010; Allaire et al., 
2010; Davey et al., 2012). In addition, depletion of Rab35 alters the endosomal trafficking of 
CI-Mannose-6-Phosphate receptors and Shiga-toxin to the TGN (Fuchs et al., 2007; Cauvin et 
al., 2016). The GEFs DENND1A-C (or Connecdenn 1,2,3) and Folliculin, and the GAPs 
TBC1D10A-C (EPI64A-C) and TBC1D13 (Chaineau et al., 2013) are upstream regulators of 
Rab35. The set of direct Rab35 effector proteins identified so far, include the PI(4,5)P2 5’-
phosphatase OCRL, the oxidoreductase MICAL1, the actin-bundling protein Fascin, the apical 
determinant Podocalyxin, and the ARF-6 GAP ACAP-2 (Zhang et al., 2009Dambournet et al., 
2011; Klinkert et al., 2016; Fremont et al., 2017). By direct interaction with these proteins 
Rab35 is implicated in a variety of cell physiological processes, such as cytokinesis, cell 
polarity, phagocytosis, cell adhesion and migration, apoptosis and cytoskeleton remodeling 
(Kouranti et al., 2006; Zhang et al., 2009; Dambournet et al., 2011; Marat et al., 2012; Chaineau 
et al., 2013; Allaire et al., 2013). In addition, Rab35 is strongly associated with cancer 
progression. A couple of recent reports implicate the small GTPase in PI3K/AKT signaling, 
though with partially contrasting results. Due to a proposed suppression of EGFR recycling or 
facilitation of EGFR degradation by Rab35, enhanced AKT activation in the absence of Rab35 
was observed in different cancer cell lines (Allaire et al., 2013; Zheng et al., 2017). In contrast, 
in somatic cancer or HEK293E cells, overexpression of the consecutive active mutant 
Rab35Q67L results in sustained AKT activation, presumably by promoting class I PI3K activity 
downstream to PDGFR internalization. Thus, the depletion of Rab35 reduced AKT activation 
in these cells (Wheeler et al., 2015).  
Consistent with its ubiquitous abundance (Zhu et al., 1994), Rab35 is also expressed in 
the nervous system (Jeong et al., 2018) and, at least for CNS cells, a couple of processes are 
reported to depend on Rab35 regulation. Among these, Rab35 is implicated in neurite 
outgrowth, but also axon elongation and even in neurodegenerative diseases associated with 
alpha-synuclein stabilization and exocytosis (Chevallier et al., 2009; Kobayashi et al., 2014a; 
b; Chiu et al., 2016; Villarroel-Campos et al., 2016; Steger et al., 2016; 2017; Bae et al., 2018). 
In addition, Rab35 is reported to function in the recycling of synaptic vesicles (SVs) in 




neuromuscular junctions (NMJs) of D. melanogaster (Fig. 1-10) (Uytterhoeven et al., 2011). 
Fly mutants with a loss of function mutation in Skywalker, a putative Rab35 GAP, display 
elevated endosomal recycling of synaptic vesicles. This phenotype is accompanied by a larger 
pool of readily releasable vesicles, increased neurotransmission and more efficient degradation 
of ubiquitinated SV proteins. An amelioration of increased neurotransmission and reduced 
endosomal SV recycling was observed by overexpression of inactive Rab35 or by the 
heterozygous deletion of Rab35 in Skywalker mutants. The authors proposed a mechanism in 
which the small GTPase promotes recycling of SVs via endosomes, which facilitates the 
degradation of dysfunctional SV proteins via the lysosomal pathway. In consequence, newly 
synthesized SV proteins would be formed with functional SV proteins only, leading to a more 
efficient neurotransmission than direct recycling. However, TBC1D24, the mammalian 
homologue of Skywalker that underlies the human DOORS (deafness, onychdystrophy, 
osteodystrophy, mental retardation, and seizures) syndrome (Campeau et al., 2014), was so far 
only identified as a GAP for ARF-6 (Falace et al., 2014; 2016) and not Rab35.  
 
In addition to its function in neurons, Rab35 has also been recently implicated in the 
myelin homeostasis of oligodendrocytes. Knockdown of the small GTPase or its GAPs 
TBC1D10A-C resulted in impaired exosome secretion in oligodendrocytic lineage cells (Oli-
neu). Exosomes are extracellular vesicles with 30-150 nm in diameter that contain mRNA, 
proteins and lipids and mediate intercellular communication (Kalra et al., 2016). They are 
released from late endosomal MVBs (LAMP-/ CD63- /TSG101-positive compartments). 
Regulated by a so far unknown mechanism, these late endosomes do not enter the degradational 
lysosomal pathway, but instead fuse with the plasma membrane and release their ILV content 
(Trajkovic et al., 2006; Frühbeis et al., 2013). OL-derived exosomes might function in the 
trophic support for neurons but also influence myelin formation (Krämer-Albers et al., 2007). 
Figure 1-10: Model of Rab35 function in SV 
recycling in D. melanogaster. In the absence of its 
putative GAP Skywalker, increased activation of Rab35 
(-GTP) directs endocytosed synaptic vesicles to recycle 
via endosomal compartments. Dysfunctional SV 
proteins are sorted into the lysosomal pathway for 
degradation. SVs with functional proteins only are 
reformed, and replenish the readily releasable pool of 
vesicles (RRP) for exocytosis. MVB – multi vesicular 
body; Lys – lysosome; ESCRT – endosomal sorting 
complex required for transport. Taken from 





The exosomal release of mRNA has been implicated in both, stimulating and inhibiting myelin 
formation (Bakhti et al., 2010; Pusic et al., 2016). In Oli-neu cells, the absence of Rab35 
resulted in an intracellular accumulation of PLP in lysosomal-associated protein 1 (LAMP-1)-
positive late endosomal/lysosomal compartments (Hsu et al., 2010). The authors proposed a 
function of Rab35 in the docking of these compartments to the PM for subsequent release of 
myelin proteins. However, the consequences on myelin formation was not investigated in that 
context. Current literature suggests that MAG and PLP delivery to LE/Lys is crucial for OL 
differentiation and myelin sheath formation (Simmons and Trajkovic, 2006; Winterstein et al., 
2008; Mironova et al., 2016). In contrast, another study reported a gain of OL differentiation 
and myelin segment formation in vitro, in the oligodendroglial cell line FBD-102b and primary 
OPCs depleted of Rab35 by siRNA or shRNA-mediated knockdown, respectively (Miyamoto 
et al., 2014). The authors proposed a function of Rab35 in the repression of OL differentiation 
and myelination, mediated by the recruitment of ACAP2 and subsequent inactivation of ARF6. 
























Impairments of the myelin homeostasis can lead to severe axonal degeneration and 
underly a wide range of common neurodegenerative diseases of the central and peripheral 
nervous system (PNS). Recent investigations, especially of inherited demyelinating disorders 
such as Charcot-Marie-Tooth (CMT) neuropathies, revealed a cohort of proteins crucially 
involved in the regulation of myelin formation. Despite of that, the molecular mechanisms by 
which these proteins contribute to a proper myelin homeostasis are incompletely resolved. The 
small GTPase Rab35 is linked to myelin formation in oligodendrocytes by two independent 
recent studies. However, the reported findings are slightly contrasting regarding the regulatory 
function of Rab35 in the formation and maintenance of myelin. 
We aimed to investigate how acute loss of Rab35 would affect oligodendrocytic myelin 
formation and thus, made use of a novel conditional Rab35 knockout (KO) mouse. Moreover, 
in order to reveal proteins which could mediate the function of Rab35 in this process, we 
performed an interactor screen. Thereby identified Rab35-effector proteins directed us to 
investigate PNS myelination upon acute Rab35 loss in Schwann cells by ultrastructural 
analysis, cell biological and biochemical approaches. 
 




2. Material and Methods 
2.1 Material 
 
2.1.1 Chemicals and consumables 
If not otherwise indicated in the corresponding section, chemicals and consumables 
were obtained from Thermo Fisher, Sigma, Roth, Sarstedt, GE Healthcare or Merck (table 2-
18). 
 
2.1.2 Solutions, media and buffers 
Solutions and buffers were prepared using millipore-filtered water and pH-adjusted 
with HCl or NaOH. 
 
Table 2-1: Solutions for molecular biology methods. 
 
Solution Composition Solvent 
10x TBE (TRIS-Borate-EDTA)  890 mM Boric Acid 
20 mM EDTA 
890 mM TRIS 
50x TAE (TRIS-Acetate-EDTA) 100 mM glacial acetic acid  
50 mM EDTA  
→ adjusted to pH 8.2 – 8.4 
200 mM TRIS 
 
10x OrangeG loading dye 2 mg/mL OrangeG (Sigma, O-1625) 70 % (v/v) glycerin 
Antibiotic stock solutions 
(sterile filtered) 
100 mg/mL Ampicillin  
50 mg/mL Kanamycin  
34 mg/mL Chloramphenicol 
H2O 
LB (Lysogeny broth) medium 1.0 % (w/v) yeast extract  
0.5 % (w/v) tryptone  
0.5 % (w/v) NaCl  
→ adjusted to pH 7.4 
H2O 
LB plates 15 g/L LB Agar powder (Roth; X965) LB medium 
2 x YT () medium   
 
1.0 % (w/v) yeast extract   
1.6 % (w/v) tryptone  
0.5 % (w/v) NaCl  
→ adjusted to pH 7.4 
H2O 
BLB (Biopsy lysis buffer) 200 mM NaCl  
5 mM EDTA 
0.2 % (w/v) SDS 
→ adjusted to pH 8.5 
100 mM TRIS 
TLB (Tail lysis buffer) 25 mM NaOH  
0.2 mM EDTA 
→ pH 12 
H2O 
TNB (Tail neutralization buffer) 40 mM TRIS-HCl 
→ pH 5 
H2O 
 






Table 2-2: Solutions and media for preparation and culturing of mammalian (primary) cells. The reagent 








10 % (v/v) FBS (heat-inactivated for primary cells) 
1% (v/v) P/S:100 U/mL Penicillin; 100 µg/mL Streptomycin 
in DMEM (Dulbecco's modified Eagle medium;  
high glucose (4.5 g/L), + 2 mM L-glutamine)   
Biochrom, S-0115 
Thermo Fisher, 15140122 
Thermo Fisher, 11965062 
Neuronal basic 
medium 
27.8 mM D-(+)-Glucose 
2.4 mM NaHCO3  
1.3 µM Transferrin Holo, Bovine Plasma   
in MEM (Minimum Esssential Medium) 
Roth, HN06 
 
Merck Millipore, 616420 
Thermo Fisher, 51200-046 
Neuronal digestion 
solution 
137 mM NaCl  
5 mM KCl  
7 mM Na2HPO4 
in 25 mM HEPES 




12 mM MgSO4 x 7H2O 
in HBSS (-Mg2+/Ca2+) 
 
Thermo Fisher, 14175-053 
Neuronal plating 
medium 
10 % (v/v) FBS (heat-inactivated) 
2 mM L-glutamine  
25 µg/mL Insulin (in 10 mM HCl) 
1 % (v/v) P/S 








5 % (v/v) FBS (heat-inactivated) 
0.5 mM L-glutamine 
1x B-27 Supplement  
1 % (v/v) P/S  
in Neuron basic medium 
Biochrom, S-0115 
Thermo Fisher, 25030081 
Thermo Fisher, 17504044 
Thermo Fisher, 15140122 




1.16 M NaCl 
54 mM KCl 
10 mM NaH2PO4xH20 








1mM MgSO4  
0.46 % (w/v) D-(+)-Glucose 
2 mM EGTA  
26 mM NaHCO3 





20 mg/mL BSA (bovine serum albumin) 
20 mg/mL Trypsin Inhibitor (Ovomucoid) 
0.005% phenol-red 
in D-PBS (Dulbecco’s Phosphate-Buffered Saline; 
+Ca2+/Mg2+) 




Thermo Fisher, 14287-080 






30 mg/mL BSA  
30 mg/mL Trypsin Inhibitor (Ovomucoid) 
0.005% phenol-red 
in D-PBS (+Ca2+/Mg2+) 




Thermo Fisher, 14287-080 
Immunopanning 
buffer 
0.02% BSA  
500 µg/mL insulin  
in D-PBS (+Ca2+/Mg2+) 
Sigma, A4161 
Sigma, I6634 
Thermo Fisher, 14287-080 
Sato-supplement  
100x 
150 mM BSA  
130 mM apo-Transferrin bovine  
10 mM Putrescine   
20 µM Progesterone  
23 µM Sodium Selenite  






Thermo Fisher, 11960044 
DSM (DMEM-Sato 
based growth  
medium) 
1x Sato-supplement 
2 mM L-glutamine  
5 µg/mL Insulin (in 10 mM HCl) 
5 µg/mL N-Acetyl-cysteine  
10 ng/mL d-Biotin 
1x Trace Elements B 
1x B-27 Supplement 
1 % (v/v) P/S 
in DMEM (4.5 g/L glucose) 
 




Thermo Fisher, 25-022-CI 
Thermo Fisher, 17504044 
Thermo Fisher, 15140122 
Thermo Fisher, 11960044 
Growth factor  
stock solutions  
(sterile filtered;  
-20 °C storage) 
10 µg/mL PDGF-AA (platelet-derived growth factor AA) 
in sterile 0.2% BSA in D-PBS (+Ca2+/Mg2+) 
PreproTech, #100-13A 
10 µg/mL NT-3 (neurotrophin-3)  
in sterile 0.2% BSA in D-PBS (+Ca2+/Mg2+) 
PreproTech, #450-03 
10 µg/mL CNTF (ciliary neurotrophic factor) 
in sterile 0.2% BSA in D-PBS (+Ca2+/Mg2+) 
PreproTech, #450-13 
10 mM Forskoline 
in DMSO  
Sigma, F6886 
4 µg/mL T3 (thyroid hormone triiodothyronine) 
in D-PBS (+Ca2+/Mg2+) 
Sigma, T6397 
10 µg/mL NRG1 (Neuregulin1) 
in sterile water 
Sigma, H7660 
5 mg/mL ascorbic acid  




10 ng/mL NT-3 
10 ng/mL PDGF-AA 
10 ng/mL CNTF 





10 ng/mL CNTF 
10 µM Forskolin  





0.25 % (w/v) Trypsin  
0.1 % (w/v) Collagenase A  
in Leibovitz’s L-15 medium (L-15) 
Thermo Fisher, 27250018 
Sigma, 10103586001 
Thermo Fisher, 11415049 






5 % (v/v) heat-inactivated horse serum (HS) 
1 % (v/v) P/S  
in DMEM (4.5 g/l glucose, +GlutaMAX, +Pyruvate)  
Thermo Fisher, 26050088 
Thermo Fisher, 15140122 
Thermo Fisher, 31966021 
SC differentiation 
medium 
1 µM Forskolin 
20 ng/mL NRG1 
40 ng/mL T3  
50 µg/mL ascorbic acid 
in DSM 
 




280 mM NaCl  
10 mM KCl  
1.5 mM Na2 HPO4   
12 mM dextrose  
in 50 mM HEPES  
→ adjusted to pH 7.05 
 
0.1x TE  
(TRIS-EDTA) buffer 
0.1 mM EDTA 
in 1 mM TRIS  





Table 2-3: Buffers used for live-cell imaging and immunocytochemistry assays. 
 
Buffer Composition Solvent 
10x Imaging basic-buffer 35 mM KCl  
1.2 M NaCl  
4 mM KH2PO4  
50 mM NaHCO3  
50 mM D-(+)-glucose water free (Roth, HN06) 
12 mM Na2SO4 
→ adjusted to pH 7.4 
      200 mM TES  
1x Imaging buffer 50 mM NaCl 
1.3 mM CaCl2 
1.2 mM MgCl2 
50 µM APV (Sigma, A5282) 
10 µM CNQX (Sigma. C-239) 
→ osmolarity-adjusted to neuron cell culture medium 
with D-(+)-Mannitol (Sigma, M4125) 
 
1x Imaging basic 
buffer  
High-potassium imaging  
buffer    
 
80 mM KCl   
1.2 mM MgCl 2    
1.3 mM CaCl 2    
→ osmolarity-adjusted to neuronal culturing medium with 
D-(+)-Mannitol (Sigma, M4125) 
1x Imaging basic 
buffer 
10x PBS (Phosphate  
buffered saline) 
100 mM Na2HPO4* 2H2O  
26.8 mM KCl 
1.37 M NaCl  
17.6 mM KH2PO4  
→ adjusted to pH 6.8 
H2O 
PFA fixative (4 %) 
 
4 % (w/v) paraformaldehyde (PFA)  
4 % (w/v) sucrose  
→ adjusted to pH 7.4 
1x PBS 





blocking solution  
0.3 % (v/v) Triton X-100 
10 % (v/v) NGS/NDS 
1x PBS 
ICC antibody solution  0.3 % (v/v) Triton X-100 
5 % (v/v) NGS/NDS 
1x PBS 
PFA fixative (2 %) 
 
2 % (w/v) paraformaldehyde (PFA)  
2 % (w/v) sucrose  
→ adjusted to pH 7.4 
1x PBS 
PIB (PIPES-based buffer) 137 mM NaCl      
2.7 mM KCl 
→ adjusted to pH 6.8 
20mM PIPES 
Lipid-ICC permeabilization 
solution   
20 µM Digitonin  
(Thermo Fisher Scientific, bn2006) 
PIB 
Lipid-ICC blocking solution   5 % (v/v) NGS (normal goat serum) 
50 mM ammonium chloride 
PIB 





Table 2-4: Solutions and buffers used for biochemical assays. 
 
Solution/Buffer Composition Solvent 
5x Lysis buffer stock  500 mM KCl 
10 mM MgCl2 
5 % (v/v) Triton X-100 (Sigma, 11332481001) 
→ adjusted to pH 7.4 
100 mM 
HEPES  
1x Lysis buffer working 
solution 
1x lysis buffer 
0.3 % (w/v) PIC (mammalian inhibitor cocktail; Sigma, P8340) 
1 mM PMSF (Roth, 6367) 
1 % (w/v) phosphatase inhibitor cocktail 2 (Sigma. P5726)  
1 % (w/v) phosphatase inhibitor cocktail 3 (Sigma, P0044) 
H2O 
2x Bradford solution 150 µM Brilliant Blue G250 
17 % (v/v) ortho-Phosphorsäure 
10 % (v/v) Ethanol  
H2O 
6x SDS-PAGE sample buffer 12 % (w/v) SDS 
60 % (v/v) glycerin 
30% (v/v) 2-mercaptoethanol 
0.3 % (w/v) bromophenol blue 
→ adjusted to pH 6.8 
375 mM TRIS 
4x Separating gel buffer 0.4 % (w/v) SDS 
→ adjusted to pH 8.8 
1.5 M TRIS 
4x Stacking gel buffer 0.4 % (w/v) SDS 
→ adjusted to pH 6.8 
0.5 M TRIS 
1x SDS running buffer 192 mM Glycine 
0.1 % (w/v) SDS  
→ adjusted to pH 8.3 
25 mM TRIS 
Coomassie staining solution 1 g/L Coomassie brillian blue G250 
10 % (v/v) acetic acid  
25 % (v/v) methanol 
H2O 




Coomassie destain solution 10 % (v/v) acetic acid  
25 % (v/v) methanol 
H2O 
1x Transfer Buffer 192 mM Glycine 
10 % (v/v) Methanol 
25 mM TRIS  
 
Ponceau S staining solution 0.3 % (w/v) Ponceau S   
3 % (v/v) glacial acetic acid 
H2O 
Ponceau destain solution 1 % (v/v) glacial acetic acid H2O 
PBS-T 0.05 % (v/v) TWEEN-20 (Roth, 9127) 1x PBS 
Immunoblot blocking buffer 
(HRP-detection) 
5 % (w/v) milk (Roth, T145) 1x PBS 
Immunoblot blocking buffer 
(Fluorescence-detection) 
Odyssey® Blocking Buffer-PBS (LI-COR, LI 927) - 
Immunoblot primary antibody 
solution  
3 % (w/v) BSA  




- wash buffer 1 
2 % (w/v) SDS H2O 
BioID- wash buffer 2 0.1 % (w/v) sodium deoxycholate  
1 % (v/v) Triton X-100 
500 mM NaCl 
1 mM EDTA 
→ adjusted to pH 6.8 
50 mM HEPES 
BioID- wash buffer 3 250 mM Lithium chloride 
0.5 % (v/v) NP-40 
0.5 % (w/v) sodium deoxycholate 
1 mM EDTA 
→ adjusted to pH 8.1 
10 mM  
TRIS-base 
BioID- wash buffer 4 50 mM NaCl 
→ adjusted to pH 7.4 
50 mM  
TRIS-base 
 
2.1.3 Enzymes  
 
Enzymes for molecular biological methods were stored at -20 °C and used in 
concentrations as indicated in the respective method part. FastDigest restriction enzymes (not 
listed) were purchased from Thermo Fisher. Enzymes used for cell biological assays are 
specified in each method section. 
 
Table 2-5: Enzymes used for molecular biological applications.  
Label Producer Order number 
FastAP – alkaline phosphatase 
Thermo Fisher  
EF0654 
Phusion high fidelity DNA Polymerase F-530L 
T4 DNA ligase ELL0016 
Taq DNA Polymerase Bio&SELL BS91.711.0500 
Proteinase K NEB P8102 





Kits were stored and used according to Manufacturer’s instructions. 
 
Table 2-6: Kits, the corresponding manufacturer’s and methods they were used for. 
Type Producer Application 
NucleoBond®Xtra Plasmid Midi-EF 
Macherey-Nagel  
Preparation of plasmid 
DNA NucleoBond® PC 20 Plasmid Mini 
NucleoSpin® Gel and PCR Clean-up Purification of DNA 
Pierce BCA Protein Assay Kit Thermo Fisher 
Determination of 
protein concentration  
Profection Mammalian Transfection System- 
Calcium Phosphate E1200 
Promega 
Transfection of 
neuronal cell cultures 
 
2.1.5 Standards for gel electrophoresis  
For gel-electrophoresis, 5 µL or 0.5 µg of the DNA- or the Protein Markers were used, 
respectively. 
 
Table 2-7: Standards used as markers in gel electrophoresis. 
Marker Producer Order number 
GeneRulerTM 1 kb DNA Ladder  
Thermo Fisher  
SM0311 
GeneRulerTM 100 bp DNA Ladder  SM0241 
PageRuler Prestained Protein Ladder 26616/ -19 
Triple Color Protein Standard II Serva 39257 
 
2.1.6 DNA oligonucleotides 
DNA oligonucleotides used as primers for polymerase chain reactions (PCR), were 
obtained from BioTeZ as lyophilized powder, dissolved in nuclease-free water (Roth, T143) 
to 100 µM and stored at -20 °C. 
 
Table 2-8: Primers used in analytical PCR reactions for genotyping of mouse genomic DNA. fw - forward; 
rev - reverse. 
 
Primer         Sequence [5’-3’] Target 
TM63_ EllaCre_fw CCGGGCTGCCACGACCAA 
CAG-Cre 
TM64_EllaCre_rev GGCGCGGCAACACCATTTTT 
P0-Cre_fw A   CCACCACCTCTCCATTGCAC  
      P0-Cre  
P0-Cre_rev       GCTGGCCCAAATGTTGCTGG  
Lox5F_fw ACTGGGATACACTGTGCTTG Rab35 WT/ Rab35Fl/-/ Rab35Fl/Fl 
Lox5R_rev GCTCCCAAGAATTCCAACTC Rab35 WT 
PL452-LoxP-Sc1R_rev  G  GAGGGACCTAATAACTTCGT Rab35Fl/-/ Rab35Fl/Fl 
 




Table 2-9: Primers used in preparative PCR reactions for cloning. Overlapping regions are highlighted in 
capital letters, restriction sites in bold. fw - forward; rev – reverse; PTP- protein tyrosine phosphatase; CC – 
coiled-coil region; PH- pleckstrin homology domain 
 
Primer Sequence [5’-3’]  
GST-Rab35_EcoR1_fw atatgaattcATGGCCCGGGACTACGACCACCTCTTCAA     
GST-Rab35_Not1_rev atatgcggccgcTTAGCAGCAGCGTTTCTTTCG 
GST-Rab35ΔC_Not1_rev atatgcggccgcttaCTGCTGTTTCGCCAAGTTGTC 
BirA*-Rab35_ EcoRV _fw aagtgatatccATGGCCCGG    




















2.1.7 RNA oligonucleotides 
2.1.7.1 siRNAs 
For RNA interference, small interfering RNA oligonucleotides (siRNA) were 
(re-)ordered as lyophilized powder from Sigma and dissolved to a concentration of 100 µM in 
nuclease-free water (Roth, T143). 
 




        Sequence [5' - 3'] Source 
MTMR2  
human GAAAAUGGGUGGAAGCUAU 
Dharmacon (L-050609)  
/ Sigma (custom) 
Rab35   human AGAAGAUGCCUACAAAUUUtt  
Ambion (s95004)  
/ Sigma (custom) 
MISSION® Universal 
Negative Control #1 
(scrambled) 
-                           - Sigma (SIC001) 
 





pLKO.1-plasmid encoded small hairpin RNA oligonucleotides (shRNA), expressed 
under the control of a U6-promoter, were used to interfere with gene expression in primary 
cells by lentiviral transduction. The non-targeting scrambled shRNA-containing construct 
with parallel eGFP-expression (RHS6848), and the mouse (ms)MTMR2-targeting shRNA-
containing construct (TRCN0000030098), were obtained from Dharmacon. Glycerol stocks of 
transformed E. coli TOP10 were prepared, from which the plasmids were purified and 
dissolved in nuclease-free water to a concentration of 1 µg/mL for the virus production in 
HEK293T cells. 
 
Table 2-11: shRNA sequences and references. 
shRNA Target organism Sequence [5' - 3'] Source 
msMTMR2  mouse AAAGGACATGATTGGAGTAGC  





2.1.8 DNA-plasmids and expression vectors 
Expression constructs were either received from elsewhere or obtained by cloning, as 
specified in table 2-12. Vectors used as backbones for the recombinant protein expression 
were chosen regarding the desired cell type. For mammalian cell lines, pcDNA3.1-based 
vectors (Invitrogen) were routinely used that drive strong and constitutive expression of 
inserted genes under control of the cytomegalovirus (CMV) promoter (Xia et al., 2006). 
pCMV6, pEGFPC2, pcEGFP_MK or pcmCherry_MK plasmids are pcDNA3.1-derived 
vectors with fluorescent tags for N-terminal fusion on the inserted protein (MK - generated by 
Michael Krauss, FMP, Berlin). For neuron-specific expression of synaptotagmin1-pHluorin in 
primary neuronal cultures, a modified pcDNA3-based plasmid that contains a human 
synapsin1 gene promoter was used (Wienisch and Klingauf, 2006). pGEX-4T vectors were 
used as backbones for the recombinant expression of proteins in bacteria, based on the 
T7-expressionsystem (Studier und Moffatt, 1986). 
Plasmid DNA was stored in nuclease- and endotoxin-free (EF) water 
(NucleoBond®Xtra Plasmid Midi-EF kit) at -20 °C or 4 °C for long-term or short-term, 
respectively. 
 




Table 2-12: Constructs for recombinant protein expression. *Plasmids were used as templates for cloning 




Vector backbone Reference 
FLAG-MTMR13* hu pcDNA3.1 gift from Gilbert Di Paolo 
FLAG-MTMR13 hu pc(HA)_MK this study 
eGFP-MTMR2 hu pcEGFP_MK cloned by Katharina Ketel 
eGFP-MTM1 hu pcEGFP_MK cloned by Katharina Ketel 
eGFP-MTMR1 ms pcEGFP_MK cloned by Katharina Ketel 
eGFP-MTMR5 hu pEGFPC2 gift from Michael Clague  
GST-Rab35 ms pGEX4T-1 this study 
GST-Rab35ΔC (aa1-180) ms pGEX4T-1 this study 
GST-Rab1A ms pGEX4T-1 
gift from Mitsunori Fukuda  
(Tohoku University, Sendai, Japan) 
GST-Rab5 hu pGEX4T-1 
GST-Rab7 hu pGEX4T-1 
GST-Rab11 hu pGEX4T-1 
mCherry-MTMR5 hu pEGFPC2 this study 
mCherry-MTMR13  
(FL_aa1-1849) 
hu pcmCherry_MK this study 
mCherry-MTMR13-DD  
(aa1-471) 
hu pcmCherry_MK this study 
mCherry-MTMR13-PH-
GRAM (aa806-1018) 
hu pcmCherry_MK this study 
mCherry-MTMR13-PTP 
(aa1100-1591) 
hu pcmCherry_MK this study 
mCherry-MTMR13-PTP+CC 
(aa1100-1697) 
hu pcmCherry_MK this study 
mCherry-MTMR13-PH 
(aa1743-1849) 
hu pcmCherry_MK this study 
mCherry-Rab35 ms pcmCherry_MK this study 
mCherry-Rab35Q67L ms pcmCherry_MK this study 
mycBirA*  E. coli pcDNA3.1 
Roux et al., 2012 (‚mycBioID') 
(addgene #35700)   
mycBirA*-Rab35 ms pcDNA3.1_mycBirA* this study 




gift from Markus Wienisch 
(Wienisch and Klingauf, 2006) 
YFP-Rab35mouse* ms pUAST 
Zhang et al., 2007  
(addgene # 46014) 
 




2.1.9 Antibodies and probes 
2.1.9.1 Primary antibodies 
Antibodies used for immunoblotting, -cytochemistry or -histochemistry were usually 
dissolved in water to a concentration of 1 mg/mL. Most antibodies, if not explicitly advised 
against by the corresponding manufacturer, were additionally diluted one to one in 90 % 
Glycerin in 1x PBS for storage at -20 °C, in order to avoid repetitive freezing and thawing. 
The depicted working dilutions listed in table 2-13 refer to the glycerol-diluted stock 
concentrations. 
 
Table 2-13: Primary antibodies listed by the corresponding antigen. ICC – immunocytochemistry; IHC – 
immunohistochemistry; IB – immunoblotting.; rb - rabbit, ms – mouse, gp – guinea pig, ch – chicken, gt – goat; 











α-tubulin ms  1:1,000 Sigma T5168 
ß-actin ms  1:5,000 Sigma A5441 
AKT rb  1:1,000 Cell signaling 4691 
AKT (p-S473) rb  1:1,000 Cell signaling 4060 
BrdU rat 1:200  Abcam ab6326 
Caspase-3 active rb 1:200  R&D technologies AF835 
CD63-AF647 ms 1:100  BD Bioscience 561983 
CNPase ms 1:200  Sigma C5922 
EEA1 rb 1:50  Cell signaling 2411 
ERK rb  1:1,000 Cell signaling 9102 
ERK  
(p-T202/Y204) 
rb  1: 800 Cell signaling 9101 
FLAG ms 1:200 1: 1,000 Sigma F3165 
GFP ch 1:2,000  Abcam ab13970 
GFP rb 1:500 1:5,000 Abcam ab6556 
HSC70 ms  1:1,000 Thermo Fisher  MA3006 
LAMP-1 (ms) rat 1:250  BD Biosciences 553792 
LAMP-1 (hu) ms 1:200  BD pharmingen 555798 
LAMP-2 rb 1:200  Abcam ab18528 
LC3  rb  1:500 Novus Biologicals NB600-1384 
LC3 ms 1:100  MBL international M152-3 
MBP rb 1:400  Synaptic Systems 295 003 
MBP rat [1:50]  kindly provided by Dr. Virginia Lee 
MTMR2 ms  1:500 BioRad MCA3595Z 
mTOR rb  1:1,000 Cell signaling 2983 
mTOR (p-S2448) rb  1:1,000 Cell signaling 5536 
Myc rb  1:5,000 Abcam ab9106 
NF-M ch [1:500]  Covance PCK-593P 
NG2 rb 1:200  Millipore AB5320 
P0 (MPZ) rb 1:200  Abcam ab31851 
PI(4)P (IgM) ms 1:200  Echelon z-p004 




PLP rb 1:200  Abcam ab28486 
Rab7 rb 1:50  Cell signaling 9367 
Rab35 rb  1:500 Proteintech Group 11329-2-AP 
RFP rb  1:1,000 MBL international PM005 
S6  ms 1:25 1:1,000 Cell signaling 2317 
S6– (p-S235/236) 
rb 1:200  Cell signaling 2211 
rb  1:1,000 Cell signaling 4858 
p70 S6K (p-T389) rb  1:500 Cell signaling 9234 
S6K rb  1:1,000 Cell signaling 9202 
Synapsin1 gp 1:200  Synaptic systems 106004 
Synaptophysin ms 1:500  Synaptic systems 101011 
Synaptophysin 
luminal domain 
rb 1:400  kind gift from Reinhard Jahn (“G96”) 
Synaptotagmin1 ms 1:100  Synaptic systems 105011 
Synaptotagmin1 
luminal domain  
rb 1:100  Synaptic systems 105103 
Tubulin ms  1:2,000 Sigma T4026 
Vinculin ms  1:10,000 Millipore 05-386 
 
 
2.1.9.2 Secondary antibodies 
Secondary antibodies for immunocytochemistry were Alexa Fluor (AF)-conjugated. 
Secondary antibodies used for immunoblotting were either horse radish peroxidase- (HRP) 
conjugated or coupled to a near-infrared fluorescent dye for fluorescence detection using the 
LI-COR system.  
 
Table 2-14: Secondary antibodies, their conjugation and reference. * highly x-adsorbed; ICC – 
immunocytochemistry; IHC – immunohistochemistry; IB – immunoblots.; rb - rabbit, ms – mouse, gp – guinea 
pig, ch – chicken, gt – goat; dk - donkey; AF –Alexa Fluor; HRP – horse radish peroxidase; TRITC – 

















ms IgG* AF568 gt 1:400  A11031 
ms IgG* AF647 gt 1:400  A21236 
rb IgG* AF488 gt 1:400  A11034 
rb IgG* AF568 gt 1:400  A11036 
rb IgG  AF647 gt 1:400  A21244 
gp IgG* AF647 gt 1:400  A21450  
rat IgG*  AF647 dk 1:400  A21247 
ms IgM  AF568 gt 1:400  A21043 
ch IgY  AF488 gt 1:400  Abcam ab150169 






rat IgG  TRITC dk [1:100]  712-025-150 
ch IgGY++ 
(IgG)  
FITC dk [1:100]  703-095-155 
rb IgG  HRP gt  1:5,000 111-035-003 
ms IgG  HRP gt  1:5,000 115-035-003 
ms IgG  HRP rb  1:5,000 Dako P 0260 




rb IgG HRP gt  1:10,000 P 0448 




rb IgG  IRDye 800CW gt  1:10,000 926 -32211 
ms IgG  IRDye 680RD gt  1:10,000 925 -68070 
ms IgG  IRDye 800CW gt  1:10,000 926 -32210 
ms IgG  IRDye 680LT gt  1:5,000 926-68020 
       
 
2.1.9.3 Probes 
Phalloidin probes were used equivalent to secondary antibodies in 
immunocytochemistry. DAPI was diluted to a stock concentration of 5 mg/mL and stored at 
4 °C. For application in immunocytochemistry assays the stock was further diluted to 
1 µg/mL in mounting medium. A eGFP-tagged tandem version of the PI(3)P binding domain 
of Hrs (eGFP-2xFYVE (Hrs)) was recombinantly expressed in E. coli, purified and stored in 
50 % glycerol at -80 °C (Uwe Fink, FMP, Berlin). 
 
Table 2-15: Probes used for fluorescence detection. 




number ICC  IB 




Phalloidin AF647 1:50  A22287 
Streptavidin HRP biotin  1:5,000 SA10001 
DAPI    - DNA 1:5,000  Sigma D9542 
eGFP-2x 
FYVE (Hrs) 
   - PI(3)P 
0.025 
µg/µL 
                        Gillooly et al., 2003 
 
 
2.1.10 Inhibitors  
Compounds used to pharmacological inhibit enzymes were dissolved in DMSO to 
indicated concentrations as stock solutions and stored at room temperature (RT) or -20 °C.  
 
Table 2-16: Compounds used for enzyme inhibition.  
 






Apilimod PIKFyve 25 mM RT BioVision, B1129 
Compound-19 VPS34 10 mM RT Selleckchem, S8456 
Rapamycin  mTORC1-component 
FKBP12 
2 mM -20 Santa Cruz, sc3504 
SAR405 VPS34 10 mM RT kind gift from Sprint 
Bioscience, Huddinge, 
Sweden 
VPS34-IN1 VPS34 10 mM RT provided by Dr. James 
Hastie (MRC PPU 
Reagents, Dundee) 





2.1.11 Mammalian cell lines 
Human embryonic kidney cells 293T (HEK) were used for biochemical experiments 
due to their high replication rate, transfection efficiency and protein expression (Wurm, 
2004). In addition, this HEK293-derived cell line (T) expresses a temperature-sensitive 
mutant version of the SV40 large T antigen that makes it especially suitable for the production 
of retrovirus (Pear et al., 1993). The epithelial cervical cancer cell line HeLa was used for 
immunocytochemistry due to its higher adherence properties compared to HEK cells (Potthoff 
et al., 2012). HEK and HeLa cell lines were obtained from ATCC. The TALEN-edited HeLa 
knock in (KI) cell line, that expresses endogeneous Rab35 N-terminally tagged with eGFP 
(eGFP-Rab35endo HeLa cells), was a kind gift of the lab of Prof. Dr. Arnaud Echard (Cauvin 
et al., 2016). Stonin-2 WT immortalized mouse embryonic fibroblasts (MEF) cells were 
kindly provided by Prof. Dr. T. Maritzen (FMP, Berlin). All mammalian cell lines were 
cultured in DMEM with 4.5 g/L glucose (Thermo Fisher) containing 10 % heat-inactivated 
FBS (Gibco) and 100 U/mL penicillin and 100 µg/mL streptomycin (Gibco) (mCCM) during 
experimental procedures and were routinely tested for mycoplasma contamination. 
 
2.1.12 Bacteria strains 
For the amplification and storage of plasmid DNA, chemically competent E. coli from 
the TOP10 strain (Invitrogen; Hanahan, 1983) were used. To express recombinant proteins, 
IPTG-induced in bacteria, the E. coli strain BL21-CodonPlus (DE3)-RP (Stratagene) was 
routinely used. For GST-Rab protein chimera, a significantly higher amount of stable proteins 
was purified upon expression in E. coli Rosetta (DE3) (Novagen), which display improved 
expression yield and a better purity of proteins due to additional eukaryotic tRNA-codons that 
are rarely used in E. coli. (Tegel et al., 2010). 
 
2.1.13 Mouse strains 
Rab35Fl/Fl mice in a C57BL/6 WT mice background, with insertions of loxP sites 
flanking exon 2 and 3 for Cre-mediated recombination, were a kind gift of and generated by 
Dr. Genaro Patiño López (formerly: NIH, Bethesda, USA), Prof. Dr. Stephen Shaw (NIH, 
Bethesda, USA) and Prof. Dr. Arnaud Echard (Institut Pasteur, Paris, France). The Cre 
recombination system, based on the Cre recombinase and the 34 bp loxP recognition sites that 
consist of two 13 bp inverted repeats separated by a spacer region of 8 bp, originates from the 
P1 phage (Sternberg & Hamilton, 1981). Cre-mediated recombination in these mice leads to 




the excision of exons 2 and 3 from the Rab35 gene as a circular DNA molecule, and thereby 
to an early transcription termination. 
To obtain a conditional Rab35 gene knockout, Rab35Fl/Fl mice were interbred with a 
Cre-ERTM (CreER) mouse line in a C57BL/6 WT background (B6.Cg-Tg (CAG-
Cre/Esr1*)5Amc/J) that was obtained from the Jackson Laboratory. This mouse line 
ubiquitously expresses a chimera of Cre recombinase and a mutated version of the ligand-
binding domain of the estrogen receptor, with an increased affinity for tamoxifen (TMX), 
under control of the CAG-promoter, and thus allows for tamoxifen-inducible Cre 
recombination (Danielian et al.1998; Hayashi and McMahon, 2002). The resulting 
heterozygeous Rab35Fl/+ x CAG-CreER mice were crossed with homozygeous Rab35Fl/Fl 
animals to obtain homozygeous Rab35Fl/Fl with (icKO) or without CreEr (WT). Breeding and 
experiments with animals for in vitro recombined Rab35 knockout were conducted according 
to the guidelines of the “Landesamt für Gesundheit und Soziales” (LAGeSo) and with their 
permission. 
For the Schwann cell-specific Rab35 gene knockout in vivo, Rab35Fl/Fl mice were 
interbred with a P0-Cre line (B6N.FVB-Tg(Mpz-cre)26Mes/J), which starts to express the Cre 
recombinase under control of the Schwann cell-specific P0-promoter on embryonic day 
(E)13.5 (Feltri et al., 1999). This work was performed in the lab of Prof. Dr. A. Bolino 
(INSPE, Milan, Italy), conducted according to the Italian national regulations and covered by 




Table 2-17: Software products, databases and internet tools. 
 
Software Source Application 
OligoCalc http://biotools.nubic.northwestern.edu/ 
OligoCalc.htmL 
Melting point calculation of  
PCR-Primer 
Adobe Illustrator CS6 Adobe Systems Incorporated Preparation of figures 
ApE plasmid editor http://jorgensen.biology.utah.edu/ 
wayned/ape/ 
DNA analysis incl. theoretical cloning 
preparation and primer design  
GraphPad Prism 5.0 GraphPad Statistical analysis and calculations, 
graph preparations 
Image J https://imagej.nih.gov/ij/ Evaluation of microscopy images 
Intas GDS  INTAS Science Imaging Instruments  
GmbH, Goettingen, Germany 
Agarose gel documentation 
Image Lab  Bio-Rad   Semi-quantitative (HRP) immunoblot 
documentation and evaluation 




LI-COR LI-COR Quantitative (fluorescent) immunoblot 
documentation and evaluation 
MARS Data Analysis 
Software 
BMG LABTECH  Analysis of microplate reader data 
(protein concentration) 
MaxQuant https://maxquant.net/ Identification and quantification of 
proteins from peptides detected in mass 
spectrometry 
Micromanager v1.4.14 https://micro-manager.org/ Image acquisition on an epifluorescence 
microcope 
Microsoft Office Microsoft Figure preparation, documentations 
NCBI/Blast http://blast.ncbi.nlm.nih.gov/ Homology determination of siRNA-
targets 
PyRAT (Python Based  
Relational Animal  
Tracking) 
Scionics Computer  
Innovation GmbH 
Animal facility software, managing of 








Identification and quantification of 
proteins from peptides detected in mass 
spectrometry 
Genesys Syngene DNA gel electrophoresis documentation 
Uniprot https://www.uniprot.org/ Gene and protein research; homology 
determination of proteins 
ZEN Zeiss Image acquisition on confocal laser-





Table 2-18: Suppliers for chemicals, consumables, devices and reagents. 
Abbreviation Company  
Abcam Abcam PLC, Cambridge, USA 
Ambion  → Thermo Fisher 
ATCC ATCC, Manassas, USA 
BD Biosciences  BD Biosciences, San Jose, USA 
Beckman Beckman-Coulter, Krefeld, Germany 
Bio&SELL Bio&SELL, Feucht, Germany 
Bio-Rad Bio-Rad LABORATORIES Inc., Hercules, USA 
BioTeZ BioTeZ Berlin Buch GmbH, Berlin, Germany 
BMG LABTECH BMG LABTECH GmbH, Ortenberg, Germany 
Cell signaling Cell signaling technologies (CST), Boston, USA 
Covance Covance Inc., Princeton, USA 
Dako Agilent Technologies, Santa Clara, USA 
Dharmacon Dharmacon Inc., Lafayette, USA 
Echelon Echelon Biosciences Inc., Salt Lake City, USA 
Eppendorf Eppendorf, Hamburg, Germany 
GE Healthcare GE Healthcare, Chicago, USA 




Harvard Apparatus Harvard Apparatus, Holliston, USA 
Invitrogen  → Thermo Fisher 
Jackson ImmunoResearch labs  Jackson ImmunoResearch Europe Ltd., Newmarket, United Kingdom 
Jackson Laboratory The Jackson Laboratory, Bar Harbor, USA 
LGC genomics  LGC genomics GmbH, Berlin, Germany 
LI-COR LI-COR Biosciences, Lincoln, USA 
Macherey-Nagel Macherey-Nagel GmbH & Co. KG, Düren, Germany 
Merck Merck, Darmstadt, Germany 
MBL International MBL International Corporation, Woburn, USA 
Millipore Merck Millipore, Billerica, USA 
NEB  New England Bio Labs, Ipswich, USA 
Nikon Nikon Corporation, Tokyo, Japan 
Novus Biologicals Novus Biologicals LLC, Centennial, USA 
Okolab Okolab Inc., San Bruno, USA 
Preprotech PeproTech EC, Ltd, London, United Kingdom 
Promega Promega GmbH, Mannheim, Germany 
Proteintech  Proteintech Group, Manchester. United Kingdom 
Roth Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
R&D technologies R&D Technologies Inc., North Kingstown, UK 
Sarstedt Sarstedt AG & Co. KG, Nümbrecht, Germany 
Semrock IDEX Health & Science, Rochester, USA 
Serva SERVA Electrophoresis GmbH, Heidelberg, Germany 
Sigma Sigma-Aldrich Chemie GmbH, Schnelldorf, Germany 
Stratagene Stratagene, La Jolla, USA 
Synaptic systems Synaptic Systems GmbH, Goettingen, Germany 
Thermo Fisher Thermo Fisher Scientific Inc., Waltham, USA 
VWR VWR International, Radnor, USA 






2.2.1 Molecular Biology Methods 
2.2.1.1 Preparative and analytical Polymerase chain reaction (PCR) 
The polymerase chain reaction (PCR) is used to amplify specific DNA sequences from 
DNA templates with thermostable DNA-polymerases, by repetitive thermo- and duration-
controlled incubation cycles. The template DNA is first denaturated from double stranded (ds) 
into single-stranded (ss)DNA by high temperature. Following this, specific DNA-
oligonucleotides can anneal to the ssDNA and serve as primers for the following DNA-
sequence synthesis. After elongation, the newly synthesized DNA strands are utilized as 
additional templates in the next cycles. This results in an exponential DNA amplification 
(Saiki et al., 1988).  
DNA fragments were amplified from plasmid or genomic DNA in a Thermocycler 




peqSTAR 2X (VWR). For preparative purpose, when the desired fragment or gene was 
further used for cloning, Phusion high fidelity DNA Polymerase was used. It possesses 3'- to 
5' –end exonuclease proofreading activity and therefore a low error rate. For analytical 
purpose the less precise Taq Polymerase was used to verify successful plasmid transformation 
of bacterial clones in colony PCRs, for instance. This polymerase was also used in genotyping 
PCRs of genomic DNA isolated from mouse biopsies (2.2.1.2).  
Primers were designed using the ApE-plasmid editor and the online tool Oligo Calc, 
with the following criteria to ensure efficient and specific annealing: The overlap with the 
DNA-template was 21 bp to 30 bp. The salt-adjusted melting temperature (Tm) was between 
50 °C and 65 °C with less than 5 °C difference between the two primers. In addition, the 
guanine-cytosine (GC) content was between 40 % and 50 %. The last nucleobase pair in the 
overlapping region was always a GC, as these nucleobases have a stronger bonding efficiency 
(three hydrogen bonds) than adenine- thymine. In the case of preparative PCR, restriction 
sites for subsequent ligation with the target DNA, and a random overhang of 4 bp for proper 
restriction enzyme reaction, were introduced at the 5’- end of each primer sequence. In order 
to screen clones in colony PCRs, one of the two primers was chosen to anneal at the vector 
backbone, and the other at the insert region. 
Deoxy nucleotide triphosphates (dNTPs; Thermo Fisher, R0181) were mixed in a 
stock solution with a concentration of each at 5 mM, serving as free nucleotides for DNA 
elongation. Polymerase buffer and MgCl2 solutions were supplied by the corresponding 
polymerase manufacturer. PCR samples were prepared in a usual volume of 20 µL. A loading 
dye, 1x OrangeG, was added for detection of DNA migration in the following agarose gel 
electrophoresis. The PCR sample composition is specified in Table 2-19. A positive and 
negative control for PCR performance, containing DNA with or without the desired fragment, 
respectively, as well as a sample containing water instead of DNA, were always carried along. 
The corresponding performance protocols are specified in tables 2-20 to 2-21. All 
PCRs were started cold. The annealing temperature (Ta) was calculated from the melting 
temperature of the least stable primer pair (Tm primer) and the PCR product (Tm product) according 
to Rychlik and colleagues (1990): 
 
(I)      Ta = 0.3 * Tm Primer + 0.7 * Tm Product - 14.9 
 
The elongation temperature and duration corresponded to the optimal working temperature of 
the used Polymerase and its elongation speed, respectively. 











Template  plasmid DNA 
20 ng/µL 
E. coli culture 
1/100 µL 
Forward primer 0.5 µM 
Reverse primer 0.5 µM 
Polymerase buffer 1x 
MgCl2 - 2 mM 
dNTPs 0.2 mM each 
DNA Polymerase 0.05 U/µL 0.1 U/µL 
10x OrangeG dye 1x 
H2O ad 20 µL 
 
Table 2-20: PCR performance protocol for preparative PCR. 
Process Temperature [°C] Duration 
Start 98 2 min 
30x 
Denaturation 98 10 s 
Annealing formula (I) 30 s 
Elongation 72 30 s/ kbp 
End 72 10 min 
 
Table 2-21: PCR performance protocol for analytical (colony) PCR. 
Process Temperature [°C] Duration 
Start 95 2 min 
30x 
Denaturation 95 30 s 
Annealing formula (I) 30 s 
Elongation 72 1 min/ kbp 
End 72 10 min 
 
In order to analyze the PCR products, the whole volume or 50 % of preparative or 
analytical PCR samples, respectively, were loaded onto 1 % to 2 % (w/v) agarose gels. 
 
2.2.1.2 Genotyping of transgenic mice  
Genomic DNA, isolated from biopsies of transgenic mice (2.2.1.13), was analyzed for 
the presence of the respective transgene by analytical PCR followed by agarose gel 
electrophoresis. The Rab35 locus was analyzed regarding the homogeneous insertion of a 
loxP sequence in the intron 1 region in front of exon number 2. Therefor three primers in two 
different combinations and PCRs were used: Lox5F as the forward primer that anneals in the 




intron 1 region. Lox5R as a reverse primer, annealing in the intron 1 region in Rab35 WT 
locus only (product: 573 bp). And PL452-Loxp-Sc1R as a reverse primer that anneals within 
the inserted loxP site (product: 647 bp) in DNA from hemizygously or homozygously loxP-
positive Rab35(Fl) mice. Homozygous Rab35Fl/Fl mice were thus identified by the lack of a 
WT-PCR product. For quality reasons, WT and “Fl” PCRs were performed separately (Table 
2-22 and table 2-23).  
The presence of the CAG-CRE-ERTM transgene was verified using the primer pair 
“TM63_EllaCre” and “TM64_EllaCre” that amplified a 445 bp product (Table 2-22 and table 
2-24).  
 
Table 2-22: PCR mixtures used for analytical amplification from mouse genomic DNA. 
Component Rab35 WT/“Fl“ CAG-Cre 
genomic DNA 1 µL 
Forward primer 0.5 µM 0.375 µM 
Reverse primer 0.5 µM 0.375 µM 
Taq Polymerase buffer 1x 
MgCl2 2 mM 
dNTPs 0.2 mM each 0.15 mM each 
Taq DNA polymerase 0.1 U/µL 
10x OrangeG dye 1x 
H2O ad 20 µL 
 
Table 2-23: PCR performance protocol for amplification of genomic Rab35 WT- and Rab35Fl-
fragments. 
Process Temperature [°C] Duration 
Start 95 2 min 
35x 
Denaturation 95 30 s 
Annealing 58 50 s 
Elongation 72 40 s 
End 72 10 min 
 
Table 2-24: PCR performance protocol for amplification of the genomic Cre-fragment. 
Process Temperature [°C] Duration 
Start 95 2 min 
30x 
Denaturation 95 30 s 
Annealing 55 30 s 
Elongation 72 30 s 
End 72 10 min 
 




2.2.1.3 Agarose gel electrophoresis 
DNA fragments or plasmids were separated according to their size using agarose gel 
electrophoresis Compact chambers from Biometra. Depending on the size of the analyzed 
DNA fragments or plasmids, 0.7 % to 2 % (w/v) agarose (Bio&Sell, BS10.35.10) were 
dissolved in 1x TBE or 1x TAE buffer by heating in a microwave. The UV 
absorbance-possessing DNA interchelator ethidium bromide (0.3 µg/mL; Roth, 2218) was 
subsequently added for UV-mediated detection of DNA. Gels were casted and chilled at RT 
until gelatinization. Except for ready-to-use PCR or DNA-restriction samples, lx OrangeG 
loading dye was added before loading onto the gel. As a reference 5µL 100 bp or 1 kb DNA-
Ladders (Thermo Fisher) were used. Electrophoresis was performed in TBE or TAE buffer at 
10 V/cm electrode distance for 20 min to 30 min until the 50 bps OrangeG-migration frontline 
reached the lower edge of the gel. DNA was visualized due to ethidium bromide incorporation 
by 302 nm UV light using the Gel documentation GBOX/F3 system and controlled by the 
corresponding software GeneSys from Syngene. For preparative agarose gelelectrophoresis 
DNA fragments were excised from the gel on a UV transillumination table (UVT-28 LV from 
Herolab) with a low and short UV exposure to prevent point mutations. 
 
2.2.1.4 Purification of DNA from agarose gels  
Amplificated PCR-fragments or restricted DNA fragments and plasmids were purified 
from excised agarose gel pieces using the NucleoSpin® Gel and PCR Clean-up kit 
(Macherey-Nagel) according to the manufacturer’s instructions. In brief, excised agarose gel 
pieces were dissolved in high-salt buffer, the DNA solution was loaded and purified on a 
silica membrane. Pure DNA-fragments were diluted in 15 µL, DNA-plasmids in 30 µL 
TE-buffer.  
 
2.2.1.5 DNA-restriction digest 
Each 10 µL of purified PCR-DNA fragments or 2 µg of target-DNA vectors were 
restricted in a 20 µL reaction volume. The samples were supplemented with 1 µL of each 
FastDigest restriction endonucleases (Fermentas) and 1x FastDigest Green buffer, allowing 
for subsequent loading on agarose gels. In order to prevent subsequent re-ligation of the 
restricted, linearized DNA-vectors, 1 U of FastAP thermosensitive alkaline phosphatase 
(Thermo Fisher, EF0654) was added to dephosphorylate the 5’-ends. The restriction reaction 
was performed at 37 °C for 20 min, followed by 5 min incubation at 80 °C to inactivate all 
enzymes. A DNA vector sample without restriction enzymes was carried along and served as a 




negative control. The samples were loaded on agarose gel for subsequent separation and 
purification of the restricted DNA. 
 
2.2.1.6 Ligation 
T4-DNA ligase (Thermo Fisher, ELL0016) was used to insert the fragment into vector 
DNA after restriction. It catalyzes the re-formation of phosphodiester bounds between the 
DNA 3’- and 5’-ends. First, the DNA-concentration of the purified restriction products was 
determined. In 20 µL reaction volume, 1 Weiss Unit of ligase, 1x ligase buffer and 50 ng to 
100 ng of target vector were used, supplemented with a three- to six-fold molar excess of the 
insert. To control for undesired plasmid re-ligation, a vector sample without fragment DNA 
was used. Ligation samples were incubated for 1 h at RT and stored at -20 °C or were 
subsequently used for transformation. 
 
2.2.1.7 Transformation of chemically competent E. coli 
For transformation, 50 µL glycerol stocks of chemically competent E. coli Top10 or 
BL21DE3 in 0.1 M CaCl2 were thawed on ice and supplemented with 10 ng plasmid DNA or 
10 µL ligation products. The samples were gently mixed and incubated for 30 min at 4 °C. 
The uptake of plasmid DNA was triggered by a heat-shock for 90 s at 42 °C. This leads to 
perforation of the bacterial plasma membrane, enabled by calcium ions that counteract the 
electrostatic repulsion between membrane and DNA. After 5 min chilling on ice, the bacteria 
were directly plated on prewarmed LB agar plates with 100 µg/mL ampicillin when the 
transformed plasmid contained the resistance marker gene for the bacteriostatic antibiotic 
ampicillin. If kanamycin resistance was encoded in the transformed plasmid, bacteria were 
supplemented with 400 µL LB medium without antibiotics and cultured first for 1 h at 37 °C 
and 180 rpm, allowing for expression of the kanamycin resistance protein before exposure to 
the bacteriocidal antibiotic kanamycin. The bacteria were then pelleted from the 
antibiotic-free suspension at 700 x g for 1 min. After removal of 4/5th of supernatant volume, 
the cells were recollected in the remaining LB-medium supernatant and plated onto 
prewarmed LB agar plates containing 50 µg/mL kanamycin.  
The plates were incubated overnight at 37 °C. Newly transformed clones, picked from 
LB agar plates with sterile plastic tips, were transferred into 200 µL LB-medium (with 
corresponding antibiotics) per well of a 96 well plate and cultured for 2 h at 37 °C on a 
Heidolph Titramax 1000 plate shaker at 350 rpm. 2 µL of the suspension was directly used to 
perform colony PCR for the verification of positive clones.  




2.2.1.8 Preparation of bacterial glycerol stocks 
Glycerol stocks were prepared for long term storage of transformed bacteria, by 
inoculating 2 mL LB medium, containing 100 µg/mL ampicillin or 50 µg/mL kanamycin, 
with the clone suspension and grown overnight at 37 °C and 180 rpm in a bacteria incubator 
shaker. The bacterial suspension was then concentrated to 750 µL by centrifugation at 4,000 x 
g for 5 min at 4 °C, diluted one to one in sterile 50 % (v/v) glycerol and stored in cryotubes 
at -80°C.  
 
2.2.1.9 Cultivation of transformed bacteria 
Transformed E. coli Top10 were picked from cryopreserved cultures or LB-Agar 
plates with a sterile pipette tip and were used for inoculation of 2 mL LB-Medium with 100 
µg/mL ampicillin or 50 µg/mL kanamycin. This preculture was incubated for 8 h at 37 °C and 
180 rpm in a bacteria incubator shaker (New Brunswick Scientific, Innova 42). For a higher 
yield of plasmid DNA, 100 mL LB-Medium with antibiotics were then inoculated with 0.1 % 
(v/v) (100 µL) of this preculture and incubated over night at 37 °C and 180 rpm. The next 
day, the bacteria were sedimented by centrifugation at 4,000 x g for 15 min at 4 °C. Bacterial 
pellets were either stored at -20 °C or immediately resuspended for isolation of plasmid DNA. 
 
2.2.1.10 Isolation of plasmid DNA 
Plasmid DNA was isolated from precultures of transformed E. coli TOP10 using the 
Plasmid Mini-Kit NucleoBond® PC20 from Macherey-Nagel. The procedure is based on a 
modified sodiumdodecylsulfate (SDS)-alkaline lysis of cells (Birnboim and Doly, 1979). In 
brief, bacterial pellets were resuspended in a TRIS-based physiological buffer containing 
EDTA, to chelate divalent metal cations. This destabilizes the cell wall and impairs the 
function of DNases. Glucose supplementation ensures iso-osmolarity of the buffer in order to 
prevent the cells from bursting, whereas RNA is hydrolyzed by supplementation of RNase. 
During subsequent lysis, the detergent SDS disrupts the cell membrane, which enables NaOH 
permeability for subsequent dsDNA-denaturation into single strands. By neutralization with a 
potassium acetate buffer, hydrogen bonds are re-established in smaller DNA fragments and 
thus, plasmid DNA is re-naturated and dissolved, while the genomic DNA precipitates 
together with SDS, cellular proteins and cell debris through hydrophobic interactions. Lysates 
were cleared from these precipitates by centrifugation and were applied to a silica column. 
The bound plasmid DNA was washed and finally eluted in nuclease-free water (Roth, T143).   




Plasmid Midi DNA preparation was performed when higher amounts of plasmid DNA 
were required using the Macherey-Nagel NucleoBond®Xtra Midi-EF kit. Here, additional 
washing steps of the silica-bound DNA were performed that ensure an efficient removal of 
the bacterial endotoxins for the subsequent usage of plasmids in cell transfections. In addition, 
plasmid DNA was eluted from the column with an alkaline buffer, precipitated with 
2-Propanol, pelleted and dissolved in millipore-filtered, endotoxin-free (EF) water (Machery-
Nagel). The DNA-concentration and purity were determined with a BioPhotomer Plus from 
Eppendorf at a wavelength of 260 nm and adjusted to 1 µg/µL. 
 
2.2.1.11 Spectrophotometric determination of DNA concentration 
The DNA-concentration in solutions was determined in UV-transparent cuvettes using 
a BioPhotometer plus (Eppendorf). The absorption was measured at a wavelength of 260 nm 
and the concentration calculated using the Lambert-Beer law:        
(II)   𝑐𝑑𝑠𝐷𝑁𝐴 =
𝐴260 𝑛𝑚
𝑏 ∗ 𝜀𝑑𝑠𝐷𝑁𝐴 
∗ 𝑑    
cdsDNA- concentration of dsDNA; A260nm – absorption at a wavelength of 260 nm; b – pathlength: 1 cm; 
εdsDNA – molar extinction coefficient for dsDNA at 260 nm (50 mL µg-1 cm-1); d - dilution 
 
DNA solutions were considered as sufficiently pure, if a ratio of absorbances at 260 nm and 
280 nm, the absorbance maximum of proteins, between 1.7 to 2 was achieved. 
 
2.2.1.12 Sequencing of DNA 
DNA samples were sequenced by LGC genomics (Germany) using the Sanger 
method, based on the incorporation of chain-terminating 2’-3’-dideoxynucleotides by 
DNA-polymerases during in vitro replication (Sanger and Coulson, 1975). 
   
2.2.1.13 Isolation of genomic DNA  
Genomic DNA was isolated from earbiopsies of adult mice with the Proteinase K 
method according to Wang & Storm (2006). Here, the tissue was digested, and cells were 
simultaneously disrupted in 350 µL/mm2 biopsy lysis buffer (BLB) containing high salt 
concentrations, SDS-detergent and EDTA. The buffer was freshly supplemented with 1 % 
(v/v) Proteinase K, to prevent the degradation of genomic DNA during lysis by digesting 
nucleases. After 30 min to 2 h incubation at 55°C and 900 rpm in a Thermomixer (Eppendorf, 
5437,), the tissue was lysed and cell remnants were removed by centrifugation for 5 min at 
17,000 x g in a tabletop centrifuge. The DNA-containing supernatant was transferred into a 




new tube and an equal volume of 2-Propanol was applied. The tube was gently inverted until 
genomic DNA visibly precipitated. The precipitates were subsequently sedimented by 
centrifugation at 17,000 x g for 5 min, washed in 70 (v/v) % ethanol and pelleted again. The 
DNA-pellet was dried for 5 min at 60 °C and dissolved in 50 µL millipore-filtered water.  
Genomic DNA from small tail biopsies of mouse pups was isolated with the 
HotSHOT method according to Warman and colleagues (Truett et al., 2000). It is based on 
the use of alkaline lysis, similar to the method of Birnboim and Doly (1979) (see 2.2.1.10) but 
omitting SDS or potassium acetate and thus, without DNA precipitation. The neutralization 
solution is replaced by 40 mM TRIS-HCl at pH 5 (TNB). The tissue pieces were digested for 
1 h at 95 °C in 50 µL/ 2 mm tail lysis buffer (TLB) and then chilled to RT. TNB was applied 




2.2.2 Cell biology methods 
2.2.2.1 Cultivation and passaging of mammalian cell lines  
Human embryonic kidney 293T (HEK), HeLa and eGFP-Rab35endo knock-in (KI) 
HeLa cell cultures were cultivated in Dulbecco's Modified Eagle Medium (DMEM) with high 
glucose (4.5 g/L) and 2 mM L-glutamine, supplemented with 10 % (v/v) fetal bovine serum 
(FBS), 100 U/mL Penicillin and 100 µg/mL Streptomycin (1% (v/v) P/S) (mammalian cell 
culturing medium, mCCM) at 37 °C under humidified conditions of 5 % CO2 in a CO2-
incubator (New Brunswick Scientific, Galaxy 170S). The cultivation of cell cultures was 
performed under sterile conditions. All solutions, buffers and reagents were filtered sterile, 
water was autoclaved before usage. Media and washing buffers were incubated in a waterbath 
to warm up to 37 °C before application. 
Confluent cells were passaged every two to five days. Therefor medium was aspirated 
and the cells were rinsed one time with Dulbecco’s Phosphate-Buffered Saline (D-
PBS -Ca2+/Mg2+; Thermo Fisher, 14190169) to remove remaining FBS, which would interfere 
with trypsinization. Cells were then dissociated from dishes by incubation in the synthetic 
trypsin substitute TrypLE Express Enzyme solution (TrypLE; Thermo Fisher, 12605036), 
used in appropriate volumes according to the manufacturer’s instructions. After 5 min at 
37 °C, dissociation was stopped by collecting the detached cells in mCCM. The cells were 
seeded in appropriate dilutions for desired confluency. Cells were cultivated and used for 
experiments until reaching a passaging number of 35. 




For immunocytochemistry (ICC), HeLa and eGFP-Rab35endo KI HeLa cells were 
seeded on glass coverslips, coated with an extracellular matrix protein solution to ensure a 
proper attachment to the glass surface. Therefor the coverslip surface was covered with a thin 
layer of 5 % (v/v) Matrigel (Corning, 356231) in serum-reduced Opti-MEMTM (Thermo 
Fisher, 51985-042). After incubation for 1 h at RT, the solution was removed by rinsing one 
time with D-PBS -Ca2+/Mg2+, and cells were seeded. 
For long-term storage, dissociated cultures from 10 cm dishes were collected in 3 mL 
mCCM, supplemented with additional 30 % (v/v) FBS to a final concentration of 40 % (v/v), 
and 10 % (v/v) DMSO. Each 1 mL was transferred into a cryotube. The stocks were frozen 
stepwise by incubation for 2 h at -20 °C followed by 12 h incubation at -80 °C before transfer 
to and long-term storage in liquid-nitrogen tanks at -196 °C. In order to cultivate cells from 
DMSO-stocks, the cells were thawed slowly on ice, supplied with an excess of mCCM and 
pelleted at 300 x g for 5 min to remove DMSO completely, before seeding in fresh mCCM.  
 
2.2.2.2 Transfection of mammalian cell lines using JetPrime 
JetPrime (VWR, 114-75) was used to transfect HeLa cells with DNA plasmids for 
ICC, or HeLa and HEK cells with siRNA for RNAi-mediated gene knockdown. Neither the 
molecular structure nor the constitution of this reagent is published. However, the transfection 
mechanism is equivalent to another commonly used “proton-sponge” reagent polyethylenimin 
(PEI; Dateki et al., 2016; Sandbichler et al., 2013). These cationic polymer-based reagents 
interact with negatively charged siRNA or DNA to form complexes, in which the nucleic 
acids are protected from nucleases. In addition, the excess of cationic charge of these 
complexes allow for binding to the negatively charged cell membrane, more specifically, to 
surface residing heparan sulfate proteoglycans. Thereby, the complex is internalized by 
endocytosis and delivered to early endosomes (Boussif et al., 1995). The high pH-buffering 
capacity of the amino nitrogen facilitates luminal accumulation of protons and thereby 
chloride ions within these endosomes. This results in osmotic swelling and eventually vesicle 
lysis of the endosomal membrane with subsequent release of the nucleic acids (Medina-
Kauwe et al., 2005). 
Cells with a confluency of 60 % to 80 % were transfected according to the 
manufacturer’s instructions, by mixing 2 µg DNA or 100 pmol siRNA per 6-well with 200 µL 
1x JetPrime buffer. JetPrime reagent was then added in a ratio of 2:1 (v/w) with the nucleic 
acids. After incubation of 10 min at RT, the transfection solution was applied to the cells. For 
co-transfections with more than one plasmid, a 1:1 amount of substance ratio was used with a 




total amount of 2 µg. After 4 h incubation, cells were rinsed with phosphate buffered saline 
(PBS) and supplied with new mCCM. The cells were fixed 24 h post-transfection. For reverse 
transfection with siRNA, the transfection solution was applied to the diluted cell suspension 
during passaging prior to the seeding onto 6-well plates. After 12 h, when cells were settled, 
wells were rinsed with PBS and fresh mCCM was applied. For biochemical analysis, siRNA-
transfected HEK cells were harvested 96 h post-transfection. For rescue experiments, plasmid 
DNA encoding the siRNA-resistant gene was introduced 48 h post-transfection using calcium 
phosphate. siRNA-transfected HeLa cells were passaged to coverslips for ICC after 48 h and 
fixed 96 h post-transfection.  
 
2.2.2.3 Transfection of mammalian cell lines using calcium phosphate 
To introduce DNA-plasmids into eGFP-Rab35endo KI HeLa or HEK cells for affinity 
purifications of proteins or lentiviral production, calcium phosphate transfection was 
performed. Its effect is based on the spontaneous precipitation of calcium ions together with 
phosphates, in which DNA and siRNA is incorporated if present during precipitate formation. 
The precipitate adheres to cell surfaces and thereby facilitates the endocytic uptake of DNA 
and siRNA into the cells (Graham and van der Eb, 1973). 
 For affinity purifications assays, cells with a confluency of 60 % to 80 % were 
transfected 12 h to 24 h after passaging. Appropriate amounts of DNA, depending on the 
culture size as specified in table 2-25, were incubated for 5 min at RT in 0.24 M CaCl2 in 0.1x 
TE. This solution was added dropwise to 2x HBS buffer in a volume ratio of 1:1, under gentle 
vortexing. After 20 min incubation at RT, the precipitate solution was added to the cells and 
incubated overnight. The cells were then rinsed and supplied with fresh mCCM. Experiments 
were performed 24 h to 48 h post-transfection. 
 
Table 2-25: Calcium phosphate transfection mixture for different cell culture dishes. 
 









0.24 M CaCl2 in 0.1x TE 
 [µL] 
6 6 250 250 
10 15 500 500 
15 30 1,250 1,250 
 
2.2.2.4 Production of lentiviral particles 
The production of lentiviral particles and transduction of mammalian cells was done in 
accordance with the S2 guidelines (LAGESO). In primary cell cultures, siRNA-transfection 




usually result in a low transfection rate. Thus, lentiviral particles are produced in order to 
deliver shRNA with a high efficiency by transduction. The lentivirus is a modified HI virus, 
able to introduce RNA and DNA into non-dividing cells but unable to replicate (Naldini et al., 
1996). For virus production, a 2nd generation lentiviral packaging system from Dharmacon 
was used. Here, HEK cells are transfected with three plasmids, of which each contains a 
component of the virus and thus, start to generate the virus upon co-expression only. The 
lentiviral packaging plasmid psPAX2 (addgene, #12260) contains the pol, gag, rev and tat 
viral genes and the rev-response element (RRE). The envelope plasmid pMD2.G (addgene, 
#12259) encodes the G protein of the Vesicular Stomatitis Virus (VSV-G) envelope for a 
broad host infectivity. The transfer plasmid contains the transgene, here, shRNAs under 
control of a U6 promoter for transcription by the RNA Polymerase III. The shRNA is encoded 
between the Long Terminal Repeats (LTRs). The plasmid also contains the psi packaging 
sequence as a recognition site for packaging of the shRNA into viral particles. As transfer 
plasmids, pLKO.1 vectors were used, encoding either for mouse (ms)MTMR2 targeting 
shRNA (Dharmacon, TRCN0000030098), or non-targeting shRNA (scrambled) as a control 
(pLKO.1_scrambled shRNA; Dharmacon, RHS6848). The latter additionally encoded eGFP 
under control of a CMV promoter.  
For lentiviral production, 15 cm dishes of HEK cells were transfected using calcium 
phosphate, 12 h after seeding and with a high confluency of 80 % to 90 %, in order to 
compensate for decreased cell proliferation and increased cell death during virus production. 
Cells, cultivated in 15 cm dishes, were co-transfected overnight with 30 µg of 
shRNA-encoding plasmids, 21 µg of pMD2.G and 9 µg psPAX2, thus, in a ratio of 1.5 : 1.05: 
0.45 and in a total volume of 2.5 mL transfection solution. The cells were treated as S2 
cultures from that point on. The next morning, the cells were washed once with D-PBS. Fresh 
mCCM was applied in a reduced volume of 60 % to increase the virus titer. Two consecutive 
rounds of virus harvest were performed after 24 h and 48 h. The virus-containing medium was 
collected and HEK cells were supplied with fresh mCCM. Mammalian cell debris was 
subsequently removed from the collected medium by centrifugation at 200 x g for 5 min at 
RT. The viral particle-containing supernatant was stored at 4 °C. Supernatants from both 
harvest rounds were pooled and filtered using a 0.45 µm falcon filter in order to remove 
remaining cell debris. The viral particles were then concentrated 100 x to high-titer viral 
supernatants by centrifugation in an Amicon Ultra-15 100 kDa filter column (Merck, 
Z740210) at 5,000 x g and 4 °C for 15 min per 15 mL supernatant. Aliquots with each 20 % 




of concentrated viral supernatant from a 15 cm dish were stored at -80 °C. Thawed aliquots 
for transduction were stored up to two weeks at 4 °C if not emptied at once. 
For calculation of the achieved infection units per mL, the virus titer, HEK cells were 
seeded in defined cell numbers in 24-well plates and transduced with different titrations of the 
concentrated viral supernatant, from 10 % to 0.001 % (v/v) volume per well. After three days, 
cells were trypsinized and the proportion of eGFP-positive cells was determined using a 













𝐧𝐜𝐞𝐥𝐥𝐬𝒕𝟎- seeded cell number; % eGFP
+- proportion of eGFP-positive = transduced cells 
 
The usual titer of concentrated viral supernatant was around 1*108 to 1*109 U/mL. For 
pLKO.1_msMTMR2 shRNA-plasmids, which did not contain an eGFP-encoding gene, the 
production of lentiviral particles was done side by side with the control plasmid to achieve a 
comparable titer. 
 
2.2.2.5 Preparation of primary cell cultures from mice 
All primary cell cultures were obtained from postnatal mice after decapitation 
according to the guidelines of the Landesamt für Gesundheit und Soziales (LAGeSo) Berlin. 
For isolation of the different cell types, mice of distinct age (postnatal day; p) were used 
according to the literature and published protocols to achieve a maximum in cell number and 
culture quality. The isolation of the respective brain regions or nerves was done in a 
semi-sterile hood, all following steps under a sterile hood. All solutions, buffers and reagents 
for preparation and cultivation of primary cell cultures were filtered sterile. Millipore-filtered 
water was autoclaved before usage. If not otherwise indicated, cells were cultivated in cell 
culture dishes or on coverslips in well plates in CO2 incubators (New Brunswick Scientific, 
Galaxy 170S) at 5 % CO2 and 37 °C under humidified conditions. Cell media were 
equilibrated in CO2 incubators, washing buffers were warmed up to 37 °C by water bath 
incubation before application. For cell counting, samples of cell suspensions were diluted 1:1 
with Trypan blue. This dye enters the cytoplasm of dead cells through their porous cell 
membrane. Thus, only alive cells were counted, under non-sterile conditions, using a 
Neubauer chamber and an Olympus CKX-31 phase contrast microscope. 
In order to improve the polypeptide coating and thereby the cell adhesion to the glass 
surface, all coverslips used for the seeding of neuronal, oligodendrocytic or Schwann cell 




cultures were cleaned before usage. Cleaning was performed in 1 N HCl for 24 h, with 
subsequent washes in Aceton and 70 % Ethanol, each for 24 h. The coverslips were then 
stored in 96 % Ethanol. On the day of preparation, coverslips were first dried under sterile 
conditions, transferred to well plates and then coated as specified in the corresponding 
preparation sections. 
 
2.2.2.5.1 Primary neuronal cultures 
Primary neuronal cultures for life cell imaging or ICC were prepared by isolating 
hippocampi from mice at postnatal days one to four (P1 to P4). After decapitation of the mice, 
brains were transferred into a 3.5 cm cell culture dish containing ice-cold Hanks' balanced salt 
solution (HBSS -Mg2+/Ca2+; Thermo Fisher, 14175-053) supplemented with 20 % (v/v) FBS 
and 1 % (v/v) P/S. Under a binocular stereo microscope, the hemispheres were first isolated 
from the middle brain and the brainstem, the meninges then removed from the cortex surface 
and finally hippocampi were separated from the entorhinal cortex. After removal of remaining 
blood vessels, isolated hippocampi from up to six animals were pooled in HBSS with 20 % 
(v/v) FBS and 1% (v/v) P/S in a new dish and cut into equally sized pieces of around 1 mm3 
to 2 mm3. The tissue pieces were transferred into a 15 mL falcon tube containing 5 mL of 
HBSS with 20 % FBS and 1% (v/v) P/S. When cells were settled down, the supernatant was 
aspirated. After two additional washing steps with 5 mL of the same solution, the tissue was 
rinsed twice with 5 mL HBSS with P/S only, in order to remove the serum before digestion. 
Following this, 2 mL neuronal digestion solution with 5 mg/mL Trypsin (Sigma, T1005) and 
375 U/mL DNase I (Sigma, D5025), in order to prevent tissue clumping by free-floating DNA 
fragments, were applied for 15 min at 37 °C. The digestion was stopped by rinsing twice with 
5 mL FBS-supplemented, and twice with FBS-omitted HBSS. The tissue was mechanically 
dissociated in 2 mL neuronal dissociation solution with 375 U/mL Units DNase I, using a 
siliconized glass Pasteur pipette with a fire-induced narrow opening at the tip. The tissue 
solution was triturated up to eight times until a homogeneous cell solution was obtained. 2 mL 
FBS-supplemented HBSS were added and the cells were sedimented by centrifugation for 
8 min at 400 x g and 4 °C. The cell pellet was resuspended in a small volume of neuronal 
plating medium (50 µL/ hippocampus), cells were counted, and the solution was adjusted to a 
cell concentration of 1,600 cells/µL before seeding. To ensure cell attachment, coverslips 
were first coated with Poly-L-lysine hydrobromide in water (PLL; Biochrom, L7240) for 2 h 
at RT, rinsed twice with water and were finally dried, before a drop of cell solution with a 




defined number of cells (2-26) was applied. After 1 hr incubation at 37 °C and 5 % CO2, 
when cells were attached to the coverslips, equilibrated neuronal plating medium was added. 
 











24 200 80 2 
18 120 50 1.5 
12 80 30 1 
 
The cultures were fed on the first day in vitro (DIV1) by replacing 50 % of the 
culturing medium with neuronal growth medium, supplemented with 2 µM Cytosine β-D-
arabinofuranoside hydrochloride (Ara-C; Sigma, C6645). In addition, the cells were 
supplemented with 0.4 µM Tamoxifen (TMX; Sigma, T5648, (Z)-4-hydroxytamoxifen) 
dissolved in Ethanol, to induce expression of the CRE recombinase and thereby the gene 
knockout in Rab35 icKO cells. On DIV2 another half of culture medium was exchanged for 
neuronal growth medium containing TMX and 4 µM Ara-C. Thus, from DIV2 on, the 
cultures were kept in the presence of 3 µM Ara-C, a nucleoside analogue which inhibits 
proliferation and thereby allows to restrict the number of glial cells, mainly astrocytes, within 
these cultures. Experiments were performed on DIV14. 
 
2.2.2.5.2 Primary astrocytic cultures 
Cortices were isolated from mice at postnatal days two to five (P2-P5), equivalent to the 
preparation primary neuronal cultures (2.2.2.5.1) but with the following modifications: The 
hippocampus was removed and discarded during dissection. The cortex’ tissue pieces were 
washed in a 15 mL falcon tube three times with 5 mL HBSS (-Ca2+/Mg2+) and digested for 
15 min at 37 °C in 5 mL of the synthetic trypsin substitute TrypLE Express Enzyme solution 
(TrypLE; Thermo Fisher, 12605036) supplemented with 375 U/mL DNase I. After additional 
three washing steps with HBSS, the cells were dissociated with siliconized Pasteur pipettes as 
described, but in 2 mL mCCM supplemented with 375 U/mL DNase I. The homogeneous cell 
suspension was filled up to 15 mL with mCCM and centrifuged. Sedimented cells were 
collected in 5 mL or 3 mL mCCM per Rab35 WT or icKO cortex, respectively. The 
suspension was filtered through a 70 µM Nylon cell strainer (Sigma, 431751), and each 10 
mL were plated per 10 cm cell culture dish.  




On DIV1 the dishes were rinsed with D-PBS (-Ca2+/Mg2+; Thermo Fisher, 14190169) and 
supplied with 10 mL fresh mCCM containing 0.4 µM TMX. The cultures were grown until 
confluency and then passaged on DIV7 to DIV8 to smaller cell culture dishes or coverslips. In 
brief, 10 cm cell culture dishes were rinsed once with D-PBS, before trypsinization in 0.5 mL 
TrypLE for 5 to 8 min in a CO2-incubator at 37 °C. Trypsinization was stopped by adding 
4.5 mL mCCM and the cell suspension was transferred to 15 mL falcons. The cell 
concentration was determined by cell counting and adjusted with mCCM to the desired 
seeding density (2-27). Cells were seeded on plastic cell culture dishes or wells for 
biochemical assays. For ICC, PLL-coated glass coverslips (see 2.2.2.5.1) were used. To 
achieve a comparable confluency on the day of experiment, Rab35 icKO cells were seeded 
with an increased density compared to WT cells. The medium was exchanged every three to 
four days and experiments were performed on DIV20 to DIV22. For serum-starvation, cells 
were washed one time with D-PBS and cultured in mCCM without FBS for 12 h prior to 
harvest. Control (serum-fed) cells were supplied with fresh FBS-containing medium instead. 
 
Table 2-27: Seeded cell numbers and medium volumes of astrocytic cultures after passaging. 
Dish/ well/ coverslip 
Cell number [x 103] Medium volume 
[mL] WT Rab35 icKO 
6 cm cell culture dish 360 900 5 
6-well 120 300 
2 
24 mm coverslip 30 80 
 
2.2.2.5.3 Primary oligodendrocytic (precursor) cell cultures 
Primary oligodendrocytic precursor cell (OPC) cultures were prepared using 
immunopanning-mediated purification from mouse cortices according to the protocol of 
Emery and Dugas (2013). Mature myelinating oligodendrocytes were obtained by 
differentiation induction of OPCs in culture. 
In brief, cortices from P6 to P8 mouse pups were isolated as described (2.2.2.5.1) and 
collected in 3.5 cm cell culture dishes containing 2 mL ice-cold D-PBS -Ca2+/Mg2+. After 
dissection of all cortices, each two were transferred to 100 µL D-PBS -Ca2+/Mg2+ in another 
3.5 cm dish and cut into pieces of around 1 mm3. The absence of calcium and magnesium is 
crucial to promote the subsequent enzymatic digestion. For this, 20 U/mL Papain 
(Worthington Biochemical, LS003126) were dissolved in equilibrated Papain buffer by 
incubation at 37 °C for 15 min. In contrast to the serine protease trypsin, papain is a cysteine 
protease and less damaging during tissue digestion. This leads to a comparably high amount 




of morphologically intact cells, particularly important for immunopanning. The enzyme was 
activated by the addition of 0.2 mg/mL L-cysteine (Sigma-Aldrich C-7477) and supplemented 
with 250 U/mL DNAse I (Worthington Biochemical, LS002007).  
The cortex tissue was supplied with each 3 mL of sterile filtered papain-containing 
digestion solution per dish and incubated for 90 min at 37 °C in a 5 % CO2-incubator. The 
tissue suspension of each three dishes was pooled and transferred into a 15 mL falcon. After 
the tissue had settled down, the supernatant was aspirated and washed with 2 mL of 
equilibrated low-ovomucoid solution (LOS), supplemented with 125 U/mL DNAse I, to stop 
the papain activity. The tissue was dissociated mechanically to single cells by gentle 
trituration in 3 mL LOS for eight times with a 1 mL plastic tip pipette. When the remaining 
tissue pieces were settled down, 1 mL of cell suspension supernatant was transferred into a 
new tube and 1 mL of fresh LOS was added to the remaining tissue for another round of 
trituration. This procedure was repeated six times until the tissue was fully dissociated and 
entirely transferred as a homogeneous suspension to the new tube. The cells were pelleted by 
centrifugation for 15 min at RT and 400 x g and washed in 6 mL equilibrated high-ovomucoid 
solution (HOS) for full papain inactivation. After another round of centrifugation, the cells 
were collected in 15 mL immunopanning buffer, filtered through a 70 µM Nylon cell strainer 
(Sigma, 431751) and applied to the prepared immunopanning dishes. 
In three consecutive rounds of immunopanning, the cells were first two times 
negatively selected for microglia with an antibody against the Griffonia (Bandeiraea) 
Simplicifolia Lectin 1 (BSL1), followed by a positive selection for OPCs against the 
platelet-derived growth factor receptor α (PDGFRα). For each negative selection, one 15 cm 
cell culture dish was coated with 20 mL of 1 µg/mL BSL1 (Vector Laboratories, L1100) in D-
PBS +Ca2+/Mg2+ (Thermo Fisher, 14287080) for 2 h at RT. The dishes were rinsed three 
times carefully with D-PBS +Ca2+/Mg2+, before the cells were applied for each 15 min. For 
the positive selection of OPCs, 10 cm cell culture dishes were first coated with 10 mL of 
3 µg/mL goat-α-rat antibody (Jackson ImmunoResearch, 112-005-167) in 50 mM TRIS-HCl 
pH 9.5 overnight at 4 °C. The primary antibody solution was then applied for 2 h at RT, 
containing 1.6 µg/mL rat-α-PDGFRα antibody (BD Pharmingen, 558774) in 0.2 % BSA 
(Sigma, A4161) in D-PBS +Ca2+/Mg2+. The cell suspension was applied for 45 min with 
slight agitation of the dishes every 15 min. The supernatant was discarded, and the dishes 
were rinsed carefully six times with D-PBS +Ca2+/Mg2+ to remove all non-attached cells. 
After another wash with 10 % CO2-equilibrated Earle’s Balanced Salt solution (EBSS; 
Thermo Fisher, 14155063), 4 mL of  5 x 103 U/mL Trypsin (Sigma, T9935) in EBSS were 




applied for 6 min to 8 min at 37 °C in a 5 % CO2-incubator. The detached OPCs were 
collected from the immunopanning dishes in 10 mL D-PBS +Ca2+/Mg2+ with 30 % (v/v) heat-
inactivated FBS to stop the enzyme reaction. The cell solution was transferred to a 15 mL 
falcon-tube for centrifugation at 400 x g for 15 min at RT. After resuspension of the cell pellet 
in 25 µL DMEM-Sato growth medium (DSM) per cortex, the cells were counted and the cell 
concentration was adjusted. OPCs were seeded in 25 µL drops with a number of 20 x 103 
cells. Cleaned 12 mm glass coverslips were used, coated overnight at 4 °C with 80 µL of 10 
µg/mL Poly-D-Lysine (PDL; Sigma, P6407) in 1.5 mM boric acid pH 8.4. After cell 
attachment (1 hr at 37 °C and 10 % CO2) 500 µL equilibrated DSM was supplemented with 
10 µM Forskolin and each 10 ng/mL of ciliary neurotrophic factor (CNTF) platelet-derived 
growth factor AA (PDGF-AA) and neurotrophin-3 (NT-3) (OPC proliferation medium) , and 
added. Cells were cultivated in 10 % CO2-incubators according to standard protocols. On 
DIV1, the coverslips were rinsed with D-PBS -Ca2+/Mg2+ before fresh medium was applied, 
supplemented with 0.4 µM TMX. For experiments with oligodendrocytic cultures, OPC 
differentiation medium was used from DIV1 on. Here, Forskolin and CNTF to raise cAMP 
levels and ensure cell survival, respectively, were added to DSM. The mitogens for OPC 
proliferation, PDGF-AA and NT-3, were replaced by 40 ng/mL thyroid hormone 
triiodothyronine (T3) to induce the differentiation into mature oligodendrocytes.  
DSM was prepared freshly every week and stored at 4 °C. The cultures were fed by 
exchanging half of culturing medium volume every two to three days and fixed on DIV7 to 
DIV8. Cultures were transduced or inhibitors were applied at DIV3 with ongoing application 
during medium exchange. 
 
2.2.2.5.4 Primary Schwann cell mono-cultures 
The preparation of Schwann cell mono-cultures was performed according to Jessen 
and Mirsky (Arthur-Farraj et al., 2011), representing an adaption of the Brockes method for 
the preparation and purification of Schwann cells from mice (Brockes et al., 1979). In brief, 
Schwann cells were purified from the sciatic nerve and the brachial plexus, isolated from P4 
to P6 mice after decapitation. For dissection of the sciatic nerve, the dorsal skin was removed 
at the level of the hindlimbs. The nerve was exposed by cutting along the gluteus maximus, 
and isolated from its origin at the spinal cord, at the head of the thigh-bone, until its allocation 
into smaller cords at the knee joint. The brachial plexus was dissected by first removing the 
ventral skin at the upper limbs from the armpit to the elbow. By cutting along the Biceps 




brachii muscles, the nerve cords were revealed underneath and then isolated from the axilla to 
their distal branching points at the elbow joint. 
Nerves of each mouse were collected in one 3.5 cm cell culture dish containing 2 mL 
ice-cold Leibovitz’s L-15 medium (L-15; Thermo Fisher, 11415049) and freed from 
remaining connective tissue and endoneurium. For digestion, clean nerves were transferred 
into a new dish with 3 mL L-15 supplemented with 0.1 % (w/v) Collagenase A (Sigma, 
10103586001) and 0.25 % (w/v) Trypsin (Thermo Fisher, 27250018) for 1 hr at 37 °C and 
5 % CO2. After dissociation of the nerve tissue by trituration with a 200 µL Gilson pipette, the 
tissue solutions of each three dishes were pooled in a 50 mL falcon-tube and SC 
pre-differentiation medium was added in a volume ratio of 1:1. The cells were pelleted by 
centrifugation at RT with 400 x g for 10 min and collected in 2 mL fresh SC pre-
differentiation medium for each four nerves. Prior to plating, each one 6-well per nerves from 
one mouse was first coated with 1 mL of 50 µg/mL PLL diluted in water (Sigma, P1274) for 
3 h at RT. PLL was then aspirated and replaced by 750 µL of 100 µg/mL Laminin (Sigma, 
L2020) diluted in DMEM. After 1 h incubation at 37 °C the cell suspension was added. 
Schwann cells were cultured in SC pre-differentiation medium with Ara-C until DIV3, 
when the number of fibroblasts was sufficiently reduced. The cells were then passaged to 24 
mm cleaned glass coverslips, sequentially coated with 60 µL of 50 µg/mL PLL and 50 µL of 
50 µg/mL Laminin. After removing the cell medium and rinsing with D-PBS -Ca2+/Mg2+, the 
cells were detached by incubating each well with 200 µL TryPLE for 5 min at 37°C and 
5% CO2. Schwann cells were collected in each 2 mL DMEM with 0.5 % (v/v) horse serum 
(HS) and 1 % (v/v) P/S, and pelleted by centrifugation at 400 x g at RT. The cell pellet was 
resuspended in 30 µL DSM per 6-well, counted and the cell concentration was adjusted. On 
each 24 mm coverslip, cells were seeded at a density of 15 x 103 cells in 15 µL. After 
incubation for 1 h at 37 °C in a 5 % CO2-incubator, 500 µL equilibrated SC differentiation 
medium, adapted from (Jessen et al., 1994; Emery and Dugas, 2013), was added to each well. 
Here, DSM was supplemented with 20 ng/mL Neuregulin1 (NRG1), 1 µM Forskolin, 40 
ng/mL T3 and 50 µg/mL ascorbic acid for differentiation and myelination induction (Eldridge 
et al., 1987; Arthur-Farraj et al., 2011), and 0.4 µM TMX. Half of the medium was 









2.2.2.6 Calcium phosphate transfection of primary neuronal cultures  
Primary neuronal cell cultures were transfected at DIV7 using the Calcium phosphate 
transfection kit from Promega. The transfection mechanism is based on the calcium phosphate 
assay (see 2.2.2.3) (Graham and van der Eb, 1973). According to the manufacturer’s 
instructions, plasmid DNA was first mixed with calcium chloride and then diluted in 
nuclease-free water (table 2-28). The mixture was applied to an equal volume of 2x 
phosphate-buffer (HB) under slight vortexing for the generation of calcium-phosphate-DNA-
precipitates, and subsequently incubated for 20 min in the dark. Neurobasal medium A (NBA; 
Invitrogen, 21103) was adjusted to the osmolarity of the culturing medium using D-(+)-
Mannitol. Neuronal cultures were then incubated in 1 mL/well equilibrated NBA for 20 min 
at 37 °C and 5 % CO2. The transfection solution was applied in a volume of 200 µL/well and 
the cultures were incubated for 30 min at 37 °C and 5 % CO2 until the precipitates were 
visibly settled onto the cells. The coverslips were washed twice with 2 mL osmolarity-
adjusted and equilibrated HBSS (-Mg2+/Ca2+) and transferred back to the culture medium.  
 
Table 2-28: Transfection reaction solution for neuronal cultures on 24 mm coverslips. 
Component Amount/well 
Plasmid DNA 6 µg 
2 M Calcium chloride (Promega)  125 mM 
Nuclease-free H2O (Promega) ad 100 µL 
2x Phosphate-buffer HB, pH 7.1 (Promega) 1x 
 
2. 2. 2. 7 Viral transduction of cell cultures 
Viral transduction of astrocytic cultures was performed with a multiplicity of infection 
(MOI) of 20. Cells were transduced in fresh medium in two consecutive rounds, at DIV11-12 
and DIV16-17, before harvest at DIV20-22. The day before harvest, cells were supplied with 
fresh medium. Similarly, MEF cells were transduced in two rounds for each three days. 
Oligodendrocytic cultures were transduced with a MOI of 50 in fresh medium on DIV3 and 
DIV6 and fixed on DIV8. 
 
2.2.2.8 BrdU treatment 
Bromodeoxyuridine (BrdU) is a nucleoside analogue for thymidine that incorporates 
into the S-phase of the cell cycle (Miller and Nowakowski, 1988; Cavanagh et al., 2011). 
BrdU (Abcam, ab142567) was dissolved to a 10 mM stock solution in DMSO and diluted to a 
working solution of 10 µM in cell culture medium prior to application. The cell medium was 




replaced by sterile filtered BrdU-containing medium for 36 h. The cultures were then fixed 
and immunolabelled using a BrdU-targeting antibody (see 2.2.2.9).  
 
2.2.2.9 Inhibitor treatments 
All compounds were dissolved in DMSO to indicated concentrations as stock 
solutions (see table 2-16). The used working concentrations are indicated for each experiment. 
For acute application, cells were treated for 1 h with indicated concentrations. For chronical 
treatments, Schwann cells were supplemented with inhibitors from DIV5 to DIV11. Control 
cells were supplemented with an equal volume of DMSO.  
 
2.2.2.10 Immunocytochemistry (ICC) 
Cell cultures, grown on coverslips, were rinsed with 1x PBS and fixed with 4 % (w/v) 
paraformaldehyde (PFA) with 4 % (w/v) sucrose in millipore-filtered water in defined 
volumes (table 2-29) for 15 min at RT. After three washes with PBS to remove remaining 
PFA, the cells were simultaneously permeabilized, to perforate the cell membrane, and 
blocked, to prevent unspecific antibody binding, for 1 h in PBS with 0.3 % (v/v) Triton X-100 
and 10 % (v/v) normal goat serum (NGS) (ICC blocking solution). If secondary antibodies 
raised in donkey were used additionally, the incubation time with the NGS-containing ICC 
blocking solution was shortened to 30 min, and another 30 min incubation was performed 
with 10 % (v/v) normal donkey serum (NDS) in ICC blocking solution. Antibodies were 
specifically diluted (table 2-13) in PBS with 0.3 % (v/v) Triton X-100 and 5 % (v/v) NGS 
(ICC antibody solution). The coverslips were placed upside down into a drop of antibody 
solution on parafilm in a dark humidified chamber. After 1 h incubation at RT with primary 
antibodies, the coverslips were washed three times in PBS, and incubated in secondary ICC 
antibody solution. Where indicated, the solution was supplemented with 6 U/mL Alexa-
fluorophore-conjugated Phalloidin, a high affinity F-actin probe to label the cell cytoskeleton. 
Excess of unbound antibodies was removed by rinsing another three times with PBS, before 
the coverslips were mounted on microscope slides in Immu-Mount (Thermo Fisher, 9990402) 
supplemented with 1 µg/mL 4',6-Diamidino-2-phenylindol (DAPI). The slides were stored at 












Table 2-29: Immunocytochemistry solution volumes. 
 
Solution 
Volume per coverslip [µL] 
6-well:  
Ø 24 mm 
12-well:  
Ø 18 mm 
24-well:  
Ø 12 mm 
PFA; ICC blocking solution 1,000 750 500 
ICC antibody solution 50 25 12.5 
 
In order to label surface-residing proteins only, the detergent Triton-X100 was omitted 
from the ICC blocking and primary antibody solutions. The cells were then post-fixed for 
15 min at RT with 2 % (w/v) paraformaldehyde (PFA) and 2 % (w/v) sucrose, and finally 
incubated with detergent-containing solutions, according to the standard protocol, for 
subsequent immunolabeling of corresponding total protein levels using distinct primary and 
secondary antibodies.  
Intracellular membrane lipids were immunolabelled using either a specific primary 
antibody (PI(4)P) or the recombinantly expressed and purified lipid-binding domain chimera 
eGFP-2xFYVE (Hrs) (Gillooly et al., 2003) which is subsequently targeted using a 
GFP-recognizing antibody. Therefor a modified ICC protocol was performed according to 
Hammond and colleagues (2009) to ensure preservation of endomembranes. The cells were 
fixed with low concentrations of 2 % PFA fixative to prevent osmotic swelling. After three 
times wash with PBS, a non-phosphate-containing PIPES-based buffer (PIB) was used for all 
subsequent steps, as free phosphates would otherwise compete with the phosphor-lipids for 
probe binding. The cells were permeabilized in PIB for 5 min at RT with 20 µM Digitonin, a 
cholesterol-selective detergent which perforates the cholesterol-rich plasma membrane 
(Lange, 1991) while internal membranes stay intact. This was followed by three thorough 
washes with PIB to get rid of remaining Digitonin, which would affect the efficiency of lipid 
staining during longer exposure. The cells were simultaneously blocked and labelled for 45 
min with 0.025 µg/µL eGFP-2xFYVE (Hrs) in PIB supplemented with 5 % (v/v) NGS. In 
addition, the solution was supplemented with 50 mM ammonium chloride, in order to quench 
the remaining free aldehyde groups from the PFA fixation with amines and thus, prevent 
non-specific binding and autofluorescence. After washing in PIB according to the published 
protocol, primary and secondary antibodies were applied in 5 % (v/v) NGS in PIB for 1 h and 
45 min, respectively. The volume of antibody solutions was increased by 20 % compared to 
the detergent-based solutions (table 2-29) to compensate for the increased surface tension and 
thus, ensure antibody decoration of the whole coverslip. The coverslips were then post-fixed 




for 5 min with 2 % PFA fixative, and washed with PBS, three times with 50 mM ammonium 
chloride, and once without. Mounting was performed as described above. 
Autophagosomes were visualized by immunodetection of the transiently autophagosomal-
associated protein LC3 (Kaminskyy et al., 2011; Kabeya et al., 2000). Here, the fixation 
duration was prolonged to 30 min. Triton X-100 was omitted from the PBS-based solutions 
and permeabilization was performed equivalent to the lipid staining protocol by using 
Digitonin, to preserve the autophagosomal membranes.  
For immunolabelling of BrdU, the cells were washed twice with 1x PBS and three times 
with 1x PBS for 2 min each, before fixation with 4 % PFA-fixative for 15 min at RT. After 
another three washes with PBS for each 2 min, first 0.1 % (v/v) Triton X-100 in PBS for 20 
min, then 2 N HCl for 30 min was added. The coverslips were then washed another three 
times with PBS. ICC blocking and antibody solutions were applied according to the standard 
protocol (table 2-29). 
 
2.2.2.11 Confocal microscopy and immunocytochemistry analysis  
Immunolabelled or fluorescently tagged proteins in fixed cultures were imaged using a 
Zeiss laser scanning microscope (LSM710) with a 63x 1.4 NA (numerical aperture) oil 
objective routinely, or a 40 x 1.3 NA oil objective for neuronal cultures. Excitation was 
performed with an Argon laser at 488 nm, a DPSS laser at 561 nm and a Helium Neon laser at 
633 nm for Alexa-Fluor488/eGFP, Alexa 568/mCherry and Alexa 647, respectively. 
Corresponding emission was detected between 503-553 nm, 581-626 nm and 649-700 nm, 
respectively. Images were acquired with the Digital microscope camera AxioCam (Zeiss), 
controlled by the Imaging-Software ZEN (Zeiss), and analyzed using ImageJ software. Single 
cell masks were routinely generated using Phalloidin signals and transferred to the channel of 
interest to measure mean fluorescence intensity per cell in the case of diffuse 
immunolabeling. For synaptic stainings, a synapsin-based bouton mask was used to measure 
mean fluorescence intensities in presynapses only. For rare punctate staining in cells, or if 
background subtraction was required, the sum intensities of ROIs (region of interest = 
fluorescent signal minus background signals) was measured and divided by the cell area. For 
LC3, background subtraction of diffuse cytoplasmic staining, representing LC3-I signals, was 
performed to reveal autophagosomal membrane associated LC3-II -positive puncta only. For 
eGFP-FYVE(Hrs) signals, a background threshold was determined in samples, acutely treated 
with the PI(3)P-synthesizing VPS34 inhibitor VPS34-IN1. HeLa cells or astrocytes 
immunolabeled for lipids were imaged using a z-stack series of usually seven slices with 




0.5 µm intervals. Prior to fluorescence intensity analysis, the slices were summed up using the 
ImageJ ‘z-projection’ tool with ‘max intensity’. P0-protein immunostainings in Schwann cell 
mono-cultures were imaged with a 10x 0.3 NA air objective. Here, sum intensities per image 
(10 images per condition and experiment) were normalized by the number of DAPI-positive 
cell nuclei per image.  
For all immunostainings, at least 10 images per condition were acquired, evaluated 
and averaged for each experiment. Statistical analysis with the mean values of independent 
experiments. 
 
2.2.2.12 Live-cell imaging and electrical field stimulation of primary neuronal cultures 
Live-cell imaging was performed on DIV14 using a pHluorin-based assay 
(Miesenböck et al., 1998), around 7 days post-transfection with the pHluorin-construct. The 
construct encoded for a pH-dependent eGFP (pHluorin), with a pKa of 7.1, excitation at 
455-485 nm and emission at 510–555 nm (Sankaranarayanan et al., 2000), coupled to the 
luminal terminus of the presynaptic vesicle protein Syt1. During electrical field stimulation, 
neuronal depolarization and thus, Ca2+ influx in the presynapse triggers exocytosis of synaptic 
vesicles (SVs), i.e SV fusion with the plasma membrane. Thereby, pHluorin is exposed to the 
physiological pH of the extracellular buffer solution and de-quenched. Subsequent endocytic 
retrieval of SVs, and therefore Syt1-pHluorin from the plasma membrane results in a 
re-quench due to subsequent reacidification of the vesicular lumen (3 - 4 s; Atluri and Ryan, 
2006). Therefore, fluorescence measurements using a GFP-filter setup allow to monitor 
recycling of synaptic vesicle (proteins) and endocytic retrieval kinetics. 
The neuronal cultures on coverslips were stimulated in a stimulation quick change 
chamber (Warner Instruments, RC-47FSLP) in 500 µL imaging buffer at 37 °C. The imaging 
buffer provided essential ions like Na+, K+ and Mg2+ on the one hand, and contained the 
glutamate receptor antagonists APV (NMDA receptors) and CNQX (AMPA receptors) on the 
other, to prevent postsynaptic responses and recurrent network excitation. Stimulation was 
performed with the MultiStim SYSTEM-D330 (Harvard Apparatus) by applying electric field 
pulses of 5 Hz for 40 s at 100 mA, with a pulse duration of 1 ms. Imaging was performed 
using a Nikon Eclipse Ti microscope, equipped with an incubator for temperature control 
(Okolab), a 200 Watt mercury lamp (Lumen 200, Prior), the eGFP filter set (Semrock, F36-
526), and operated by ImageJ-based MicroManager 4.11 software. The samples were 
illuminated with 100 ms exposure time. Recording were done using a 40x oil-immersion 
objective and the PerfectFocus Autofocus system (Nikon). Images were acquired with a 




sCMOS camera (Neo, Andor) controlled by the ImageJ plugin “Time Series Analyzer” at a 
frame rate of 0.5 Hz for 2 min, starting 10 s prior to stimulation. Evaluation of time-series 
fluorescence intensities from hand-masked boutons was performed using Image J. The 
fluorescence intensity course over time of around 50 boutons per image-series were averaged, 
background subtracted and corrected for bleaching. The bleaching factor was calculated from 
the mono-exponential decay of the fluorescence intensity trend prior to stimulation. For 
analysis of the relative fluorescence increase upon stimulation, representing the apparent SV 
release, the peak of fluorescence upon stimulation (Fmax) was normalized to the mean initial 
fluorescence (F0) prior to stimulation (Fmax/F0). In order to determine the endocytic time 
constant (τ), the initial fluorescence F0 was subtracted from the fluorescence F at each time-
point (t) to obtain the absolute change in fluorescence ΔF(t) (F-F0). ΔF was then normalized 
to ΔFmax (ΔF/ΔFmax) to obtain relative values for the fluorescence time course scaled between 
1 (Fmax) and 0 (F0). This allowed for a mono-exponential fit of the decay using GraphPad 
Prism 5 software to calculate τ: 







(𝚫𝐅/𝚫𝐅𝐦𝐚𝐱)(𝐭)- Normalized fluorescence intensity course over time; y0- extreme value approached at tmax;  
A = F(t)max (= 1); τ – endocytic time constant (t at F(t) = 1/e) 
 
The mean data from 5 to 7 image-series per experiment were averaged, and statistic was 
performed on the mean curves from independent experiments. 
 
2.2.2.13 Ultrastructural analysis of HRP-uptake in neuronal cultures by electron microscopy 
Horse-radish peroxidase (HRP) is a glycoprotein and was used in this assay as a fluid 
phase marker, uptaken from the extracellular medium by synapses during endocytosis 
(Clayton et al., 2008). HRP can be detected by oxidation of diamino-benzidine with hydrogen 
peroxide (Graham and Karnovsky, 1966). Oxidized diamino-benzidine-precipitates are 
converted to an electron-dense product (osmium-black) in the presence of Tetraosmium 
(OsO4) (Johansson and Backman, 1983).  
Cultured hippocampal neurons grown on coverslips were preincubated with 10 mg/mL 
Type VI HRP (Sigma, P8375) in 1x imaging buffer for 5 min and then stimulated with high-
potassium imaging buffer including HRP for 90s. Following stimulation, cultures were 
washed with imaging buffer for 5 minutes and fixed with 2% (w/v) glutaraldehyde in 1x PBS 
for 40 minutes. 




Electron microscopy was performed by Dr. Dmytro Puchkov from the EM facility at 
Leibniz Research Institute for Molecular Pharmacology (FMP, Berlin). Following fixation 
and one wash with PBS, neurons were incubated for 20 min in 0.1 M glycine in PBS to 
quench remainder of glutaraldehyde. HRP was visualized by incubating the fixed cultures for 
25 min in 3,3′-diaminobenzidine tetrahydrochloride (DAB; 0.75 mg/mL) in 0.05 M TRIS-
HCl, pH 7.6, containing 0.01 % (w/v) hydrogen peroxide. Neurons were washed in PBS, post-
fixed with 1% (w/v) OsO4 for 1 h, washed with distilled water, dehydrated, and embedded 
into Epoxy resin. Coverslips were cracked away by liquid nitrogen and sections of 60 nm 
thickness were viewed with a Zeiss EM900 transmission electron microscope. Morphometric 
analysis of synaptic boutons terminals was performed using ImageJ software. Vesicles were 
considered as HRP-positive if the intensity of DAB labeling in the vesicle lumen was at least 
three times higher than background labeling. Excitatory synapses were taken for analysis. 80 
synapses per genotype were analyzed. Regular shaped vesicles smaller than 50 nm in 
diameter and 2,000 nm2 in cross-section area were counted as synaptic vesicles. All other 
larger vesicles observed in synaptic terminals were classified as endosomes of different sizes. 
 
 
2.2.3 Biochemical methods  
2.2.3.1 Harvest of mammalian cells 
Mammalian cells were harvested with a non-ionic and therefor non-denaturating 
detergent-based buffer. It lyses the cell membrane and releases the cytoplasmic proteins, 
which are kept in solution due to the physiological pH and the stabilizing salt and metal ions 
provided by the buffer. All steps of cell lysis were performed on ice in order to prohibit 
protease activity and therefor protein degradation within the cell lysates. In addition, 
mammalian protease inhibitor cocktail (PIC), and the serin- and cysteine protease inhibitor 
phenylmethylsulfonyl fluoride (PMSF), with a half-life of 30 min in water, were always 
added freshly to the lysis buffer prior to use. The phosphatase inhibitor cocktails 2 and 3 
(Sigma, P5726, P0044) were applied when the phosphorylation status of lysate proteins was 
meant to be analyzed, to inhibit effects from massive dephosphorylation during lysis. The 
lysis buffer was applied in defined volumes for the different confluent cell cultures (table 
2-30), depending on the cell type, the surface area of the culture dish and the required 
minimal protein concentration for the corresponding experiment. Cultures were grown on 6 
cm dishes or 6-well plates for lysate protein analysis by SDS-PAGE and Western Blot. For 
affinity purification assays, 10 cm or 15 cm culture dishes were used to achieve high protein 




amounts and a protein concentration of around 5 µg/µL with the corresponding lysis buffer 
volumes (table 2-30).  
Mammalian cell cultures were rinsed once with ice-cold autoclaved 1x PBS before 1x 
cell lysis buffer was applied. The cells were collected in buffer with a cell scraper and the 
suspension was transferred to an Eppendorf tube. Lysis was performed by incubation for 
20 min on ice with gentle inversions every 5 min. Remaining intact cells were pelleted 
together with the membrane fraction by centrifugation at 17,000 x g for 5 min at 4 °C in a 
tabletop cooling centrifuge (Eppendorf). For general analysis of protein content by 
SDS-PAGE and Western Blot, the protein concentration of the supernatant was directly 
determined by Bradford Assay, adjusted to the desired protein concentration of 1 µg/µL to 
2 µg/µL with lysis buffer and prepared for SDS-PAGE. 
For affinity purification assays, the lysates were further cleared from potentially 
interfering smaller membrane pieces. Therefore, ultracentrifugation at 180,000 x g for 15 min 
at 4 °C in a TLA110 rotor (Sorvall) was performed. The supernatants were then freshly 
supplied with 1 mM PMSF. After determination and adjustment of the protein concentration, 
the samples were used as “inputs” in the corresponding assays. 
  




Lysis buffer volume [µL] 
Astrocytes HEK cells 
eGFP-Rab35endo 
KI HeLa cells 
6-wells 40 200  
6 cm 80 350  
10 cm  300  
15 cm   300 
 
2.2.3.2 Determination of protein concentration 
The protein concentration of cell lysates was determined using the Bradford protein 
assay. It is based on an equilibrium shift of Coomassie brillant Blue G250 upon protein 
binding, from a stable double protonated red into a stable unprotonated blue form with an 
absorbance maximum of 595 nm (Bradford, 1976). In this assay, 1 µL of cell lysate was 
added to 1 mL of 1x Bradford solution diluted in millipore-filtered water. Each three 
replicates were analyzed per sample. The mixtures were incubated for 5 min at RT in the 
dark. The absorbance at 595 nm was measured using a photometer (BioPhotometer Plus, 
Eppendorf). Samples were blanked with 1 µL lysate buffer in Bradford solution. A BSA 
(bovine serum albumin) standard curve, i.e. the extinction of samples with known BSA 




concentrations from 1 µg to 10 µg, served as a reference. The lysate protein concentration was 
calculated using the parameters from the linear regression of the standard curve. 
Alternatively, samples were measured in a 96-well plate in 250 µL 1x Bradford solution using 
the SPECTROstarNano microplate reader (BMG LABTECH) and evaluated using MARS Data 
Analysis Software (BMG LABTECH) 
 
2.2.3.3 SDS-PAGE  
The discontinuous Sodium dodecyl sulfate - Polyacrylamide gel electrophoresis (SDS-
PAGE) was performed according to Laemmli (1970), in order to analyze the protein levels of 
cell lysates or other samples by protein fractionating according to their molecular weight. All 
reagents, including the SDS-running buffer, SDS-sample buffer and the gel components were 
prepared according to the Laemmli buffer system. The gel electrophoresis chamber Mini 
Protean Tetra Cell System (Bio-Rad), and corresponding plates, combs and pouring stations 
were used for gel preparation (table 2-31) with 1 mm thickness, and a polyacrylamide 
concentration according to the molecular weight of the proteins of interest. To ensure a 
straight passage between stacking and separating gel, a layer of 2-Propanol was added on top 
of the separating gel during polymerization incubation, and washed off twice with water 
before the stacking gel was poured.  
 





8 % 10 % 12 % 
1x buffer Separating gel buffer; pH 8.8 Stacking gel buffer; pH 6.8 
Acrylamide/Methylen  
bisacrylamide - 37.5:1 (v/v) 
8 % 10 % 12 % 3 % 
TEMED (v/v) 0,1 % 
APS (w/v) 0,1 % 
 
 
The samples with desired protein amounts (20 µg to 40 µg) were mixed with 6x SDS-
sample buffer and boiled for 5 min at 95 °C in a heating block. This step results in protein 
denaturation, mediated by the disulfide bond-reducing reagent 2-Mercaptoethanol and the 
anionic detergent SDS. The latter binds to proteins in a ratio of around 1.4 g per 1 g protein, 
and thereby leads to an equal negative charge of all proteins. Thus, the protein mobility 
through the gel from cathode to anode is dependent on their molecular weight only. After 
centrifugation at 17,000 x g, samples were loaded into the equilibrated gel pockets in volumes 
of 20 to 40 µL. Gels were run in electrophoresis chambers filled with 1x SDS-running buffer. 




As a reference, 0.5 µg of a protein marker was used. To achieve approximately equal sample 
volumes per gel, 1x sample-buffer was added to empty pockets as well as to pockets 
containing the low volume of protein marker. Electrophoresis was started with 90 V 
corresponding to a current of around 10 mA/gel, until the migration front accumulated at the 
edge between stacking and separating gel. With the passage of the samples to the separating 
gel, the voltage was increased to 130 V. The electrophoresis was stopped as soon as the 
bromophenol blue frontline of the sample buffer reached the bottom of the gel. For detection 
of proteins the gels were stained with Coomassie or further processed by immunoblotting. 
 
2.2.3.4 Coomassie staining of SDS-gels 
SDS-polyacrylamide gels were incubated in Coomassie staining solution for 2 h at RT, 
to visualize the fractionated proteins by its electrostatic interaction with Coomassie blue 
G-250 dye. Background staining of the gel was removed by two consecutive incubation 
rounds in Coomassie destain solution, first overnight and then for 2 h at RT.  
  
2.2.3.5 Immunoblotting  
For the selective detection of proteins, immunoblots (Western Blots) were performed. 
First, the separated and negatively charged proteins were transferred from SDS-
polyacrylamide gels to nitrocellulose membranes (Amersham Protran 0.2 NC; GE Healthcare) 
by application of an electric current, using the tank electroblotting Mini Trans-Blot system 
(Bio-Rad). The SDS-polyacrylamide gel, the membrane and four sheets of Whatman paper 
(Grade GB003; Sigma, WHA10427826), all equally sized, were equilibrated in 1x Transfer 
buffer containing 10 % Methanol. They were subsequently arranged in a stack between two 
sponges, starting with two Whatman papers followed by the membrane, the gel and two 
Whatman papers on top. After removing air bubbles between the layers, the stack was placed 
into the blotting chamber with the gel at the side of the cathode and the membrane towards the 
anode. Transfer was performed at 4 °C for 2 h by applying a constant voltage of 110 V for 
90 min. In order to verify transfer performance and equal protein loading among the samples, 
the membrane was reversibly stained with the protein binding Ponceau S-staining solution for 
20 min and subsequent removal of background staining by three washes with Ponceau 
destaining solution. The membrane was imaged and, if necessary, cut at distinct molecular 
weights for the parallel detection of differently sized proteins. Ponceau S staining, which 
would interfere with antibody detection, was removed by several washes with PBS. All 
subsequent incubations were performed on a lab shaker.  




For qualitative protein analysis or the detection of weak antibody signals, 
chemiluminescence detection was used. The membrane was blocked with 5 % (w/v) milk in 
PBS for 1 h, to prevent unspecific antibody-binding. Primary antibody solution was applied 
for 2 h at RT or overnight at 4 °C. After four times wash for 5 min with PBS-T, horseradish 
peroxidase (HRP)-conjugated secondary antibodies were applied in blocking buffer for 1 h. 
The membrane was rinsed two times for 5 min with PBS-T and another two times with PBS. 
An enhanced chemiluminescent substrate (Amersham ECL; GE Healthcare, RPN223) for 
detection of the secondary antibody-coupled HRP was used. This solution contains luminol 
and becomes oxidized and therefore chemiluminescent by HRP-mediated catalysis. The 
chemiluminescence reaction was detected with the Bio-Rad ChemiDoc™-System and 
recorded with Image Lab software (Bio-Rad).  
For the quantitative analysis of protein levels, IRDye-conjugated secondary antibodies 
were used. To not interfere with the fluorescence detection, the commercial Odyssey blocking 
buffer from LI-COR was used instead of milk, undiluted for blocking or 1:1 diluted in PBS-T 
as a secondary antibody solution. Fluorescent signals were detected with the LI-COR 
Odyssey® Fc Imaging system and recorded and evaluated with Image Studio Lite software 
(LI-COR). 
 
2.2.3.6 Affinity purification using nucleotide-loaded GST-recombinant Rab proteins 
2.2.3.6.1 Recombinant protein expression in bacteria 
For the expression of recombinant GST-fusion proteins, based on the T7-
expressionsystem (Studier und Moffatt, 1986) in E. coli BL21(DE3), 50 mL LB-medium with 
100 µg/mL ampicillin was inoculated with glycerol stocks of the corresponding pGEX4-T 
constructs and cultivated overnight as described above. The next morning, 500 mL 2x yeast 
extract tryptone (2x YT) medium with 100 µg/mL ampicillin were inoculated with 10 % of 
the pre-culture. The bacteria suspension was grown at 37 °C in a bacteria flask shaker for 
around 1 h to 1.5 h until a density of OD600 of 0.5 to 0.7 was reached. Recombinant protein 
expression was then induced by applying 500 µM Isopropyl-β-D-thiogalactopyranosid (IPTG) 
for 3 h at 30 °C.  
For the less soluble GST-Rab fusion proteins, E. coli Rosetta (DE3) strains with 
additional eukaryotic tRNA-codons rarely used in E. coli (Tegel et al., 2010) were used. This 
strain expresses an additional antibiotic resistance gene and was therefore cultivated in the 
presence of 68 µg/mL chloramphenicol in addition to ampicillin. For protein expression, 100 
µM IPTG in combination with a low temperature incubation of 20 °C were used. These 




slow-expressing conditions were chosen to avoid the accumulation of instable or denaturated 
protein within inclusion bodies. To still achieve a sufficient amount of stable proteins in the 
bacterial cytoplasm, the incubation duration was prolonged to 20 h.  
The bacteria were then pelleted via centrifugation at 4,000 x g for 15 min at 4 °C and 
resuspended in volume of 5 mL to 20 mL ice-cold PBS, depending on the expected yield. 
Dissolved pellets were stored at -20 °C as 5 mL aliquots for one-shot thawing prior to use. 
 
2.2.3.6.2 Nucleotide-free affinity purification of recombinant GST-fusion Rab proteins from 
bacterial lysates 
For nucleotide-mediated affinity purification assays, GST-coupled Rab proteins were 
extracted nucleotide-free from bacterial lysates by the presence of EDTA during cell lysis. 
This chelator complexes Mg2+, the essential co-factor of nucleotide-binding to GTPases, and 
thus, increases the off rate of already bound nucleotides on the one hand, while inhibiting de 
novo binding of GTP on the other (Burstein and Macara, 1992). Nucleotide-free Rab proteins 
were purified using a glutathione-sepharose assay, in which the tripeptide Glutathione 
(Glutamine-Cysteine-Glycine) is immobilized by its sulfhydryl group to cross-linked beaded 
agarose. This sepharose serves as a specific substrate for the glutathione S-transferase (GST). 
Thus GST-fusion proteins are specifically captured by this enzyme-substrate binding reaction. 
For the purification of around 1 mg recombinant protein, one aliquot of bacterial pellet 
was thawed on ice and filled up to a volume of 25 mL with PBS, freshly supplemented with 2 
mM EDTA, 50 U CyanaseTM Nuklease (Serva, 18542), 0.5 mg/mL Lysozyme (Roth, 8259), 1 
mM PMSF and one tablet per 50 mL of EDTA-free Protease Inhibitor Cocktail (Sigma, 
11873580001). In order to increase the stability of the recombinant Rab-proteins, 150 mM 
NaCl was added. The samples were incubated for 15 min at 4 °C on a tube rotator (VWR), 
followed by sonification in order to break the cell wall. Sonification was performed in two 
cycles of each 2 min with 30 % power every 2nd minute (Branson digital sonifier 450). For 
perforation of the cell membrane, 1 % (v/v) TritonX-100 was added and the lysates were 
incubated for another 15 min rotating at 4 °C. The lysates were cleared from cell debris by 
centrifugation in a SS-34 rotor (Sorvall) at 35,000 x g and 4 °C for 15 min. Glutathione-
sepharose beads were equilibrated by adding 10 mL ice-cold PBS to 300 µL of a 50 % (w/v) 
GST-bind resin slurry (Millipore, 70541). The beads were pelleted at 3,000 x g for 3 min at 
4 °C, PBS was aspirated, and the lysate supernatant was applied. GST-fusion proteins were 
coupled to the beads by an incubation for 2 hr at 4 °C on a tube rotator. The beads were 
washed three times with ice-cold PBS as described above, and stored under phosphate-free 




conditions in 500 µL of 20 mM HEPES pH 7.5 with 5 mM EDTA at 4°C until usage for 15 h 
maximum.  
The protein concentration of the bead-suspension was estimated from a 1:10 dilution 
using the Bradford assay. As this method is often inaccurate for proteins immobilized on 
agarose beads, the samples were additionally analyzed by SDS-PAGE and subsequent 
Coomassie-staining. Therefor volumes with estimated protein concentrations of 2, 4 and 8 µg 
were loaded. The integrated density of each GST-fusion protein was determined by 
Coomassie-staining using the Image Lab software (Bio-Rad). The calculated protein 
concentration was then adjusted according to the GST-control in order to use equal amounts 
of recombinant proteins in the subsequent affinity purification assay. 
 
2.2.3.6.3 Affinity purification using nucleotide-loaded GST-fusion proteins 
For GST-mediated pulldown assays, each 100 µg of bead-coupled GST-fusion 
proteins was first washed three times in ice-cold 500 µL lysis buffer, supplemented with 
5 mM EDTA and without MgCl2. Therefor the beads were pelleted at 3,000 x g for 2 min at 
4 °C, the washing solution was aspirated, and fresh buffer was applied. Immobilized GST-
Rab proteins were then loaded with either 1 mM GTPyS (Sigma, G8634), a non-hydrolyzable 
GTP-analogue, or GDP (Sigma, G7127) in 50 µL lysis buffer (without MgCl2) for 15 min at 
30 °C with slight agitation on a Thermomixer 5437 (Eppendorf). GST-control beads were 
instead incubated with 5 mM EDTA as a control. Afterwards, MgCl2 was added to a final 
concentration of 10 mM, in order to activate and strengthen the nucleotide binding. After 
incubation of 10 min at 4 °C lysate inputs were applied.  
HEK cells were harvested as described (2.2.3.1), 24 h post-transfection with calcium 
phosphate. Cleared and concentration-adjusted lysate inputs, supplemented with fresh PMSF, 
were distributed each on GTP-loaded-Rab, GDP-loaded-Rab- and pure GST-coupled beads. 
GTPyS or GDP were added to a final concentration of 1 mM. GST-control beads were 
supplied with 5 mM EDTA. Around 5 % of the total protein amount of each sample served as 
the input reference and was kept separately on ice during the assay. For affinity purification, 
the lysate inputs were incubated with immobilized GST-fusion proteins for 90 min on a tube 
rotator at 4 °C. The beads were pelleted and, after discarding the supernatant, washed three 
times by rotation for 10 min. Therefor lysis buffer with reduced concentrations of 50 mM KCl 
and 0.5 (v/v) % TritonX-100 was used, in order to remove unspecifically bound proteins. A 
final wash was performed without detergent. In order to avoid the disengagement of bound 
nucleotides, the washing buffers were additionally supplemented with either 0.1 mM GTPyS 




or GDP to achieve an excess of free nucleotides in the solutions. After complete removal of 
buffer using a Hamilton pipette, the proteins were eluted in 30 µL of 1x SDS-sample buffer at 
95 °C for 5 min. The beads were then pelleted by centrifugation at 17,000 x g, and the 
protein-containing supernatant was analyzed by SDS-PAGE and immunoblotting.  
 
2.2.3.7 Affinity purification using magnetic agarose beads 
For (co-)immunoprecipitation of eGFP-fusion proteins, GFP-Trap®_MA beads 
(Chromotek, gtma) were used. These types of magnetic agarose beads are coupled to a single 
variable domain (VHH), which binds GFP with a high affinity. The domains are known as 
nanobodies and derived from Alpaca single heavy chain antibodies. A magnetic rack is used 
for sedimentation of the beads. 
Lysates were prepared from eGFP-Rab35endo KI HeLa cell as described (2.2.3.1), 24 h 
post-transfection with calcium phosphate, and applied to 20 µL of lysis buffer-equilibrated 
GFP-Trap® MA beads. The protein concentration of the lysate input has been again adjusted 
to around 5 µg/µL and a small sample volume was kept separately as the input reference. The 
lysates were incubated with the beads for 90 min rotating at 4 °C before the supernatant was 
discarded. Beads were then washed three times with lysis buffer with 50 mM KCl and 0.5 % 
TritonX-100, and once without detergent. Proteins were eluted from the beads in 30 µL 1x 
SDS-sample buffer at 95 °C for 5 min. The beads were finally sedimented by centrifugation at 
17,000 x g for 5 min and the supernatant was analyzed by SDS-PAGE and immunoblotting.  
 
2.2.3.8 Proximity-dependent biotin identification (BioID) 
2.2.3.8.1 BioID in HEK cells 
In order to identify potential interaction partners of a protein of interest (POI), 
proximity-dependent biotin identification (BioID) was performed according to Roux et. al. 
(2012). This assay is based on the prokaryotic biotin protein ligase BirA from E. coli, which 
biotinylates specific substrate peptides. The enzyme first combines biotin and ATP to form 
biotinoyl-5’-AMP (bioAMP), which is then added to a specific lysine residue within the 
biotin acceptor tag, a minimal recognition sequence of the substrate. For the BioID assay, a 
promiscuous form of BirA, BirA*, with a low affinity to bioAMP is used. It releases the 
generated bioAMP into the cell environment. Free bioAMP will readily react with primary 
amines and thereby unspecifically biotinylates proteins within the proximity of BirA*. In this 
assay, a POI is fused C-terminally to BirA* and introduced into mammalian cells, which are 
supplemented with biotin-containing culturing medium. Subsequently, proteins within the 




proximity of the expressed BirA*-POI chimera get biotinylated. These proteins can be 
captured from lysates using immobilized streptavidin, a biotin binding protein with a high 
affinity (Kd= 10 – 15 mM). As a control for POI-independent biotinylation, lysates from cells 
that express the construct encoding for BirA* only are used. Overexpression of BirA* on its 
own results in a random biotinylation, especially of proteins involved in the process of 
translation or other biosynthetic pathways, which can be thus excluded as POI-relevant. 
In brief, 6 cm dishes of HEK cells were transfected using JetPrime with a construct 
containing either mycBirA*-POI (Rab35) or myc-BirA* alone. The medium was exchanged 
after 4 h for fresh mCCM, supplemented with 50 µM biotin (Sigma, B4639). 24 h post-
transfection, lysate inputs were prepared as described. Streptavidin-coupled agarose beads 
(Millipore, 69203) were equilibrated by washing 200 µL bead-slurry (50 % (w/v)) with 500 
µL lysis buffer for three times. Cell lysate, adjusted to a protein concentration of 3 to 4 µg 
protein/µL, was applied in a volume of 250 µL and affinity binding was performed at 4 °C 
overnight on a rotating shaker.  
The next morning, the beads were collected and extensively washed in six consecutive 
rounds for each 8 min rotating at RT. Four different denaturating washing buffers were used 
to remove unspecifically bound proteins thoroughly, without impairing the high affinity 
streptavidin-biotin interaction. A SDS-containing buffer (BioID- wash buffer 1) was applied 
first for two times, followed by a high-salt buffer (BioID- wash buffer 2) and a lithium 
chloride buffer (BioID- wash buffer 3), supplemented with the detergents TritonX-100 and 
NP-40, respectively. The physiological BioID- wash buffer 4 was applied twice in order to 
remove detergents and lithium chloride remnants, before the specifically bound protein 
fraction was eluted by incubation in 60 µL 1x SDS-sample buffer at 95 °C for 5 min. The 
sample buffer has been supplemented with an excess of biotin (30 mM), to facilitate the 
release of biotinylated proteins by the free biotin competing for the streptavidin binding sites.  
After pelleting the beads at 17,000 x g for 5 min, the supernatant was collected and 
50 % of the volume was loaded on a 4-15 % gradient Mini-PROTEAN® TGX™ Precast 
Protein Gel (Bio-Rad, #4561086) for SDS-PAGE. The gels were then either processed for 
immunoblot detection of proteins, or for Coomassie staining and further protein analysis by 
mass spectrometry.  
 
2.2.3.8.2 Label-free quantification of BioID samples by mass spectrometry (LC-MS/MS)  
Mass spectrometry was performed by Heike Stephanowitz from the Eberhard Krause 
laboratory, the mass spectrometry facility at Leibniz Research Institute for Molecular 




Pharmacology (FMP, Berlin). For liquid chromatography (LC)–mass spectrometry (MS)/MS 
analysis, Coomassie-stained lanes of label free BioID samples (BirA*Rab35 vs. BirA*) were 
cut into each 15 gel pieces per sample and digested in-gel by trypsinization, essentially as 
described (Lange et al., 2010). Peptides were analyzed by a reversed-phase capillary liquid 
chromatography system (Ultimate 3000 nanoLC system, Thermo Fisher) connected to an 
Orbitrap Elite mass spectrometer (Thermo Fisher). Identification and quantification of 
proteins were performed using MaxQuant (version 1.5.2.8) software, searched against the 
HUMANswiss database (april, 2014) and summarized with the software Scaffold (Proteome 
Software). The mass tolerance of precursor and sequence ions was set to 10 ppm and 0.35 Da, 
respectively.  Methionine oxidation and the acrylamide modification of cysteines were used as 
variable modifications. Proteins with at least two detected peptide sequences (razor unique 
peptides) with a minimum length of 7 amino acids were counted as biotinylated and 
specifically bound. False discovery rates were estimated to be less than 1%, based on matches 
to reversed sequences in the concatenated target-decoy database. Enrichment of proteins in 
the Rab35-BioID sample was calculated as follows: The label free quantification (LFQ)-
intensity for each protein (defined by the number and abundance of detected peptides) was 
compared between the Rab35-BioID- and the control BioID-sample (BirA*). Proteins were 
considered as enriched, if the LFQ-intensity ratio of Rab35-BioID/BioID was greater than 5, 
or if exclusively detected in the Rab35-BioID sample.  
 
 
2.2.4 Schwann cell-specific Rab35 ablation 
All work was performed by Prof. Dr. A. Bolino and her team (F. Grandi, M. 
Mignanelli and R. Di Guardio) from the INSPE in Milan, Italy. 
 
2.2.4.1 In vivo analysis of Schwann cell-specific Rab35 knockout (cKOSC) mice 
Rab35 cKOSC with conditional ablation of Rab35 in Schwann cells (Rab35Fl/Fl x P0-
Cre) were always compared with phenotypically normal control mice (Rab35Fl/Fl or 
Rab35Fl/+). Semithin section and ultrastructural analyses of sciatic nerves were performed as 
described previously (Wrabetz et al., 2000). Morphometric analysis was performed on 
digitalized images of cross sections obtained from sciatic nerves with a 100x objective and a 
Leica DFC300F digital camera (Milan, Italy). At least five images per animal were analyzed 
using the Leica QWin software (Leica Microsystem) to calculate the g-ratio (axon diameter 
over fiber (myelin + axon) diameter), while aberrant-myelinated fibers (tomacula, 




outfoldings, degenerations) were excluded. To estimate the percentage of myelinated fibers 
that carried alterations, the entire nerve section was reconstructed, and the total number of 
myelinated fibers was assessed. For morphometric analysis on ultrastructural sections, 20-40 
images per animal were taken using TALOS L120C transmission electron microscope 
(Thermo Fisher) at 120 kV and a 3,400x objective (for P20). 
Sciatic nerve lysates were prepared for immunoblot analysis using a lysis buffer 
containing 2% (w/v) SDS, 50 mM TRIS buffer pH 8.0, 150 mM NaCl, 10 mM NaF, 1 mM 
NaVO3, complete protease and phosphatase inhibitors (Roche). Protein quantification was 
performed using a BCA assay (Pierce, Thermo Fisher). Rapamycin (LC Laboratories) was 
dissolved in Ethanol and administered once daily by intraperitoneal injection 5 days a week at 
a final concentration of 10 mg/kg in a vehicle solution containing 5% (w/v) Polyethylene 
glycol 400 (PEG 400), 5% (v/v) TWEEN-80 and 0.9% (w/v) NaCl as reported (Goebbels et 
al., 2012). 
 
2.2.4.2 Ex vivo analysis of Schwann cell-specific Rab35 knockout (cKOSC) mice 
Myelin-forming Schwann cell (SC)/DRG neuron co-culture explants were established 
from E13.5 mouse embryos (Taveggia and Bolino, 2018). Organotypic explants were kept in 
Neurobasal (NB) medium supplemented with 50 ng/mL NGF-2.5S and B27 for 8-9 days prior 
to induce myelination in C-media supplemented with 50 µg/mL ascorbic acid for additional 
15 days (Sigma). For immunohistochemistry, co-culture explants were fixed for 15 min in 4 
% (w/v) paraformaldehyde, permeabilized for 5 min in ice-cold methanol at -20°C, and then 
blocked for 20 min with 10 % (v/v) NGS and 1% (w/v) BSA. Anti-MBP primary antibody 
was applied for 1 hour at room temperature in 1x PBS and Anti-NF-M antibody overnight in 
5 % (w/v) BSA, 1 % (v/v) NGS and 0.6% (v/v) TritonX-100 in 1x PBS at 4 °C. Coverslips 
were washed and incubated for 30 min with secondary antibodies prior to another wash and 
mounting. A fluorescence microscope was used to quantify the number of MBP-positive 
myelinated segments in at least 5-10 random fields per coverslip. The mean of each coverslip 
was used as "n" for statistical analysis. To quantify the myelinated fibers that carried 
abnormalities, at least 300 MBP-positive myelinated fibers were evaluated, from "n" different 









2.2.5 Statistical analysis  
All data are represented as mean ± standard deviation (SD) for n = 2 independent 
experiments or mean ± standard error of the mean (SEM) for n > 2 independent experiments 
and are normalized where indicated. In in vivo experiments the number of animals is given. 
GraphPad Prism 5 and ‘R‘ software were used to perform statistical analysis. If not otherwise 
indicated, normalized data were analyzed using a one-sample two-tailed student’s t-tests, with 
prior testing of a Gaussian distribution using the Kolmogorov-Smirnov (KS) test (Smirnov, 
1944). For data sets from more than two different genotypes, depicted p-values were corrected 
for multiple testing using Holm’s multiple comparison test (Holm, 1979). Level of 
significances are depicted in each graph: *p < 0.05, **p < 0.01, ***p < 0.001, ****p<0.0001. 
Exact p-values are provided in the respective figure legends for p > 0.05.  
 
 





Myelination, the glial membrane ensheathment of axons, not only facilitates axonal 
conductance by electrical insulation but is also important for maintaining axonal integrity and 
providing trophic support for neurons (Fünfschilling et al., 2012; Nave and Werner, 2014). In 
consequence, pathological conditions in which myelin homeostasis is impaired often lead to 
severe axonal degeneration (Bjartmar et al., 1999; Reilly et al., 2011). Myelin homeostasis is 
tightly regulated by a cohort of extrinsic and intrinsic factors and proteins. So far, at least 80 
different mutated genes have been identified to cause the heterogeneous, most commonly 
inherited peripheral neuropathy group of CMT diseases (Rossor et al., 2013; Saporta et al., 
2014; Pareyson et al., 2017). Among these, proteins that have been primarily associated with 
demyelination are essential myelin components, but also regulators of endomembrane 
trafficking or cell signaling pathways, such as phosphatidylinositides (PI) –catalyzing 
or -binding proteins (Suter, 2007; Rossor et al., 2013). Interestingly, the Ras-related GTPase 
Rab35 has been recently linked to myelin formation by oligodendrocytes. Rab35 is reported to 
negatively regulate oligodendrocyte differentiation and myelination via an ACAP2-ARF6 
dependent, but otherwise still elusive mechanism (Miyamoto et al., 2014). On the other hand, 
Rab35 and its GAPs TBC1D10A-C were observed to mediate secretion of myelin proteins from 
late endosomal MVBs (Hsu et al., 2010). However, effector proteins downstream of Rab35 and 
the consequence of Rab35 depletion on myelin formation were not further investigated in that 
context. In this study, we aimed to unravel the function of Rab35 in myelin regulation, using a 
novel mouse model that allows for acute depletion of protein levels. 
 
3.1 Rab35 represses myelin formation and interacts with CMT-associated 
MTMR-complexes 
3.1.1 Generation of tamoxifen-inducible conditional Rab35 knockout mice 
In order to elucidate the role of Rab35 in myelin regulation, we aimed to acutely deplete 
its protein levels using a knockout (KO) approach. We took advantage from a “floxed” Rab35 
(Rab35Fl/Fl) mouse, generated and kindly provided by Prof. Dr. Arnaud Echard (Institut Pasteur, 
Paris, France), Dr. Genaro Patiño López (formerly: NIH, Bethesda, USA) and Prof. Dr. Stephen 
Shaw (formerly: NIH, Bethesda, USA). In these mice, Rab35 exons number 2 and 3 are flanked 
by loxP insertions, specific recognition and targeting sites of Cre-recombinases. Cre-mediated 
recombination in these mouse cells results in the deletion of the 2nd and 3rd Rab35 exon from 
the genome, and finally in an early termination of Rab35 gene transcription. Ubiquitous 





control of a ß-actin promoter, results in early embryonic lethality of mice (unpublished, with 
courtesy of Dr. Genaro Patiño López). Therefore, we generated tamoxifen-inducible 
conditional Rab35 knockout (icKO) mice by crossing Rab35Fl/Fl mice with the transgenic Cre-
ERTM -mouse line (Danielian et al.1998; Hayashi and McMahon, 2002). These mice encode for 
a chimera of the Cre recombinase and a mutant, tamoxifen-responsive form of the estrogen 
receptor ligand-binding domain (LBD-ERTM), ubiquitously expressed under the control of a 
CAG-promoter (Fig. 3-1a). Upon tamoxifen binding, the cytoplasmically sequestered Cre-
LBD-ERTM (CreER) is released from the chaperone protein Hsp90, translocates to the nucleus 
and introduces the gene knockout (Fig. 3-1b). Primary cell cultures were prepared from 
Rab35Fl/Fl or Rab35Fl/Fl x CAG-CreER littermates, cultured in the presence of tamoxifen and 
referred to as wild type (WT) or icKO cultures, respectively. Sufficient Rab35 depletion, for 
instance in primary astrocytic cultures, was achieved by constant tamoxifen application (0.4 
µM) starting at DIV1 (Fig. 3-1d).  
Figure 3-1: Generation of conditional Rab35 knockout mice for tamoxifen-inducible Rab35 depletion 
in vitro. (a) Tamoxifen-inducible conditional Rab35 knockout (icKO) mice were generated by crossing 
Rab35Fl/Fl mice with CAG-CreER mice, which express Cre-ERTM (CreER) recombinase under CAG promoter 
control. Littermates from backcrossed F2-generation were used to prepare primary cultures of Rab35 wildtype 
(WT) and inducible conditional knockout (icKO) cells from Rab35Fl/Fl and Rab35Fl/Fl x CAG-CreER mice, 
respectively. Both cultures were supplemented with tamoxifen. CRE+LBD-ER – Chimera of CRE and the 
ligand-binding domain of estrogen receptor. (b) Tamoxifen application induces Rab35 depletion in Rab35 
icKO cultures only. Cytoplasmically sequestered CreER can translocate to the nucleus upon tamoxifen 
binding to its LBD-ER. Cre-mediated recombination results in an early transcriptional termination of Rab35. 
(c) PCR-amplification products from mouse biopsy DNA to reveal the genotypes for further breeding and 
primary cell culture preparation. From the left: Amplified DNA-fragment from Rab35 without (-) or with (+) 
inserted loxP-sites, and from CreER-locus in Cre-positive animals. (d) Primary cultures of astrocytes were 




supplemented with tamoxifen from DIV1 on, and lysed at DIV7, 10, 14 and 20. Acute depletion of Rab35 at 
DIV14 and DIV20 was confirmed by immunoblotting. ß-tubulin served as a loading control. 
 
3.1.2 Rab35 depletion does not impair synaptic vesicle recycling in neuronal cultures 
Rab35 is reported to direct SVs to an endosomal recycling route upon endocytosis in 
NMJs of D. melanogaster, which promotes the formation of endosomal-like compartments in 
presynapses and eventually increases neurotransmitter release (Uytterhoeven et al., 2011). We 
investigated the synaptic vesicle recycling in primary cultures of hippocampal neurons from 
Rab35 icKO mice in order to unveil a function of the small GTPase in presynapses of 
mammalian cells. We analyzed the presynaptic steady-state surface and total levels of two SV 
proteins, synaptotagmin1 (Syt1) and synaptophysin (Syph), by immunocytochemistry (Fig. 
S1a-e), and the endocytic retrieval of Syt1-pHluorin upon neuronal activity (Fig. S1f-h). 
However, we did not detect any alterations in neuronal cultures depleted of Rab35. In addition, 
we analyzed the abundance of endocytic compartments in presynapses after neuronal 
stimulation by ultrastructural analysis, performed by Dr. Dmytro Puchkov (FMP Berlin), for a 
potential increase in the formation of endosomes (Fig. S1i,j). However, neither the number of 
SVs nor of endosomal-like vesicles (ELVs) was different in the absence of Rab35. These data 
indicate, that Rab35 is not essential for proper SV recycling in mammalian neuronal cultures.  
 
3.1.3 Characterization of Rab35 icKO oligodendrocytic cultures 
Rab35 has been reported to promote the secretion of myelin proteins on the one hand 
but to repress OL differentiation and myelination on the other (Miyamoto et al., 2014). We 
made use of primary Rab35 icKO oligodendrocytic mono-cultures in order to investigate in 
vitro myelination upon acute Rab35 depletion by gene knockout. Mono-cultures of 
oligodendrocytes are described to form in vitro ‘myelin sheets’ that resemble in vivo sheaths in 
their molecular composition, even in the absence of neuronal co-culturing (Aggarwal et al., 
2011). 
Cultures of myelinating oligodendrocytes were obtained by the differentiation of 
oligodendrocytic precursor cells (OPCs), isolated from Rab35 icKO and WT mice by 
immunopanning. OPC cultures were supplemented with tamoxifen for knockout induction and 
first kept under proliferating conditions by the presence of mitogens. Rab35-depleted 
NG2-positive OPCs displayed an increased cell size (Fig. 3-2d,e). In addition, a strongly 
reduced cell number was observed in Rab35 icKO cultures. In order to dissect if the latter was 
resulting from either reduced proliferation or increased cell death, we supplemented the cultures 





replicating DNA and can be visualized by immunolabelling. In Rab35 icKO cultures only 38 % 
of cells were positively stained for BrdU whereas a cell fraction of 85 % was actively 
proliferating in WT cultures in the considered time window (Fig. 3-2a,b). Moreover, 65 % of 
cells depleted of Rab35 showed positive signals for cleavage-activated Caspase-3, a major 
apoptotic effector protease that serves as an indicator for apoptotic cell death activation (Kaiser 
et al., 2008). In Rab35 WT cultures 15 % of the cells were apoptotic only (Fig. 3-2a,c). All cells 
in these cultures were either labeled for BrdU or Caspase-3, or both. Considering the 
overlapping fraction of BrdU- and Caspase-3- positive cells with none or only 3 % in Rab35 
WT and icKO cultures, respectively, could suggest that impaired proliferation in Rab35-
depleted OPCs might underlie the increased apoptotic induction. On the other hand, a direct 
involvement of Rab35 in the suppression of apoptosis or apoptotic degradation was recently 
reported (Wheeler et al., 2015; Haley et al., 2018).  
Figure 3-2: Primary Rab35 icKO OPCs display less proliferation, more apoptotic induction and an 
increased cell area. (a-c) Immunostainings of oligodendrocytic precursor cells (OPCs) from Rab35 icKO 
and WT mice, cultured in the presence of tamoxifen and mitogens. Proliferating OPCs, supplemented with 
BrdU for 36 h, and subsequently immunostained for BrdU (magenta) and cleavage-activated Caspase-3 
(green). Rab35 icKO OPC cultures display less proliferation and more apoptotic induction than Rab35 WT 
cells; (n = 3 independent experiments). (a) Representative confocal images. Phalloidin (red) and DAPI (blue) 
labelled the total cell fraction; Scale bars, 30 µm. (b,c) Calculated cell fractions positively labelled for (b) 
BrdU or (c) Caspase-3; (mean ± SEM; two-tailed paired student’s t-test; *p < 0.05). (d-g) Rab35 icKO cells 
have an increased cell area. (d) Proliferating OPCs, immunolabelled for the OPC marker NG2 (green) and 
Phalloidin-AlexaFluor568 (red). Scale bars, 30 µm (e) The NG2-masked cell area is threefold increased in 
Rab35 icKO OPCs compared to WT cells (100 %); (n = 3 independent experiments; p = 0.1). (f) Primary 
oligodendrocytes (OLs), differentiated in culture, and immunolabelled for OPC marker NG2 (green) and 
oligodendrocytic marker CNPase (red); Scale bars: 30 µm. (g) The CNP-masked somata of Rab35 icKO OLs 




are larger than of WT cells (100 %); (mean ± SEM; n = 3 independent experiments; one sample two-tailed 
student’s t-test with a theoretical mean of 100; **p < 0.01). 
 
 
Since we aimed to investigate cultures with a sufficient number of myelinating 
oligodendrocytes, we induced differentiation of primary OPCs already at DIV1 in parallel to 
knockout induction, to circumvent proliferating and hence, survival defects upon Rab35 
depletion. At DIV8, differentiated oligodendrocytes (OLs) could be identified in both cultures 
by loss of NG2- and gain of CNPase expression. Similar to OPCs, Rab35 icKO OLs were 
marked by an increased cell soma area (Fig. 3-2f,g). To investigate the in vitro myelin sheet 
formation, OL cultures were immunolabelled for the myelin compaction protein MBP. 
Strikingly, Rab35 icKO cultures displayed an increased MBP-positive area per cell compared 
to WT oligodendrocytes (Fig 3-3 a,b). In addition, mean fluorescence intensities of the myelin 
compaction protein, PLP, and two proteins associated with non-compacted myelin, MAG and 
CNPase, were significantly increased upon Rab35 depletion (Fig 3-3 c,d). Hence, by acute 
Rab35 depletion upon differentiation induction, we could confirm a negative regulatory 





Figure 3-3: Elevated in vitro myelination in Rab35 icKO oligodendrocytic cultures. Differentiated 
oligodendrocytes (OLs) immunostained for myelin proteins. (a, b) Rab35 icKO oligodendrocytic cultures 
produce an increased area of MBP-positive myelin sheets in vitro. (a) Representative confocal images with 
lower (left) and higher (right) magnification of primary OLs immunolabelled for myelin compaction protein 
MBP (green) and oligodendrocytic marker protein CNPase (magenta); Scale bars: 30 µm. (b) Quantification 
of the MBP-positive area normalized to the number of cells per image, and WT cultures (100 %) in n = 3 
independent experiments. (c, d) Increased fluorescence intensity of myelin marker proteins PLP, MAG and 
CNPase in OLs depleted of Rab35. (c) Confocal images of primary OLs immunolabelled for PLP (left) and 
MAG (right), shown in green; Scale bars: 30 µm. (d) Mean fluorescence intensities in Phalloidin-based cell 
masks and normalized to WT cultures (100 %); (mean ± SEM; n = 4 (PLP, MAG) or 3 (CNPase) independent 





3.1.4 Active Rab35 interacts with MTMR pseudophosphatases  
Rab35 is implicated in the regulation of diverse cell physiological pathways. However, 
only a few effector proteins have been identified so far (Chaineau et al., 2013). The function of 
Rab35 in myelination is proposed to be either mediated by a still elusive mechanism involving 
ACAP2 and ARF6 (Miyamoto et al., 2014), or via exosome secretion with not yet identified 
effector proteins (Hsu et al., 2010). We asked if additional, so far unknown Rab35-interaction 
partners could reveal more insight into the mechanism of myelin-regulation by Rab35. For this 
purpose, we performed an unbiased proteomic screen using a BioID assay according to Roux 
and colleagues (2012). Rab35 was C-terminally fused to the mutant biotin protein ligase BirA*, 
which promiscuously biotinylates proteins in its close proximity, and was overexpressed in 
HEK cells. First, by immunoblot detection we analyzed the biotinylated protein fraction, 
captured by Streptavidin-mediated affinity purification from lysates of BirA*-Rab35-
expressing cells, and compared to BirA* or mock-transfected ones. This confirmed functional 
biotinylation by the Rab35 chimera, when cells were cultured in the presence of biotin for 24 h 
before lysis (Fig. 3-4a). Using mass spectrometry (LC-MS/MS), performed by the lab of Dr. 
Eberhard Krause (FMP, Berlin), we analyzed the biotinylated protein fractions from BirA*-
Rab35- (Rab35-BioID sample) compared to BirA*- expressing cells (BioID) by label-free 
quantification (LFQ) (Fig. 3-4b). Potential Rab35-interacting proteins were determined by 
dividing the LFQ-intensity of each protein in the Rab35-BioID fraction by its intensity in the 
BioID-fraction. We could identify 150 proteins enriched in the Rab35-BioID sample (Suppl. 
table S1, S2). Among those were two members from the same small protein family, which are 
both strongly associated with myelin homeostasis. MTMR5 and MTMR13, two 
pseudophosphatases from the myotubularin-related phosphatidylinositol (MTMR) phosphatase 
family, were 30-fold enriched or detected selectively in the Rab35-BioID sample, respectively 
(Fig. 3-4c). Interestingly, the fly homologue of both proteins, Sbf, has been detected in a 
previous study in the Rab35-affinity purified fraction from fly lysates (Gillingham et al., 2014). 
 Since missense mutations in either of these proteins result in the demyelinating 
peripheral neuropathy Charcot-Marie-Tooth disease type 4B in humans (Senderek et al., 2003; 
Nakhro et al., 2013), we hypothesized that Rab35 by interacting with these CMT-associated 
MTMR proteins might be involved in PNS myelin homeostasis as well. To investigate this 








Figure 3-4: BioID-screen in HEK cells reveals novel interactors for Rab35. (a) mycBirA*Rab35 displays 
functional biotinylation in HEK cells. Streptavidin-mediated affinity capture and –HRP-immunoblot analysis 
reveals biotinylated proteins in lysates from BirA* or BirA*Rab35 but not mock-transfected cells, and upon 
biotin supplementation only. (b) Coomassie blue-stained SDS-PAGE gel of streptavidin-captured 
biotinylated protein fractions prior to analysis via mass spectrometry. (c) MTMR5 and MTMR13 are 
specifically associated with BirA*Rab35. The protein-specific ratio of label free quantification (LFQ)-
intensity detected in BirA*Rab35-, divided by the BirA*-sample, was used to express the enrichment of 
proteins in n = 2 independent experiments (mean ± SD). MTMR13 was detected in association with 
BirA*Rab35 only. All Rab35-enriched proteins are listed in table S1 and S2. 
 
MTMR13 and its closest relative MTMR5 are multi-domain proteins. Their N-terminal 
DENN domain is a typical motif for GEFs that promote GDP to GTP exchange of Rab proteins. 
Rab21 and Rab28 are already identified for being regulated by this MTMR-DENN domain 
(Yoshimura et al., 2010; Jean et al., 2012). In order to reveal if the pseudophosphatases function 
as GEFs for Rab35 as well, we performed affinity purification with recombinantly expressed 
GST-Rab35, either activated or inactivated by loading with GTPyS or GDP, respectively. Due 
to a lack of an antibody for endogeneous detection, we used lysates from HEK cells that 
overexpressed FLAG-MTMR13 as a bait. First, we could confirm the association of MTMR13 
with Rab35. Interestingly, the relative amount of bound MTMR13 was five-fold higher in 
Rab35^GTPyS than in ^GDP (Fig. 3-5a,b). As GEFs bind Rabs in their GDP-bound form, this 
finding excluded the possibility of MTMR13 to function as a GEF for Rab35, in line with the 





of a Rab35 deletion mutant that lacks 20 amino acids at the C-terminus and is presumed to form 
more stable complexes with GEF proteins in vitro (Wu et al., 2011). In contrast, MTMR13 
bound to GST-Rab35(ΔC) with an even higher relative binding preference of more than ten 
times for GTPyS- over the GDP-loaded form (Fig. 3-5b). Despite of the observed lower overall 
binding affinity of MTMR13 to GST-Rab35(ΔC), we used the latter in all following assays to 
better discriminate nucleotide-dependent and hence, specific binding for other proteins as well. 
First, using different GST-chimera of other prominent intracellular trafficking Rab proteins 
side-by-side, we could confirm that binding of MTMR13 is specific to Rab35 only. Neither 
GST- Rab1A, -Rab5, -Rab7 nor -Rab11 could capture overexpressed MTMR13 (Fig. 3-5c,d).  
 
Next, we performed this assay including MTMR5 and a set of eGFP-fused active 
MTM(R) phosphatases. MTMR5 displayed a similar binding preference to 
GST-Rab35^GTPyS over ^GDP as observed for MTMR13, though with a lower enrichment 
considering the high expression levels (Fig. 3-6). However, neither MTM1, MTMR1 nor 
Figure 3-5: MTMR13 specifically interacts with active Rab35. (a, b) FLAG-MTMR13 was affinity 
captured from HEK cell lysates using GST-chimera of Rab35 and Rab35ΔC (-20 aa) loaded with GTPyS (T) 
or GDP (D). (a) Representative immunoblot of MTMR13-detection using a FLAG-antibody, and HSC70 as 
a negative binding control. Input: 5 % of total protein. (b) Bound MTMR13 fraction, normalized to 
GTPyS-loaded GST-Rab35, (mean ± SD) from n = 2 independent experiments. MTMR13 binds 
preferentially to GTPyS- over GDP-loaded Rab35 (GTPys/GDP: Rab35 - 5x, Rab35ΔC - 12x). (c, d) 
MTMR13 binds selectively to Rab35 but not Rab1A, Rab5, Rab7 or Rab11. Affinity chromatography as in 
(a,b) using different GST-Rab chimera as a prey. (c) Representative blotting membrane of affinity captured 
protein fractions, visualized by Poinceau-S staining, verifies comparable protein amounts of GST-Rab 
chimera. (d) Representative immunoblot from n = 6 independent experiments for MTMR13 detection. ß-actin 
served as negative binding control; 5 % Input; T – GTPyS, D – GDP. 




MTMR2 could be eluted from any Rab35-bound fraction, indicating a specific interaction of 
Rab35 with the MTMR pseudophosphatases. 
 
In contrast to small GTPases which mainly interact with other proteins via their 
conserved globular G-domain (Milburn et al., 1990; Wittinghofer and Vetter, 2011), MTMR13 
and -R5 are large multi-domain proteins. Besides the N-terminal GEF domain they harbor two 
lipid-binding domains, PH-GRAM and PH, the inactive protein tyrosine phosphatase domain 
(iPTP) with unknown function, and a coiled-coil (CC) region for oligomerization (Fig. 3-7a) 
(Goryunov et al., 2008). In order to further dissect the nature of interaction between Rab35 and 
these closely homologous pseudophosphatases, we aimed to map the MTMR-domain which 
confers binding to Rab35. Due to the close domain homology of both pseudophospatases, we 
focused on MTMR13 which possessed the stronger binding affinity to Rab35 in our previous 
assays. We generated constructs encoding for mCherry-fused single domains of MTMR13, with 
the exception of the coiled coil region that was not soluble on its own, and therefore expressed 
in conjunction with the inactive PTP domain. The constructs were introduced into a 
TALEN-edited HeLa knock-in (KI) cell line which expresses endogeneous Rab35 with an N-
terminal eGFP-tag (eGFP-Rab35endo), generated in the lab of Arnaud Echard (Cauvin et al., 
2016). eGFP-Rab35endo protein was captured from lysates using GFP-nanotrap magnetic beads. 
Bound fractions were then analyzed for overexpressed MTMR13 full-length or single domains 
by immunoblotting for mCherry. Importantly, full-length MTMR13 also bound to the 
Figure 3-6: Rab35 interacts specifically with the pseudophosphatases MTMR13 and MTMR5. Affinity 
purification of lysates from HEK cells overexpressing eGFP- MTM1, MTMR1, MTMR2, MTMR5, or 
FLAG-MTMR13 using GST-Rab35^GTPyS (T) or ^GDP (D). (a) Representative Ponceau S stained blotting 
membrane shows comparable protein amounts of applied GST-Rab35^GTPyS, ^GDP and GST. (b) 
Representative immunoblots. MTM(R)-detection with antibodies against GFP- or FLAG-epitope. 
Overexpressed eGFP served as a negative control (ctrl); 5 % Input. (c) Bound protein fractions (depicted 
relative to the input) show specific binding of MTMR5 and MTMR13 to Rab35-GTPyS, but not MTM1, 
MTMR1 or MTMR2; (mean ± SEM from MTM1: n = 4, MTMR1:  n = 5,  MTMR2: n = 7, MTMR5:  n = 4, 





endogeneously expressed Rab35 (Fig. 3-7b). From the single MTMR13-domains, the iPTP 
domain was detected in the Rab35-bound fraction only. Surprisingly, the conjunction peptide 
of iPTP and CC region could not be captured. This might result from sterical interference by 
the CC region in this construct. Nevertheless, selective binding to the inactive PTP domain 
provides a possible explanation for the observed pseudophosphatase-specific MTMR protein 
association of Rab35. 
 
3.1.5 Rab35 can recruit MTMR phosphatase complexes 
The GTP-loading state of Rab GTPases represents their active form. Accordingly, we 
could also observe MTMR13-binding to a constitutively active mutant Rab35Q67L (CA), upon 
co-overexpression and affinity purification using nanotrap beads against the epitope-tag of the 
latter (Fig. 3-8b). In their active state, Rab proteins can either interact with effector proteins 
downstream or with their regulatory Rab GTPase activating proteins (GAPs) upstream (Pfeffer 
and Aivazian, 2004; Blümer et al., 2013). However, Rab GAPs are usually characterized by 
TBC domains that mediate their binding to Rab proteins (Barr and Lambright, 2010). Our 
finding that Rab35 binds to the inactive PTP domain of MTMR13, and the fact that a TBC 
sequence has not been identified so far in MTMR5 or MTMR13 let us suggest a potentially 
upstream regulatory function of Rab35 in this interaction. In order to confirm this hypothesis, 
we aimed to dissect the influence of active Rab35 on the cellular localization pattern of 
MTMR13 by confocal microscopy. Localization studies of MTMRs are rare. MTMR13 and 
MTMR5 are mainly described as complex interaction partners for MTMR2 (Berger et al., 2003; 
Kim et al., 2003b; Robinson and Dixon, 2006), that is assigned to function at late endosomes 
(Cao et al., 2008). As Rab35 was recently identified on LAMP-positive late endosomal/ 
Figure 3-7: Rab35 binds to the inactive PTP domain of MTMR13. (a) Schematic presentation of the full-
length multi-domain protein MTMR13, adapted from Goryunov et al., (2008). (b) eGFP-Rab35endo knock in 
(KI) HeLa cells, expressing mCherry-tagged MTMR13 full-length (FL) or single domains, were lysed and 
subjected to affinity capture using GFP-nanotrap magnetic beads. Representative immunoblot shows binding 
of mCherry-MTMR13 FL and -PTP domain to affinity captured endogeneously expressed Rab35. (5 %) Input 
(I) and bound (B) protein fractions were analyzed using antibodies against GFP, RFP, or ß-actin as a control. 




lysosomal membranes as well (Hsu et al., 2010; Wheeler et al., 2015), we made use of LAMP-1 
co-immunostaining to identify these compartments (Johansson et al., 2005; Schröder et al., 
2007). First, we analyzed the localization of endogeneously expressed Rab35 in 
eGFP-Rab35endo KI HeLa cells by probing the eGFP-epitope. We could observe signals at the 
plasma membrane and at perinuclear puncta that partially overlapped with LAMP-1 (Fig. 3-
8a). In addition, overexpression of the GTP-locked mutant Rab35CA in HeLa cells resulted in 
a similar localization pattern (Fig. 3-8c). Co-expression of Rab35 with MTMR13 did not alter 
the localization of the small GTPase, but interestingly the pseudophosphatase was translocated. 
Overexpression of FLAG-MTMR13 on its own resulted in a diffuse cytoplasmic localization 
pattern (Fig. 3-8d), consistent with earlier observations (Robinson and Dixon, 2006). In 
contrast, in the presence of Rab35CA we detected FLAG-positive fluorescent signals at the 
plasma membrane, and discrete perinuclear puncta (Fig. 3-8e) that partially co-localized with 
LAMP-1 (Fig. 3-8f). These data strongly suggest that Rab35 acts upstream in this interaction 
and can recruit MTMR13 to late endosomal/ lysosomal compartments. 
Complex formation between an active and an inactive MTMR phosphatase by 
heterodimerization is accompanied by changes in their localization, lipid specificity and 
phosphatase activity. This has led to the assumption that pseudophosphatase members of the 
MTMR family act as recruitment factors for their respective active partner and thereby mediate 
their specific function (Caldwell et al., 1991; Kim et al., 2003b; Mochizuki and Majerus, 2003; 
Berger et al., 2006b; Zou et al., 2009, 2012). MTMR5 and MTMR13 form both active 
complexes with MTMR2, which increases the phosphatase activity of the latter towards PI(3)P 
and PI(3,5)P2 in vitro (Kim et al., 2003b; Berger et al., 2006b). Moreover, missense or nonsense 
mutations in one of these pseudophosphatases largely phenocopy loss of function mutations of 
MTMR2 in humans (Azzedine et al., 2003; Senderek et al., 2003; Nakhro et al., 2013). In order 
to unveil if these complexes are still formed when MTMR5 or MTMR13 are bound to Rab35, 
we performed GST-Rab35-mediated affinity purification from HEK cells that co-express 
MTMR2 with MTMR13 or MTMR5. Indeed, in the presence of MTMR13 or MTMR5, but not 
their epitope-tags alone as a control, MTMR2 was detected in the bound fraction of 
Rab35^GTPyS (Fig. 3-9, 3-10). Next, we replaced the active phosphatase MTMR2 by its 
closest homologues MTMR1 and MTM1. Surprisingly, also MTMR1 specifically bound to 
Rab35^GTPyS upon co-expression with MTMR13, whereas MTM1 did not (Fig. 3-9c,d). Thus, 
MTMR1 is as an additional, so far unknown complex partner of MTMR13. In sum, these data 






Figure 3-8: Active Rab35 recruits MTMR13. (a) Immunostaining of eGFP-Rab35endo HeLa KI cells for 
GFP (green) and LAMP-1 (red) shows partial overlap; Scale bars: 30 µm (upper), 5 µm (lower). (b) 
MTMR13 binds to Rab35CA. Lysates from HeLa cells that co-expressed FLAG-MTMR13 and constitutively 
active eGFP-Rab35 (Rab35CA) were affinity purified using GFP-nanotrap magnetic beads. Representative 
immunoblot with (5 %) Input (I) and bound protein fractions (B) analyzed by immunoblotting using 
antibodies for the eGFP- and FLAG-epitope. (c-f) Confocal images of HeLa cells expressing constitutively 
active eGFP-Rab35 (Rab35CA) or FLAG-MTMR13, or both. Cells were immunostained for GFP, LAMP1 
and FLAG. Arrows mark examples of co-localizing puncta. White squares in upper panels are shown in 
inserts in lower panels; Scale bars: 30 µm (top), 5 µm (bottom). (c) eGFP-Rab35 (Rab35CA) (green) localizes 
to perinuclear LAMP1 overlapping (red)-positive puncta. (d) FLAG-MTMR13 is diffusively localized to the 
cytoplasm when co-expressed with mCherry as a control protein (red). (e, f) Co-localization of MTMR13 
(green) with (d) Rab35CA (red) at the plasma membrane (top-1) and in perinuclear puncta (bottom-2), that 
(f) contained LAMP-1 (red). 
 





Figure 3-9: Active Rab35 interacts with MTMR1 and MTMR2 via MTMR13. Lysates from HEK cells 
co-expressing eGFP- MTM1, -MTMR1 or -MTMR2 with FLAG-MTMR13 or FLAG (as a control) were 
incubated with nucleotide-loaded GST-Rab35. The bound fraction was analyzed by immunoblotting with 
antibodies against GFP, FLAG, and ß-actin. (a) Representative immunoblot. 5 % Input; T – GTPyS, D – 
GDP. (b-d) Quantification of the bound protein fraction relative to the input (mean ± SEM) shows specific 
association for (b) MTMR2 (n = 3) and (c) MTMR1 (n = 4) to GTPyS-loaded Rab35 when co-expressed 




Figure 3-10: MTMR2 binds to active Rab35 via MTMR5 as well. eGFP- MTM1 or -MTMR2 were co-
expressed with mCherry-MTMR5 or mCherry (as a control) in HEK cells. Lysates were incubated with 
nucleotide-loaded GST-Rab35 and analyzed by immunoblotting with antibodies against GFP, RFP, and ß-
actin. (a) Representative immunoblot. 5 % Input; T – GTPyS, D – GDP. (b, c) Quantification of the bound 
protein fraction relative to the input (mean ± SEM) shows specific association of (b) MTMR2 (n = 3), but 









3.1.6 Loss of MTMR2 phenocopies Rab35 depletion in oligodendrocytic cultures 
So far, we could show a novel interaction between Rab35 and CMT-associated MTMR 
proteins that have been strongly associated with myelin homeostasis regulation in the PNS. 
Nevertheless, MTMR proteins including MTMR2, are ubiquitously expressed and also in CNS 
cells (Laporte et al., 1998; Berger et al., 2002; Bolino et al., 2002) (and see below). We were 
interested, if the observed increase in myelin protein expression in Rab35-depleted cells in vitro 
could result from an impaired recruitment of active MTMR complexes. To address this 
question, we made use of lentiviral transduction with shRNA to deplete the active phosphatase 
MTMR2 in differentiated oligodendrocytes in culture. Due to the lack of a functional antibody 
for immunocytochemistry, successful knockdown of mouse MTMR2 with this approach was 
confirmed in mouse embryonic fibroblast (MEF) cultures by immunoblotting (Fig. 3-11a). 
Indeed, shRNA-mediated knockdown of MTMR2 in WT oligodendrocytic cultures caused an 
increase of MAG and PLP-fluorescence intensities compared to WT cells transduced with non-
targeting (scrambled) shRNA. Moreover, for both proteins the increase in protein levels was 
comparable to the mean increase observed in Rab35 icKO cells transduced with control shRNA 
(Fig. 3-11b,c,d). MTMR2 knockdown in Rab35 icKO oligodendrocytes resulted in partially 
elevated protein levels compared to the single depletion of either Rab35 or MTMR2. These 
results might implicate that the involvement of Rab35 in oligodendrocytic myelination is 
mediated by active MTMR complexes. 
Figure 3-11: MTMR2 depletion phenocopies loss of Rab35 with increased in vitro myelination in 
oligodendrocytic cultures. (a) Transduction with shRNA depletes MTMR2 protein levels in mouse cells. 
Mouse embryonic fibroblast (MEF) cell cultures were transduced with non-targeting scrambled or 
MTMR2-targeting shRNA using a lentiviral system. Representative immunoblot of MEF lysates probed for 
MTMR2 and ß-actin as a loading control. (b-d) Oligodendrocytic (OL) cultures were transduced at DIV3 
with lentiviral non-targeting scrambled or MTMR2-targeting shRNA and fixed at DIV7. (b) Representative 
confocal images of immunolabelling for MAG (upper) and PLP (lower) (grey); Scale bars: 30 µm. (c,d) Mean 




fluorescence intensities, normalized to WT + scr (100%), of (c) MAG and (d) PLP, are elevated upon 
shRNA-mediated knockdown of MTMR2 in Rab35 WT and icKO cells; (mean ± SEM; n = 4 independent 
experiments; one sample two-tailed student’s t-test for each genotype compared to control (Rab35 WT + scr) 
with a theoretical mean of 100, followed by p-value correction for multiple testing using Holm’s Multiple 
Comparison Test; *p < 0.05, **p < 0.01, PLP: WT + scr vs. WT + shMTMR2: p = 0.1013).  
 
 
3.2 Rab35 represses mTORC1 via MTMR-mediated lipid regulation, and controls 
PNS myelination in vivo and in vitro 
3.2.1 Focal hypermyelination upon loss of Rab35 in Schwann cells in vivo 
We could identify Rab35 as a potential regulator of active MTMR complexes and 
observed that depletion of MTMR2 mimics the effect of Rab35 loss on in vitro myelination of 
oligodendrocytes. However, distinct MTMR family proteins are strongly associated with the 
regulation of PNS myelination. Loss of function or missense mutations in either MTMR2, -R5 
or -R13 cause the peripheral demyelinating neuropathy CMT4B (Senderek et al., 2003; Bolino 
et al., 2004; Nakhro et al., 2013). Thus, we hypothesized that the small GTPase could regulate 
PNS myelination as well. Therefore, in collaboration with Prof. Dr. A. Bolino (INSPE, Milan, 
Italy), we generated a conditional Rab35 knockout mouse that is specifically depleted of Rab35 
in Schwann cells. The “floxed” Rab35 mice (Rab35Fl/Fl) were bred with a mouse line that 
expresses a Cre-recombinase under control of the myelin protein 0 (P0)-promoter (P0-Cre) as 
early as embryonic day E13.5 (Feltri et al., 1999) (Fig. 3-12a). Successful recombination in 
vivo was confirmed by a mean reduction in Rab35 protein levels of 75 % in sciatic nerve (SN) 
lysates of Rab35 cKOSC (Rab35Fl/Fl x P0-Cre) compared to Ctrl animals (Rab35Fl/Fl) (Fig. 3-
12b,c). As the detected residual protein amount of 25 % only, is presumably representing levels 
in SN axons and fibroblasts, Rab35 is comparably high abundant in Schwann cells. Importantly, 
Rab35 cKOSC sciatic nerves from mice of different postnatal days (P), investigated by semi-
thin section analysis, displayed striking myelin alterations in form of tomacula, outfoldings and 
myelin degeneration, that were not observed in Ctrl mice of any age. In contrast, in Rab35 
cKOSC nerves, these forms of abnormal myelin morphologies were observed already at P20, of 
progressive worsening with ageing, and resulted in a mean fraction of around 30 % altered 
myelinated fibers in 3 month old mice (Fig. 3-12d,e,f). The number of myelin layers wrapped 
around an axon per internode is tightly regulated and highly correlated to the axon diameter as 
expressed by a relatively constant g-ratio for healthy myelinated fibers between 0.6 and 0.7, 
slightly increasing with the axonal diameter and the age of the animal (Rushton, 1951; Berthold 





Figure 3-12: Loss of Rab35 in Schwann cells causes focal hypermyelination in vivo. Performed by the 
laboratory of Prof. Dr. A. Bolino (INSPE, Milan, Italy):  (a) Schwann cell-specific Rab35 knockout (cKOSC) 
mice were generated by crossing Rab35Fl/Fl mice with transgenic mice that encode a Cre recombinase under 
control of the Schwann cell-specific P0-promotor (P0-Cre). Rab35 Ctrl – Rab35Fl/Fl; Rab35 cKOSC - 
Rab35Fl/Fl x P0-Cre. (b, c) Reduced Rab35 protein expression in sciatic nerve lysates from Rab35 cKOSC 
mice at postnatal day (P) 30. (b) Representative immunoblot for Rab35. Tubulin was used as a loading 
control.  (c) Rab35 protein levels, normalized to Tubulin and Ctrl levels (= 100 %), were reduced to 25 % in 
Rab35 cKOSC sciatic nerve lysates; (mean ± SEM; n = 5 independent experiments; one sample two-tailed 
student’s t-test with a theoretical mean of 100; ***p < 0.001). (d) Semithin section analysis of Rab35 cKOSC 
sciatic nerves at P20, P30 and P90 revealed myelinated fibers carrying myelin degenerations (green arrows), 
tomacula (red asterisks) and myelin outfoldings (yellow arrows); Scale bar: 20 µm. (e) Quantification of the 
fraction of aberrant myelinated fibers (% of total) in Rab35 cKOSC sciatic nerves at P20, P30, P70 and P90, 
reveals increasing abundance of alterations in aged animals. Ctrl fibers were 0 % aberrantly myelinated; 
(mean; n = 5 (P20) and 4 (P30, P70, P90) animals per genotype). (f) Example images of ultrastructural 




analysis of Rab35 Ctrl and cKOSC sciatic nerves depicting myelin outfoldings (yellow arrows), myelin 
degeneration (green arrows) and a tomaculum (red asterisk); Scale bar: 5 µm. (g, h) Quantification of the g-
ratio by ultrastructural analysis, as a function of axonal diameter in sciatic nerves at (g) P20 (n=5 animals per 
genotype) or (h) P90 (n= 4 animals per genotype). No significant differences in Rab35 cKOSC compared to 
Ctrl at P20 or P90, except for fibers larger than 5 µm at P90 which displayed a significantly increased g-ratio 
(two-tailed nonparametric Mann-Whitney test; **p < 0.01). 
 
The g-ratio is calculated by dividing the axonal diameter by the fiber (axon + myelin) 
diameter. By analyzing the remaining fraction of non-altered fibers in Rab35 cKOSC sciatic 
nerves, no change in the number of myelinated axons and largely unaltered g-ratios were 
observed at P20 and P90 (Fig. 3-12g,h). At P90 only, fibers with an axonal diameter greater 
than 5 µm displayed reduced myelin thickness, represented by an increase in the g-ratio 
compared to Ctrl nerves (Fig. 3-12h). In sum, these data reveal that loss of Rab35 in Schwann 
cells results in focal hypermyelination in form of redundant-focally folded myelin sheaths 
including myelin outfoldings, reminiscent to MTMR2 KO and MTMR13 KO mice (Bolino et 
al., 2004; Robinson et al., 2008; Tersar et al., 2007; Ng et al., 2013). Notably, signs of 
hypomyelination in aged animals have also been observed in MTMR13 KO mice (Robinson et 
al., 2008; Ng et al., 2013). 
 
3.2.2 Depletion of Rab35 and/ or MTMR2 results in mTORC1 hyperactivity  
We aimed to investigate the underlying molecular mechanism by which Rab35 and 
active MTMR complexes could regulate myelination. Interestingly, focal hypermyelination in 
peripheral nerves is also a hallmark in transgenic mice with overactivated PI3K/AKT/mTOR 
signaling in Schwann cells (Goebbels et al., 2012; Beirowski et al., 2017). Rab35 has been 
implicated in AKT activation, though with contrasting findings from different cell types 
(Allaire et al., 2013; Wheeler et al., 2015; Zheng et al., 2017). In addition, overexpression of 
MTMR2 is reported to result in sustained AKT activation (Berger et al., 2011), though CMT4B 
mouse models do not display altered AKT activity (Ng et al., 2013; Bolino et al., 2016). 
In order to analyze if depletion of Rab35 and/ or the active phosphatase MTMR2 affects 
PI3K/AKT/mTOR signaling, we first made use of a mammalian cell line as an easily genetically 
manipulatable system. We performed siRNA-mediated depletion of Rab35 and its indirect 
interaction partner, the active phosphatase MTMR2, in HEK cells, which sufficiently reduced 
the levels of each protein to less than 20 % (Fig. 3-13a,b,c). The cell lysates were analyzed by 
immunoblotting for activation of the main signaling pathway-components AKT and mTOR, 
displayed by the ratio of phosphorylated over total protein levels (Fig. 3-13a). In neither of the 





activation (Fig. 3-13d). In contrast, activation of the kinase complex mTORC1, downstream to 
and indirectly regulated by AKT upon mitogen and growth factor stimulation (Inoki et al., 
2002), is elevated in Rab35- and MTMR2-depleted cells. In both conditions, the ratio of the 
phosphorylated mTORC1-target p70 S6 Kinase 1 (p-S6K) to total S6K levels is increased by 
twofold (Fig. 3-13e). Cells depleted of Rab35 and MTMR2 display an even higher increase in 
the ratio of p-S6K/ S6K. Additionally, the levels of S2448-phosphosporylated mTOR, a specific 
mTORC1-phosphorylation site for S6K in a presumable positive feedback-loop (Chiang and 
Abraham, 2005; Copp et al., 2009; Rosner et al., 2010), display a similar tendency as depicted 
by the ratio of p-mTOR/ mTOR protein levels (Fig. 3-13f). This suggests that both, Rab35 and 
MTMR2 repress mTORC1 activity, independent of the PI3K/AKT axis in mammalian cells. 
Figure 3-13: Depletion of Rab35 and/ or MTMR2 in HEK cells results in mTORC1 hyperactivation. 
Lysates of HEK cells depleted of Rab35, MTMR2, or both by siRNA-mediated knockdown were analyzed 
for proteins of the PI3K/AKT/mTOR pathway by immunoblotting. Scrambled siRNA (scr) transfected cells 
were used as controls. (a) Representative immunoblot for S473-phospho AKT (p-AKT), total AKT, T389-
phospho p70 S6 Kinase (p-S6K), total p70 S6K (S6K), S2448-phospho mTOR (p-mTOR), total mTOR, 
Rab35 and MTMR2. ß-actin served as a loading control. (b-f) Quantification from n = 5 independent 
experiments. (b) Rab35 and (c) MTMR2 are efficiently depleted upon siRNA-mediated knockdown. (d) p-
AKT/ AKT ratio normalized to scrambled siRNA (scr) (=1) is not altered in any condition; (siRNA: Rab35, 
p = 0.93502; MTMR2, p = 0.9073; Rab35 + MTMR2, p = 0.18496). (e) p-S6K/ total S6K ratio normalized 
to scrambled siRNA (scr) control (=1) as a readout for mTORC1 activity, is significantly increased upon 
depletion of MTMR2 or Rab35, or both. (f) p-mTOR / total mTOR ratio normalized to scrambled siRNA 
(scr) control is elevated in all knockdown conditions (p = 0.0688); (mean ± SEM; one sample two-tailed 
student’s t-test with a theoretical mean of 100 (b,c) or 1 (d-f), for all conditions normalized to scr, followed 
by p-value correction for multiple testing using Holm’s Multiple Comparison Test; *p < 0.05, **p < 0.01; 
****p < 0.0001). 
 




3.2.3 Rab35 represses mTORC1 activity via MTMR2 
Since hyperactivation of mTORC1 in myelinating glial cells of the CNS and PNS causes 
a strong impairment of myelin homeostasis in vivo (Narayanan et al., 2009; Goebbels et al., 
2010; 2012; Beirowski et al., 2017; Figlia et al., 2017), we aimed to test if the observed 
repression of mTORC1 activity by Rab35 and MTMR2 is also displayed in cells of the nervous 
system. To that end, we made use of primary astrocytic cultures, proliferating CNS-derived 
cultures that provide a sufficient number of cells for lysate protein level analysis by 
immunoblotting. Indeed, in Rab35 icKO cultures we could detect a mean increase of 50 % for 
p-S6K/ S6K protein levels at steady state (+ FBS) (Fig. 3-14a,b). Serum starvation, the 
withdrawal of the major source for growth factors and mitogens, down-regulates PI3K class I- 
and thereby AKT- signaling. When cultures were serum-starved for 12 h before lysis (- FBS), 
hyperactivation of mTORC1 is still observed in Rab35 icKO compared to WT cultures (Fig. 3-
14a,b), indicating that altered mTORC1 regulation is independent of AKT activation. 
Accordingly, p-AKT protein levels are not increased in Rab35 icKO cultures (Fig. 3-14c,d). In 
contrast, a robust decrease of p-AKT/ AKT protein levels is detected upon acute Rab35 
knockout. This result is consistent with a previous study that claims a promoting function of 
Rab35 in PI3K-mediated AKT activation (Wheeler et al., 2015). In sum, our data confirm a 
negative regulatory role for Rab35 in mTORC1 activation in cells of the nervous system, 
independent of the PI3K/AKT axis. 
As a signaling hub at which external and internal cues such as nutrient, energy and oxygen 
availability are integrated, mTORC1 is an important master regulator in the control of the cell 
anabolic versus metabolic state. Upon activation in favorable environmental conditions, for 
instance by nutrient or energy availability, this complex promotes protein and lipid synthesis, 
thus cell growth, and simultaneously downregulates autophagy and lysosome biogenesis 
(Laplante and Sabatini, 2012). Similar to primary Rab35 icKO OPCs and oligodendrocytes, 
and consistent with the established function of mTORC1 activity in the regulation of cell size 
in different eukaryotic cell types (Fingar et al., 2002; Laplante and Sabatini, 2012), we could 






Next, we probed astrocytic lysates for the autophagic marker protein LC3/ATG8 by 
immunoblotting. In Rab35 icKO lysates, we observed a significant reduction of protein levels 
for both, the cleaved cytosolic form LC3-I and the phosphatidylethanolamine-conjugated LC3-
II that is associated to autophagosomal membranes (Kabeya et al., 2000), to 60 % and 80 % of 
WT levels, respectively (Fig. 3-15c,d). In contrast, the ratio of the autophagosome-associated 
LC3-II over cytosolic LC3-I levels is increased upon Rab35 depletion, at steady state (+ FBS) 
by 40 % and upon serum-starvation (-FBS) by 200 % (Fig. 3-15c,e). This implicates that 
autophagy is starvation-induced with a higher rate in Rab35 icKO than WT cultures, with 4- 
and 2.5-fold, respectively (Fig. 3-15e). Moreover, comparable results were obtained by 
immunolabelling for LC3, using short-term digitonin permeabilization to preserve 
autophagosomal membranes (Kaminskyy et al., 2011). Background subtraction of diffuse 
cytoplasmic (LC3-I) signals revealed a significantly increased intensity of LC3-II punctate 
signals, representing autophagosomal structures (Kabeya et al., 2000; Kaminskyy et al., 2011), 
in Rab35 icKO astrocytic cultures at steady state and under starvation conditions (Fig. 3-15f,g). 
These might indicate increased formation or impaired maturation and thus, degradation of 
autophagosomes. In agreement, a function of Rab35 in the maturation of autophagosomes is 
reported (Minowa-Nozawa et al., 2017). In contrast, the prominent down-regulation of LC3 
protein levels is likely caused by hyperactivation of mTORC1. The complex inhibits the nuclear 
translocation of TFEB, a master transcription factor for LC3 and lysosomal biogenesis 
(Settembre et al., 2011; Martina et al., 2012). Despite of that, we could not detect any overt 
Figure 3-14: mTORC1 hyperactivation in primary Rab35 icKO cells is independent of AKT. (a, b) 
mTORC1 hyperactivity in Rab35 icKO astrocytes independent of growth factor stimulation. Astrocytic 
cultures were either serum-fed (+ FBS) or serum-starved (- FBS) for 12 h before lysis. (a) Representative 
immunoblot probed with antibodies against p-S6K1, total S6K1, and ß-actin used as a loading control. (b) p-
S6K/ total S6K ratio as a readout for mTORC1 activity, normalized by setting WT + FBS to 1, is increased 
in Rab35 icKO cells under both conditions (n = 9 independent experiments). (c, d) mTORC1 hyperactivity 
in Rab35 icKO astrocytes is independent of p-AKT. (c) Representative immunoblot of WT and Rab35 icKO 
astrocytes for p-S6K, total S6K, p-AKT and total AKT, and for Rab35 and ß-actin as controls. (d) p-AKT/ 
AKT is decreased in Rab35 icKO astrocytes compared to WT (set to 1); (mean ± SEM; n= 12 independent 
experiments; one sample two-tailed student’s t-test with a theoretical mean of 1; *p < 0.05; **p < 0.05). 




alterations in compartments of the endo-/lysosomal system. EEA1-positive early endosomal, 
Rab7-positive late endosomal, LAMP-1-positive late endosomal/lysosomal and LAMP2-
positive lysosomal compartments appeared normal in shape and abundance in Rab35 icKO 




Figure 3-15: Rab35 icKO astrocytes in culture have an increased cell area and elevated autophagosome 
levels. (a, b) The cell area of cultured astrocytes was visualized using Phalloidin-AlexaFluor568 (grey) and 
analyzed by confocal imaging. (a) Representative confocal images with DAPI (blue) to visualize cell nuclei, 
Scale bar: 30 µm. (b) Quantitative determination of the cell area, using Phalloidin as a mask and normalized 
to WT (100 %). (n = 10 independent experiments) (c-e) Reduced steady-state levels of LC3 are accompanied 
by an increased ratio of LC3-II/-I in Rab35 icKO astrocytes. (c) Representative immunoblot of lysates from 
Rab35 WT and icKO cultures, supplemented with (+FBS) or without serum (-FBS) for 12 h before lysis, 
probed for cytosolic LC3-I and autophagosomal membrane-associated LC3-II, and ß-actin as loading control. 
(d) Quantification of steady state (+ FBS) LC3-I and LC3-II levels presented in c), normalized to the loading 
control and WT levels (100 %); (n = 13 (I) and 12 (II) independent experiments) (e) LC3-II/ LC3-I protein 
ratio, normalized to Rab35 WT +FBS (=1) as a readout for autophagosome formation. Note the differently 
scaled y-axes for ‘+FBS’ (left) and ‘-FBS’ (right); (n = 12 independent experiments). (f, g) More 
autophagosomes in Rab35 icKO cells. Astrocytic cultures were supplemented with or without FBS for 12 h 
before fixation and immunolabelled for LC3. (f) Representative confocal images with LC3-II (green) and 
DAPI-visualized cell nuclei (blue). Scale bar: 30 µm. (g) The mean LC3-II fluorescence intensity in 
Phalloidin-labelled cells, normalized to Rab35 WT +FBS (100 %), is significantly increased in Rab35 icKO 
cultures under both conditions; (n = 12 independent experiments). (mean ± SEM; one sample two-tailed 
student’s t-test with a theoretical mean of 100 (b, d, g) or 1 (e), comparing genotypes in each condition; *p < 






To corroborate the results obtained from HEK cells, we aimed to investigate if 
downregulation of MTMR2 elevates mTORC1 activity in cells of the nervous system as well. 
First, we confirmed the expression of MTMR2 in lysates of primary astrocytic cultures (Fig. 3-
17a). Surprisingly, we could detect significantly reduced MTMR2 levels of 25 % on average in 
Rab35 icKO compared to WT cells (Fig. 3-17b). A reduction in MTMR2 is also reported in 
tissue from MTMR13 KO mice and vice versa, MTMR2 KO mice display reduced protein levels 
of MTMR13 (Robinson et al., 2008; Ng et al., 2013). This is presumed to reflect a decreased 
protein stability in the absence of the MTMR complex partner and thus, a strong 
interdependence, which was also observed for other complex-forming MTMRs (Robinson et 
al., 2008; Zou et al., 2009, 2012; Gupta et al., 2013; Ng et al., 2013). 
Figure 3-17: Interdependence of Rab35 and MTMR2 protein levels. (a, b) MTMR2 protein levels are 
reduced in Rab35 icKO astrocytic cultures. (a) Representative immunoblot of MTMR2 and Rab35 detection. 
ß-actin was used as a loading control. (b) Quantification of MTMR2 protein levels in Rab35 icKO astrocytes, 
normalized to the loading control and depicted as a fraction of WT levels (100 %); (n = 8 independent 
experiments). (c, d) Performed by the laboratory of Prof. Dr. A. Bolino (INSPE, Milan, Italy): Rab35 protein 
levels are reduced in MTMR2 KO mice. Sciatic nerves from MTMR2 WT (MTMR2+/+) and KO (MTMR2-/-) 
mice were lysed and analyzed by immunoblotting. (c) Representative immunoblot for Rab35, and tubulin as 
Figure 3-16: Rab35 loss does not cause major alterations in the endo-/lysosomal system. Representative 
confocal images and quantitative analysis of steady-state levels of (a, b) early endosomal antigen 1 (EEA1), 
(c, d) late endosomal Rab7, (e, f) late endosomal/ lysosomal LAMP-1, and (g, h) the lysosomal marker 
LAMP-2 (green) in Rab35 WT and icKO astrocytic cultures. Sum intensities were normalized to the 
Phalloidin-labelled cell area and depicted as a fraction of Rab35 icKO to WT signals (100 %); Scale bars: 30 
µm; (mean ± SEM; n = 3 (EEA1), 4 (Rab7), 7 (LAMP-1) and 3 (LAMP-2) independent experiments; one 
sample two-tailed student’s t-test with a theoretical mean of 100; EEA1: p = 0.4956, Rab7: p = 0.5061, 
LAMP-1: p = 0.1104, LAMP-2: p = 0.9769). 




a loading control. (d) Quantification of Rab35 level in MTMR2 KO mice, with MTMR2 WT levels set to 100 
%; (n = 4 animals/ genotype); (mean ± SEM; one sample two-tailed student’s t-test with a theoretical mean 
of 100; d: p = 0.079; **p < 0.01). 
 
Therefore, our data might indicate an interdependence of Rab35 and MTMR2 protein 
levels. Notably, this hypothesis was further strengthened by the observation, in collaboration 
with Prof. Dr. A. Bolino (INSPE, Milan, Italy), that vice versa Rab35 protein levels are reduced 
in tissue from MTMR2 KO mice (Fig. 3-17c,d).  
Next, we analyzed mTORC1-activation upon MTMR2 depletion in astrocytic cultures. By 
lentiviral transduction with MTMR2-targeting shRNA, protein levels were sufficiently reduced 
in these cells as well (Fig. 3-18a,b). Quantification of the p-S6K/ S6K ratio, as a readout for 
mTORC1 activation, revealed a 50 % mean increase in MTMR2 shRNA- compared to 
scrambled shRNA- transduced WT cultures. This increase was comparable to Rab35-depleted 
cultures, transduced with scrambled shRNA. In three out of six experiments, an further increase 
of p-S6K was observed in astrocytes depleted of both, MTMR2 and Rab35 (Fig. 3-18a,d). 
Nevertheless, AKT activation was notably unaffected by MTMR2 knockdown in both, Rab35 
WT and icKO cells (Fig. 3-18c).  
In sum, these data confirm that MTMR2 represses mTORC1 activity independent of AKT 
activation in cells of the nervous system as well, similar to Rab35.  
Figure 3-18: Loss of MTMR2 results in mTORC1 hyperactivity in primary astrocytic cultures. Lysates 
from lentiviral-transduced Rab35 WT or icKO astrocytes with shRNA targeting MTMR2 or non-targeting 
scrambled (scr) control shRNA were analyzed by immunoblotting; (n = 6 independent experiments). (a) 
Representative immunoblot probed with antibodies for p-S6K, total S6K, p-AKT, total AKT, MTMR2 and 
ß-actin (loading control). (b) Efficacy of MTMR2 knockdown. MTMR2 levels are normalized to ß-actin and 
WT + scr control (100 %). (c) p-AKT/ AKT ratio, normalized to WT + scr control (= 1), is not altered upon 
MTMR2 knockdown (WT + MTMR2 shRNA: p = 0.8170). (d) pS6K/ total S6K ratio, normalized to WT + 
scr (= 1) as a readout for mTORC1 activity, is significantly increased upon MTMR2 knockdown in WT cells, 
comparable to the level in Rab35 icKO (+scr) lysates. Double depletion of MTMR2 and Rab35 partially 
elevates mTORC1 activity; (mean ± SEM; one sample two-tailed student’s t-test with a theoretical mean of 
100 (b) or 1 (c,d), followed by p-value correction for multiple testing using Holm’s Multiple Comparison 





Next, in order to dissect whether increased mTORC1 activity in vivo is underlying the 
striking phenotype of focal hypermyelination in Rab35 cKOSC mice, sciatic nerves were lysed 
at postnatal day (P)30, after the peak of PNS myelination (P10-P21), and analyzed by 
immunoblotting. In Rab35 cKOSC nerves, both, phosphorylated S6K and its target the 
ribosomal protein S6 were increased by a mean of 50 % and 250 %, respectively (Fig. 3-19a,b). 
As expected from our in vitro data, the ratio of p-AKT/ AKT levels was unaltered (Fig. 3-19c). 
In addition, activation of the MAPK pathway component ERK, an alternative upstream 
activator of mTORC1 that is also implicated in myelin regulation (Ma et al., 2005; Newbern et 
al., 2011; ; Sheean et al., 2014; Furusho et al., 2017), was unchanged upon Rab35 depletion as 
well (Fig. 3-19b). These data confirm that Rab35 depletion in the PNS results in mTORC1 
hyperactivity in vivo, independent of PI3K/AKT- and MAPK/ERK-dependent mTORC1 
regulation.  
Next, we aimed to test the hypothesis that repression of mTORC1 activity is mediated 
by Rab35-dependent recruitment of active MTMR phosphatases. To that end, we analyzed 
mTORC1 activation upon overexpression of MTMR2 in cells depleted of MTMR2 or Rab35. 
Indeed, introducing an excess of siRNA-resistant mouse MTMR2 caused reduced 
hyperactivation of mTORC1 in form of ameliorated p-S6K/ S6K protein levels in MTMR2 and 
notably also Rab35 knockdown cells (Fig. 3-20a,b). These results indicate that Rab35 represses 
mTORC1 activity by the recruitment of active MTMR complexes.  
Figure 3-19: mTORC1 is hyperactivated in vivo in sciatic nerves from Rab35 cKOSC mice. Performed 
by the laboratory of Prof. Dr. A. Bolino (INSPE, Milan, Italy): Sciatic nerves from P30 Rab35 Ctrl and 
cKOSC mice were lysed and analyzed by immunoblotting. (a) Representative immunoblot for p-S6K, total 
S6K, p-S6 and total S6 as a readout for mTORC1 activity. Vinculin and Tubulin were used as loading 
controls. (b) Mean ratio of p-S6K/ S6K and p-S6/S6 in Rab35 cKOSC sciatic nerves, normalized to Ctrl (= 
1), is 1.5-fold and 2.5-fold increased, respectively; (mean ± SEM; one sample two-tailed student’s t-test with 
a theoretical mean of 1; p-S6K/ S6K: n = 6 animals/genotype, p=0.0706; p-S6/ S6: n = 4 animals/genotype, 
*p < 0.01). (c) Immunoblot for p-AKT, total AKT, T202/Y204-phosphorylated ERK1/2 (p-ERK) and total 
ERK in sciatic nerve lysates. No alterations were observed. Vinculin was used as a loading control.  
 





3.2.4 Accumulation of PI(3)-phosphates causes mTORC1 hyperactivity in the absence of 
Rab35 
Active MTMR phosphatases possess specificity to dephosphorylate PI(3)P and 
PI(3,5)P2 in complex with their pseudophosphatase partners (Caldwell et al., 1991; Kim et al., 
2003b; Berger et al., 2006b; Zou et al., 2012). Thus, we hypothesized that impaired recruitment 
of MTMR phosphatases by Rab35 depletion could conceivably lead to imbalanced levels of 
these phosphatidylinositol (PI) species. As no functional probes for quantitative monitoring of 
PI(3,5)P2 in eukaryotic cells are available so far (Hammond et al., 2015), we focused on PI(3)P. 
This lipid is detectable by the use of a PI(3)P-binding FYVE-tandem domain of Hrs, fused to 
eGFP (eGFP-2xFYVE) (Gillooly et al., 2003). Additionally, PI(3)P levels can also reflect 
imbalanced PI(3,5)P2 abundance, as it serves as the only known precursor for its synthesis by 
PIKfyve (Sbrissa et al., 1999; Zolov et al., 2012). We used HeLa cells as a more convenient 
cell type for confocal microscopy than HEK cells, due to a better adhesion and shape 
preservation during immunocytochemistry. Importantly, siRNA-mediated depletion of Rab35 
resulted in increased p-S6K level in HeLa cells as well (Fig. 3-21a). Next, we probed HeLa 
cells depleted of MTMR2 and Rab35 after fixation with recombinantly expressed 
eGFP--2xFYVE and subsequently immunolabelled the cultures with an antibody recognizing 
the eGFP-epitope (Hammond et al., 2009). As expected due to the knockdown of MTMR2, 
significantly increased PI(3)P levels were observed (Fig. 3-21b,c). We identified these puncta 
as PI(3)P-specific by acute inhibition of the main PI(3)P-synthesizing enzyme VPS34 using 
Figure 3-20: MTMR2 re-expression rescues mTORC1 hyperactivity caused by Rab35 reduction. 
Lysates of HEK cells depleted of Rab35 or MTMR2 by siRNA-mediated knockdown were transfected with 
plasmids encoding either eGFP (ctrl) or siRNA-resistant mouse MTMR2 (msMTMR2) and analyzed by 
immunoblotting. (a) Representative immunoblot for p-S6K, total S6K, Rab35 and MTMR2. ß-actin was used 
as loading control. (b) p-S6K/ total S6K, normalized to scr + ctrl (=1), is significantly increased for Rab35 
and MTMR2 in ctrl- but not msMTMR2-overexpressing cells; (mean ± SEM; n = 5 independent experiments; 
one sample two-tailed student’s t-test with a theoretical mean of 1 for targeting siRNA samples compared 
with scr within each overexpression condition, followed by p-value correction for multiple testing using 





10 µM VPS34-IN1 for 1 h prior to fixation, which completely abrogated the signal, in line with 
previous work (Bago et al., 2014). Strikingly, an increase in PI(3)P puncta was also observed 
in Rab35 icKO primary astrocytic and oligodendrocytic cultures without simultaneous 
depletion of MTMR2 (Fig. 3-22). This indicates that the absence of Rab35 indeed causes an 
accumulation of PI(3)P, and maybe PI(3,5)P2, which likely results from the impaired 
recruitment of 3’-phosphatases such as MTMR2.  
Figure 3-22: PI(3)P accumulation in primary Rab35 icKO cells. Primary Rab35 icKO cells were fixed 
and immunolabelled for PI(3)P (green) using recombinant eGFP-2xFYVE and F-actin (red). Representative 
confocal images of primary (a) astrocytic and (c) oligodendrocytic cultures; Scale bars: 30 µm. 
Quantification of mean PI(3)P fluorescence intensity, normalized to the cell area and WT cells (= 100 %) for 
(b) astrocytic cultures (n = 4 independent experiments) and (d) oligodendrocytic cultures (n = 3 independent 
Figure 3-21: Elevated PI(3)P levels in HeLa cells depleted of Rab35 and MTMR2. (a) Immunoblot for 
Rab35, p-S6K and total S6K protein levels confirms upregulation of mTORC1 activity in HeLa cells depleted 
of Rab35 using siRNA-transfection. (b, c) HeLa cells were treated with non-targeting scrambled (scr) control 
siRNA or siRNAs specific for Rab35 and MTMR2, and immunolabelled for PI(3)P using recombinant eGFP-
2xFYVE as a probe. As a control for specific labeling, 10 µM VPS34-IN1 was acutely applied to scr 1 h 
before fixation for acute VPS34 inhibition. (b) Representative confocal images of siRNA transfected HeLa 
cells stained for PI(3)P (green) and F-actin by fluorescently-labelled phalloidin (red);  Scale bars: 30 µm. (c) 
Quantification of PI(3)P levels as the sum intensity of eGFP-2xFYVE-positive puncta normalized to the cell 
area and scr + DMSO control conditions (100 %). (d) Depleted HeLa cells tend to an increased cell area. 
Quantification of Phalloidin-masked cell area in Rab35- and MTMR2- co-depleted cells and normalized to 
scr. (mean ± SEM; n = 5 independent experiments; two-tailed paired student’s t-test with a theoretical mean 
of 100; d: p = 0.2340; *p < 0.05). 




experiments). Acute VPS34 inhibition (10 µM VPS34-IN1) completely abrograted eGFP-2xFYVE puncta 
(n = 1 experiment each); (mean ± SEM; one sample two-tailed student’s t-test with a theoretical mean of 100; 
*p < 0.05). 
 
MTMR2 is presumed to act on lipid levels at late endosomal/ lysosomal compartments 
(Cao et al., 2008). In addition, we had observed recruitment of the MTMR2-complex partner 
MTMR13 to these organelles by Rab35. Hence, we further investigated the PI(3)P levels 
specifically at these late endo-/ lysosomal sites by co-immunolabelling of HeLa cells for PI(3)P 
and the late endosomal marker protein CD63 (Kobayashi et al., 2000). Interestingly, PI(3)P 
levels at CD63-positive late endosomal compartments were significantly increased by around 
25 % upon knockdown of either Rab35, MTMR2, or both (Fig. 3-23).   
 
 
Given the fact that mTORC1 is recruited to and activated at late endosomal/ lysosomal 
organelles (Sancak et al., 2008; 2010), and both lipid substrates of the MTMR2 phosphatase, 
Figure 3-23: Depletion of Rab35 and/ or MTMR2 causes PI(3)P accumulation on late endosomes/ 
lysosomes. HeLa cells depleted of Rab35, MTMR2, or both, by siRNA-mediated knockdown, were 
immunolabelled for PI(3)P and the late endosomal/ lysosomal marker protein CD63, and analyzed by 
confocal imaging. (a) Representative confocal images of HeLa cells immunostained for PI(3)P (red) and 
CD63 (green). Cell nuclei were visualized with DAPI (blue). White arrows indicate examples of co-
localization. Scale bars: 10 µm (left), 5 µm (right). (b) The mean intensity of PI(3)P in CD63-positive 
(CD63+) compartments is depicted as a fraction of control cells (scr ; 100 %); (mean ± SEM; n = 5 






PI(3)P and PI(3,5)P2, are reported signaling lipids in PI3K/AKT-independent activation of 
mTORC1 (Byfield et al., 2005; Nobukuni et al., 2005; Jaber et al., 2011; Bridges et al., 2012; 
Jin et al., 2014; Mohan et al., 2016; Yoon et al., 2016; Hong et al., 2017), we hypothesized that 
hyperactivation of mTORC1 in MTMR2- and Rab35-depleted cells is due to the observed 
imbalance of PI(3)P levels. According to this hypothesis, normal activation of mTORC1 should 
be re-stored by interfering with the cellular PI(3)P production. To test this, we first depleted 
PI(3)P levels in Rab35 WT and icKO astrocytic cultures using acute inhibition of VPS34 by 
treatment with 5 µM or 10 µM VPS34-IN1 for 1 h and analyzed mTORC1 activation. 
Strikingly, the significant increase in p-S6K/ S6K protein levels in Rab35 icKO compared to 
WT lysates in control conditions was completely abrogated upon treatment with VPS34-IN1 
(Fig. 3-24a,b). The same effect was observed upon treatment of cultures with two other specific 
VPS34 inhibitors, SAR405 (Ronan et al., 2014) or Compound-19 (Bilanges et al., 2017) (Fig. 
3-24a). Moreover, WT-comparable mTORC1 activity was also re-stored by acutely treating 
Rab35 icKO astrocytic cultures with VPS34-IN1, which were simultaneously depleted of 
MTMR2, (Fig. 3-24c,d). This finding indicates that the accumulation of PI(3)-phosphates in 
the absence Rab35 and MTMR2 could be the underlying cause for mTORC1 hyperactivity. 
Figure 3-24: Pharmacological inhibition of PI(3)-phosphate synthesis rescues mTORC1 hyperactivity 
upon Rab35- and MTMR2-depletion. (a,b) Inhibition of VPS34-dependent PI(3)-phosphate synthesis 
rescues mTORC1 hyperactivity in Rab35 icKO astrocytes. Astrocytic cultures were treated with indicated 
concentrations of the selective VPS34 inhibitors VPS34-IN1, SAR405, or Compound-19 (Cmp-19) or with 
DMSO for 1 h prior to lysis. (a) Lysates were analyzed by immunoblotting for Rab35, total S6K and pS6K 
as a readout for mTORC1 activity. ß-actin was used as a loading control. (b) The significant increase in the 
ratio of p-S6K to total S6K, normalized to WT cells (= 1) in Rab35 icKO cells is ameliorated upon inhibitor 




treatments; (n = 6 (10 µM VPS34-IN1) and 3 (5 µM VPS34-IN1) independent experiments). (c, d) VPS34 
inhibition rescues mTORC1 hyperactivation in Rab35- and MTMR2-depleted primary astrocytes. Astrocytic 
cultures were transduced with lentiviruses containing non-targeting scrambled (scr) control shRNA (co-
expressing eGFP) or shRNA targeting MTMR2, treated with DMSO or 10 µM VPS34-IN1 for 1 h before 
lysis, and analyzed by immunoblotting. (c) Representative immunoblots for p-S6K, S6K, eGFP (scr), 
MTMR2 and Rab35. (g) Quantification of p-S6K/ S6K, normalized to control (WT + scr + DMSO = 1); (n 
= 5 independent experiments); (mean ± SEM; one sample two-tailed student’s t-test with a theoretical mean 
of 1, comparing the genotypes in each treatment condition; *p < 0.05; **p < 0.01). 
 
 
So far, our data reveal a novel physiological pathway in which Rab35-mediated 
recruitment of active MTMR complexes to lysosomes limits mTORC1 activity by 
dephosphorylating PI(3)P, and likely PI(3,5)P2, which serve as a platform for the recruitment 
and activation of the cell signaling complex. 
 
3.2.5 Counteracting mTORC1 hyperactivity ameliorates myelin abnormalities upon 
Rab35 depletion  
mTORC1 has a dual role in Schwann cells. It inhibits the cell cycle exit and is reported 
to repress KROX20 on the one hand, and promotes myelin lipid synthesis and myelin protein 
expression on the other (Norrmén et al., 2014; Beirowski et al., 2017; Figlia et al., 2017; Jiang 
et al., 2018). Thus, mTORC1 activity in Schwann cells must be physiologically tightly 
regulated and alterations result in time- and dosage-dependent effects (Figlia et al., 2018).  
To corroborate the hypothesis that mTORC1 activity is causative for the observed focal 
hypermyelination in Rab35 cKOSC mice, our collaboration partners (Prof. Dr. A. Bolino, 
INSPE, Italy) prepared embryonic explants of myelin-forming Schwann cell/dorsal root 
ganglion (DRG) neuron co-cultures, and analyzed axonal myelination in the absence of Rab35 
ex vivo. Surprisingly, the number of MBP-positive myelin segment was reduced to 40 % in 
Rab35 cKOSC explants (Fig. 3-25c,d). Furthermore, more than 50 % of the MBP-positive fibers 
possessed structural myelin abnormalities in Rab35 cKOSC co-cultures (Fig. 3-25e,f), 
reminiscent of in vitro myelin outfoldings in MTMR2 and MTMR13 KO explants (Bolis et al., 
2009; Robinson et al., 2018). Importantly, when co-cultures were treated with Rapamycin, a 
specific mTORC1-component FKBP12 inhibitor (Sehgal et al., 1975; Sabatini et al., 1994), the 
reduced abundance of myelin segments was fully rescued and aberrant myelin formation 
strikingly ameliorated (Fig. 3-25d,f). This confirms that increased mTORC1 underlies the 







Figure 3-25: Repression of mTORC1 hyperactivity ameliorates aberrant myelination in the absence of 
Rab35 ex vivo and in vivo. Performed by the laboratory of Prof. Dr. A. Bolino (INSPE, Milan, Italy): 
Schwann cell/ DRG neuron co-culture explants were prepared from Rab35 Ctrl and cKOSC mouse embryos. 
(a, b) Loss of Rab35 in co-culture explants. (a) Representative immunoblot for Rab35 and Tubulin as control 




protein. (b) Rab35 protein levels, normalized to Tubulin and WT levels (= 100 %); (mean ± SEM; n = 6 
coverslips/DRG explants; one sample two-tailed student’s t-test with theoretical means of 100; **p < 0.01). 
(c, d) Rab35 WT and cKOSC mouse explants were fixed and immunolabelled. (c) Representative confocal 
images of Myelin-forming Schwann cell/ DRG neuron co-culture explants, with axonal marker Nf-M (green), 
myelin segment marker MBP (red) and DAPI (blue) to visualize Schwann cell nuclei. Scale bar: 7 µm (d) 
The number of MBP-positive myelin segments is reduced by 40 % in untreated (NT) Rab35 cKOSC co-culture 
explants compared to WT cultures. Rapamycin treatment (Rapa) of Rab35 cKOSC co-cultures rescued the 
number of myelin segments; (mean ± SEM; n = 12 (WT), 10 (cKOSC – NT) and 8 (cKOSC +Rapa) 
coverslips/DRG explants; two-tailed paired student’s t-test; *p < 0.05, **p < 0.01). (e, f) Myelin abnormalities 
in Rab35 cKOSC are ameliorated by treatment with Rapamycin. (e) Higher magnification images of MBP 
staining in untreated and Rapamycin-treated Rab35 cKOSC cells. Asterisks mark myelin abnormality 
examples. Scale bars: 4 µm (f) The fraction of MBP-positive fibers carrying myelin abnormalities, with a 
mean of 50 % in Rab35 cKOSC –NT cultures, was reduced to 30 % in cKOSC +Rapa; (mean ± SEM; n = 6 
coverslips/DRG explants; two-tailed paired student’s t-test; ***p < 0.001). (g, h) Focal hypermyelination in 
Rab35 cKOSC sciatic nerves is ameliorated upon Rapamycin treatment in vivo. (g) Repressed mTORC1 
activation by Rapamycin treatment in sciatic nerves. Immunoblot for p-S6 in sciatic nerve lysates from Rab35 
cKOSC mice treated with vehicle (Veh) or Rapamycin (Rapa). (h) Semithin section analysis of sciatic nerves 
from Rab35 cKOSC mice (P70) following vehicle or Rapamycin treatment and quantification of the 
percentage of fibers carrying myelin degenerations, tomacula or myelin outfoldings; (mean ± SEM; n=7 
animals from each genotype; two-tailed non-parametric Mann-Whitney test; *p < 0.05, **p < 0.01). (i-k) 
Ultrastructural analysis of sciatic nerves at P5. (i) Representative image of Rab35 cKOSC sciatic nerves with 
myelin degenerations (green arrows) and myelin outfoldings (yellow arrows) already at P5; Scale bar: 4 µm. 
(j) Rab35 cKOSC sciatic nerves contain an increased fraction of abnormal fibers; (mean ± SEM; n = 5 animals/ 
genotype; two-tailed Mann-Whitney t-test; **p < 0.01). (k) The fraction of myelinated fibers is not altered; 
(n = 5 animals /genotype; two-tailed Mann-Whitney t-test; p = 0.84).  
 
 
In order to substantiate these findings in vivo, Rab35 cKOSC animals were treated with 
10 mg Rapamycin per kg of body weight. Treatment was started at P12, the earliest time point, 
when animals were yet able to tolerate the long-term drug application. Ultrastructural analysis 
of sciatic nerves from Rab35 cKOSC at P70 revealed an amelioration of focal hypermyelination, 
particularly a significantly reduced proportion of fibers displaying tomacula and myelin 
degeneration (Fig. 3-25g,h). In contrast to the in vitro observation, myelin outfoldings were 
unchanged in nerves of Rapamycin-treated Rab35 cKOSC mice. Crucially, the analysis of sciatic 
nerves at P5 revealed an early onset of focal hypermyelination upon loss of Rab35 (Fig. 3-
25i,j). As Rapamycin was applied from P12 on only, manifestation of the phenotype at that 
early age might be an explanation for incompletely restored myelin homeostasis in Rapamycin-
treated Rab35 cKOSC mice. Earlier treatment with this inhibitor at the used dose was so far 
lethal. Interestingly, in vivo, the number of myelinated fibers in was unaltered between the 
genotypes (Fig. 3-25g,h). 
  Nevertheless, these data reveal Rab35 as an important regulator of PNS 
myelination, and, in agreement with our findings from other cell types in vitro, show that loss 





hyperactivity contributes to the observed impairment of myelin homeostasis in form of focal 
hypermyelination in Rab35 cKOSC sciatic nerves in vivo and aberrant myelination ex vivo.  
 
 
3.2.6 Interfering with PI(3)-phosphate synthesis rescues mTORC1 hyperactivity and 
abnormal myelin protein expression in primary cultures of Rab35 icKO Schwann cells  
Focal hypermyelination, as seen in the absence of Rab35 in vivo is not only a 
phenotypical hallmark in sciatic nerves from adult mice with mTORC1 hyperactivation 
(Goebbels et al., 2012; Beirowski et al., 2017; Figlia et al., 2017) but also from MTMR2 KO or 
MTMR13 KO animals (Tersar et al., 2007; Robinson et al., 2008; Bolino et al., 2004; Ng et al., 
2013). Moreover, myelin outfoldings are observed in organotypic explants of both, MTMR2 
and MTMR13 KO animals (Bolis et al., 2009; Robinson et al., 2018). In agreement with our 
data from several cell types in vitro, we presumed that impaired recruitment of active MTMR 
phosphatase complexes contributes to the observed impairment of the myelin homeostasis in 
the absence of Rab35. To test this hypothesis, we made use of primary Schwann cells from 
Rab35 icKO mice, induced for knockout and differentiation with tamoxifen and ascorbic acid, 
respectively. Due to the limited amount of material in these cultures, we analyzed mTORC1 
activation by immunolabelling for p-S6 and S6 protein levels. This approach revealed the 
expected increase in the ratio of p-S6 over S6 protein levels as a readout for mTORC1 activity 
in primary Schwann cells from Rab35 icKO animals (Fig. 3-26a,b), as also recapitulated in 
primary astrocytic cultures (Fig. 3-26c,d). Accordingly, chronical inhibition of mTORC1 by 
application of 15 nM Rapamycin for six days sufficiently diminished p-S6 protein levels in 
Rab35 WT and icKO Schwann cells (Fig. 3-26a,b). In addition, immunolabelling using eGFP-
2xFYVE(Hrs) probe revealed increased PI(3)P levels in Rab35 icKO Schwann cells, indicating 
an impaired PI(3)-phosphatase function in these cells as well (Fig. 3-27a,b). In contrast, PI(4)P 
levels were not altered (Fig. 3-27c,d). 




Figure 3-26: Repression of mTORC1 hyperactivity by interfering with PI(3)-phosphate synthesis in 
Rab35-depleted primary Schwann cells. (a,b) Primary Schwann cell cultures, prepared from tamoxifen-
inducible Rab35 icKO (Rab35Fl/Fl x CreER) and WT (Rab35Fl/Fl) mice, were induced for knockout and 
differentiation at DIV3, and chronically supplemented with DMSO, 1 µM VPS34-IN1, 2.5 µM Cmp-19, 50 
nM Apilimod or 15 nM Rapamycin (Rapa) from DIV5 until fixation and subsequent immunolabelling at 
DIV11. (a) Representative confocal images of Schwann cells supplemented with DMSO or inhibitors, and 
immunolabelled for ribosomal p-S6 (green) and S6 (red) protein. Areas marked by white squares in upper 
images (scale bars: 30 µm) are shown as insets below (scale bars: 10 µm). (b) Quantification of mTORC1 
activity by the ratio of p-S6 to S6 mean intensity in SC somata, normalized to WT + DMSO control (=1). 
Significantly increased mTORC1 activity in Rab35 icKO Schwann cells is rescued in all inhibitor conditions; 
(n = 6 (DMSO), 4 (Cmp-19, Apilimod) and 3 (VPS34-IN1, Rapa) independent experiments). (c, d) Increased 
p-S6/ S6 protein levels in Rab35 icKO astrocytes as a readout for mTORC1 hyperactivity. (c) Confocal 
images of Rab35 WT and icKO astrocytes immunostained for p-S6 (green) and total S6 (red); Scale bar, 30 
µm. (d) p-S6/ S6 ratio in Phalloidin-masked cells normalized to WT (100 %), is increased in Rab35 icKO 
cells; (n= 3 independent experiments). (mean ± SEM;; one sample two-tailed student’s t-test with a 
theoretical mean of 1, comparing the genotypes in each condition; *p < 0.05). 
 
Our data so far indicated that accumulation of the MTMR substrate PI(3)P could be the 
underlying cause of increased mTORC1 activation in the absence of Rab35 and MTMR2. In 





icKO cultures with VPS34-IN1 or Compound-19 to interfere with PI(3)P and eventually 
PI(3,5)P2 synthesis (Ikonomov et al., 2015). In addition, we made use of chronical treatment 
with the specific PIKfyve-inhibitor Apilimod to selectively block the PI(3,5)P2 production 
(Gayle et al., 2017). In agreement with our previous findings, VPS34-inhibitors evidently 
abrogated PI(3)P levels (Fig. 3-27b) and reduced mTORC1 activity to WT levels in Rab35 
icKO Schwann cells as well (Fig. 3-26b). Inhibition of PIKfyve caused an elevation of PI(3)P 
levels in both, Rab35 WT and icKO Schwann cells (Fig. 3-27b), in agreement with the role of 
this lipid as a precursor for PI(3,5)P2. In contrast, mTORC1 activity was also restored to WT 
levels in Rab35 icKO SC cultures treated with Apilimod (Fig. 3-26b). These data indicate that 
mTORC1 hyperactivity upon Rab35 depletion is rather not elicited by the observed 
accumulation of PI(3)P but instead by simultaneously elevated PI(3,5)P2 levels in Schwann 
cells. 
Figure 3-27: Elevated PI(3)P levels in Schwann cells depleted for Rab35. (a,b) Primary Schwann cell 
cultures were treated chronically with DMSO or 50 nM Apilimod for six days, or acutely (1 h) with 10 µM 
VPS34-IN1 or 10 µM Cmp-19 prior to fixation with subsequent immunolabelling for PI(3)P. (a) 
Representative confocal images of differentiated Schwann cells, immunolabelled for PI(3)P using eGFP-
2xFYVE (green) and cell bodies using fluorescent phalloidin (red). Areas marked by white squares in upper 
images (scale bars: 30 µm) are shown as insets below (scale bars: 10 µm). (b) Quantification of PI(3)P sum 
intensity, normalized to the somata area and WT + DMSO control (100 %); (n = 4 (DMSO) and 3 (Apilimod) 
independent experiments). (c, d) Rab35 depletion does not alter the levels of PI(4)P in Schwann cells. (c) 
Representative confocal images of Schwann cells in culture, immunostained with an antibody against PI(4)P 
(red). Cell bodies were labelled using fluorescent phalloidin (green); Scale bars: 30 µm (upper), 10 µm (lower 
images). (d) The sum intensity of PI(4)P-positive puncta in Rab35 icKO Schwann cell somata, normalized 
to the somata area and Rab35 WT cells (100 %), is unaltered (p = 0.3854); (n = 3 independent experiments). 
(mean ± SEM; one sample two-tailed student’s t-test with a theoretical mean of 100, comparing the genotypes 
in each condition; *p < 0.05). 





So far, we could observe hypomyelination in Rab35 icKO coculture explants with early, 
embryonically induction of Rab35 depletion. These results would be in line with the dual role 
of mTORC1 in repressing differentiation induction on the one hand, and promoting myelin lipid 
and protein synthesis on the other (Norrmen et al., 2017; Beirowski et al., 2017; Figlia et al., 
2017). Thus, we aimed to reveal the effect of late Rab35 knockout induction on myelin protein 
levels in Schwann cells upon simultaneous induction of differentiation and Cre-recombination. 
Mono-cultures of Schwann cells usually express low amounts of myelin proteins as they are 
not able to form “in vitro” myelin sheets as cultured oligodendrocytes (Arthur-Farraj et al., 
2011; Liu et al., 2015b). In agreement, we observed low levels of fluorescent signals in WT SC 
cultures immunolabelled for myelin protein 0 (P0), one of the major myelin components in the 
PNS (Shy et al., 2006) (Fig. 3-28). Interestingly, in Rab35 icKO cultures a high proportion of 
cells with strikingly elevated P0 protein levels were observed. Upon chronical treatment with 
Rapamycin, the mean P0 levels were indeed reduced to WT levels in Rab35 icKO cells. 
Importantly, this effect was also rescued by interfering with PI(3)-phosphate synthesis using 
VPS34-IN1, Cmp-19 or Apilimod (Fig. 3-28b), presumably by the indirect repression of 
mTORC1 activation as observed under these conditions. In sum, these data indicate that Rab35 
depletion in differentiated Schwann cells causes an increase in myelin protein levels in vitro, 
consistent with the myelin promoting function of mTORC1, once differentiation is induced 
(Beirowsky et al., 2017; Figlia et al., 2017). It additionally suggests that the observed reduction 
of mTORC1 repression in these cells is mainly due to an accumulation of the MTMR-






Figure 3-28: Increased myelin protein expression in Rab35 icKO Schwann cell cultures is rescued by 
inhibition of mTORC1, VPS34 or PIKfyve. Primary Schwann cell cultures, induced for knockout and 
differentiation, were treated chronically with DMSO, 1 µM VPS34-IN1, 2.5 µM Cmp-19, 50 nM Apilimod 
or 15 nM Rapamycin (Rapa) for six days. Cells were fixed and immunostained. (a) Representative confocal 
images of Rab35 WT and icKO cells immunolabelled for P0 (green). The total number of cells was visualized 
using DAPI (magenta). Areas marked by white squares in upper images (scale bars: 100 µm) are shown as 
insets below (scale bars: 30 µm). (b) Quantification of the sum P0 fluorescence intensity divided by the cell 
number, and normalized to WT + DMSO controls (100 %); (mean ± SEM; n = 7 (DMSO), 5 (Cmp-19, 
Apilimod), 4 (VPS34-IN1) and 3 (Rapa) independent experiments; one sample two-tailed student’s t-test 
with theoretical means of 100 comparing WT and KO in each treatment condition; **p < 0.01). 
 
 
Collectively, our data identify Rab35 as a novel regulator of PNS myelination and reveal 
that elevated mTORC1 activity contributes to the impaired PNS myelin homeostasis upon loss 
of Rab35 in vivo, ex vivo and in vitro. Furthermore, repression of mTORC1 activity by Rab35 
is likely mediated by PI(3)-phosphate regulation through the recruitment of active MTMR 
phosphatases complexes. 





This work unravels a novel function of Rab35 in the control of PNS myelin 
homeostasis. We demonstrate that loss of the small GTPase leads to a crucial impairment of 
Schwann cell myelination in vivo and in vitro. Furthermore, we identified Rab35 as a 
repressor of mTORC1 activity, which contributes to the regulation of myelin homeostasis. 
This action is mediated by the conversion of PI(3)-phosphates through Rab35-dependent 
recruitment of MTMR lipid phosphatase complexes. We observed this mechanism in different 
cell types, including primary cell cultures of the nervous system. Specifically in cultured 
Schwann cells, interfering with PI(3,5)P2 synthesis ameliorates not only mTORC1 
hyperactivation upon loss of Rab35 but also aberrant myelin protein levels. These data reveal 
insights how dysregulated PI(3)-phosphate conversion can lead to severe demyelination as 
displayed in CMT-disease types 4B, and thus might have therapeutic implications for the 
treatment of peripheral neuropathies. 
 
4.1 Rab35 is a novel repressor of mTORC1 and controls PNS myelin homeostasis 
4.1.1 mTORC1 hyperactivity in the absence of Rab35 affects PNS myelin homeostasis 
Perturbances in the regulation of mTORC1 and thus dysregulation of cell metabolism 
is the underlying cause for several diseases, including cancer and neurodegeneration 
(Laplante and Sabatini, 2012; Tatebe and Shiozaki, 2017). In peripheral nerves, mTORC1 
promotes proliferation of Schwann cell (SC) precursors, radial sorting of axons by immature 
SCs and myelin growth (Norrmén et al., 2014; Figlia et al., 2017). In SCs, mTORC1 is 
mainly activated via MAPK/ERK and PI3K/AKT signaling downstream of axonal NRG1-
ligand binding to Schwann cell ErbB2/B3 receptors (Goebbels et al., 2012; Heller et al., 
2014; Belin et al., 2018). Expression levels of ErbB3, ERK and AKT are downregulated 
during the maturation of nerves, from the first to the second postnatal week in mice when 
myelin growth reaches a plateau (Sheean et al., 2014). Similarly, mTORC1 activity declines 
during that time and remains at relatively low levels throughout further development (Heller 
et al., 2014; Figlia et al., 2017; Beirowski et al., 2017) (Figure 4-1). This mechanism seems to 
ensure proper axonal myelination by limiting further myelin growth. In accordance, 
abnormally high mTORC1 activity during adulthood results in excessive myelin growth with 
focal hypermyelination (Goebbels et al., 2012; Beirowski et al., 2017; Figlia et al., 2017; 
Jiang et al., 2018). Interestingly, in disease mouse models with insufficient myelin formation, 
hypomyelination is ameliorated by overexpression of ErbB-activating NRG1-III or 





(Scapin et al., 2018; Belin et al., 2018). In turn, focal hypermyelination in mouse models of 
Charcot-Marie-Tooth (CMT) disease type 4B1 or Hereditary Neuropathy with liability to 
pressure palsies (HNPP) is rescued by pharmacological TACE activation (Bolino et al., 
2016). Rab35 cKOSC mice display not only progressive focal hypermyelination (Figure 3-12), 
but also mTORC1 hyperactivation in vivo (Figure 3-19a,b). Interfering with mTORC1 
activity in these mice by rapamycin treatment partially ameliorated the abundance of 
aberrantly myelinated fibers (Figure 3-25g,h). In agreement, the SC-specific ablation of 
PTEN, a negative regulator of mTORC1 activation, results in focal hypermyelination, and is 
ameliorated by rapamycin treatment (Goebbels et al., 2012). Similarly, tomacula and myelin 
outfoldings are observed upon genetic inactivation of TSC1 in Schwann cells (Beirowski et 
al., 2017). Moreover, elevated MAPK/ERK signaling in SCs results in mTORC1 
hyperactivity, focal hypermyelination and an increase in the myelin thickness, whereas the 
latter is partially mediated by mTORC1-independent ERK-targets (Sheean et al., 2014). As 
neither AKT- nor ERK-activity was elevated in Rab35 cKOSC mice (Figure 3-19c), our data 
further strengthen previous suggestions that increased mTORC1 activation is the underlying 
cause for focal hypermyelination in transgenic mice with upregulated MAPK/ERK- or 
PI3K/AKT-signaling in SCs. Excessive myelin growth due to elevated mTORC1 activity can 
be explained by its regulatory function in the synthesis of lipids. mTORC1 promotes the 
activation, trafficking and maturation of SREBP transcription factors and thus, regulates the 
expression of enzymes involved in the lipid, fatty acid and cholesterol synthesis in different 
cell types (Porstmann et al., 2008; Düvel et al., 2010; Li et al., 2010; Peterson et al., 2011; 
Han et al., 2015b), as well as in Schwann cells (Norrmén et al., 2014). The potential 
upregulation of these enzymes remains to be investigated in Rab35 cKOSC mice. However, g-
ratios are mainly unaltered in Rab35 cKOSC sciatic nerves and thus, do not indicate an 
increase in the overall myelin thickness (radial hypermyelination) which is displayed, at least 
for small diameter fibers (< 2 µm), in other transgenic mice with mTORC1 hyperactivation 
(Goebbels et al., 2010; 2012; Beirowski et al., 2017). This might be a dosage-dependent 
effect of mTORC1 activity (see below). On the other hand, the underlying molecular 
mechanisms that mediate the formation of these common pathological features and thus, how 
they result from elevated mTORC1 activity, are still elusive. Interestingly, genetic ablation of 
different myelin proteins leads to focal hypermyelination as well (Sander et al., 2006; Fabrizi 
et al., 2000). This is observed in HNPP, caused by haploinsufficency of the compaction 
protein PMP22 (Adlkofer et al, 1997). Similarly, MAG-deficient mice display myelin 
outfoldings that eventually result in the formation of tomacula (Cai et al., 2002). In addition, 




focal hypermyelination is caused by different mutations in P0 (Fabrizi et al., 2000; Kochański 
et al., 2003; Iida et al., 2012), whereas other mutations in the same gene result in 
hypomyelination as displayed in CMT1B patients (D’Antonio et al., 2013). The phenotypical 
rescue in a CMT1B mouse model by overexpression of NRG1-III is suggested to result from 
an improvement in the stoichiometry of myelin lipid and protein synthesis (Scapin et al., 
2018). Accordingly, these animals display elevated AKT- and ERK-signaling, and, 
presumably due to increased mTORC1 activation, an upregulation in the lipid synthesis. In 
turn, the balanced upregulation of myelin lipid synthesis and myelin protein expression might 
underly radial hypermyelination, whereas focal hypermyelination could result from an 
imbalanced myelin formation. An increase in mTORC1-mediated myelin lipid synthesis 
accompanied by physiological levels of myelin protein expression or an impaired myelin 
protein incorporation into the nascent sheath, as discussed below, might account for the 
formation of focal but not radial hypermyelination in Rab35 cKOSC mice in vivo. 
Distinct Cre-recombinases used for conditional ablations of negative upstream 
regulators of mTORC1 partially account for observed differences in the extent of hypo- and 
hypermyelination upon mTORC1 hyperactivation in vivo (Figlia et al., 2018). Whereas strong 
hypomyelination results from Cre-expression controlled by the Dhh-promoter from E12 on, 
an initial hypomyelination followed by focal hypermyelination is observed in conditional 
TSC1 cKOSC animals using a Cre recombinase expressed at E13.5 under control of the 
P0-promoter (Beirowski et al., 2017; Jiang et al., 2018). Similarly, the conditional ablation of 
Rab35 was controlled by a P0-Cre (Figure 3-12a). These mice do not display 
hypomyelination in sciatic nerves at early stages of development, but Rab35 depletion ex vivo 
leads to a striking reduction in myelin segment formation in SC/DRG organotypic explants 
(Figure 3-25a-d). This might reflect the postulated time-dependent effect on myelination by 
altered mTORC1 activation (Beirowski et al., 2017; Figlia et al., 2017). The cause for such a 
difference in myelin formation in vivo and ex vivo, which is not reported so far in other 
transgenic mouse models with mTORC1 hyperactivity, remains to be investigated (Beirowski 
et al., 2017; Figlia et al., 2017; Jiang et al., 2018). Despite of that, myelin segment formation 
was restored in Rab35 cKOSC explants to WT levels by rapamycin treatment, suggesting that 
mTORC1 hyperactivity is indeed causative (Figure 3-25d). Importantly, a significant number 
of myelin segments ex vivo displayed abnormal structures, resembling of focal 
hypermyelination in vivo or myelin outfoldings in explants from CMT4B mouse models, and 
could be rescued by rapamycin (Figure 3-25e,f). Thus, mTORC1 hyperactivation in Rab35 





The observed initial hypomyelination upon mTORC1 hyperactivation in vivo is 
attributed to an elevated proliferation of immature SCs on the one hand (Beirowski et al., 
2017; Jiang et al., 2018), and repression of the myelination-initiating transcription factor 
KROX20 by the mTORC1-target S6K on the other (Figlia et al., 2017). Notably, 
hyperproliferation of Schwann cells correlates with the extent of mTORC1 hyperactivity and 
thus, the impairment in myelination onset. In agreement with the fact that mTORC1 
hyperactivation is more pronounced upon TSC2 than TSC1 depletion (Zeng et al., 2011), 
TSC2Fl/Fl x P0-Cre mice display persistent hypomyelination into adulthood (Beirowski et al., 
2017). However, both, mTORC1 and Rheb are implicated in repression of the cell cycle exit 
by regulating the cyclin dependent kinase (CdK)-inhibitor p27kip1 for instance (Hong et al., 
2008; Lacher et al., 2010; Ji et al., 2012; Ke et al., 2016; Jiang et al., 2018). Thus, the 
observed hyperproliferation of TSC-depleted Schwann cells also results from mTORC1-
independent regulation of p27kip1 by Rheb (Beirowski et al., 2017). In conclusion, more 
moderate activity elevation of mTORC1 and Rheb in TSC1Fl/Fl x P0-Cre than in TSC2 cKOSC 
mice results in modest hyperproliferation and slightly delays the onset of myelination only 
(Beirowski et al., 2017; Jiang et al., 2018). The latter is represented by a reduced number of 
myelinated fibers in the first weeks postnatally, which indicates a lack of differentiated 
Schwann cells. However, in Rab35 cKOSC mice the number of myelinated fibers was 
comparable to control sciatic nerves already at P5 (Figure 3-25k). In addition, focal 
hypermyelination could be observed even at that young age. This difference to other mouse 
models with mTORC1 hyperactivity might be caused by additive effects. First, in contrast to 
TSC knockout animals, Rab35 cKOSC presumably do not display Rheb hyperactivity as 
neither AKT nor ERK are upregulated. Thus, less hyperproliferation than in TSC knockout 
animals can be expected. Second, in sciatic nerves of TSC1Fl/Fl x P0-Cre animals at P28, 
phosphorylated S6 protein levels are more than five times increased over WT levels 
(Beirowski et al., 2017). In contrast, sciatic nerves of Rab35 cKOSC mice displayed a more 
moderate 2- to 3-fold increase in p-S6/ S6 levels (Figure 3-19b). Thus, lower mTORC1 
hyperactivation might account for the lack of a delayed SC differentiation in these animals. 
Moreover, Rab35 is a known regulator of cytokinesis, due to its relevance in the cytokinetic 
abscission (Kouranti et al., 2006; Dambournet et al., 2011; Chesneau et al., 2012; Fremont et 
al., 2017). Accordingly, the rate of proliferation was markedly reduced in Rab35 icKO OPC 
cultures and slowed down by more than 50 % in Rab35 icKO astrocytes in culture (data not 
shown). A slower cytokinesis might counteract the increased proliferation induction upon 
mTORC1 hyperactivation. In sum, mTORC1 hyperactivity does not lead to hyperproliferation 




or a delayed myelination onset in Rab35 icKO mice and thus, not to early hypomyelination in 
vivo.  
Interestingly, if mTORC1 hyperactivity is induced in mice upon adulthood, focal 
hypermyelination is accompanied by radial hypermyelination of large diameter fibers as well 
(Goebbels et al., 2012; Beirowski et al., 2017; Figlia et al., 2017; Jiang et al., 2018). This 
might indicate that mTORC1 activation upon myelin induction can cause an upregulated 
homeostatic wrapping of myelin layers by promoting myelin lipid as well as myelin protein 
synthesis. KROX20 regulates myelin protein translation during myelin induction (Jang et al., 
2010), and is suppressed by mTORC1. However, KROX20-independent upregulation of 
myelin protein expression is also reported, for instance upon NRG1 overexpression and 
presumably mTORC1 hyperactivation (Scapin et al., 2018). In addition, an upregulation of 
myelin protein levels is observed upon SC-specific overexpression of hyperactive AKT in 
vivo, whereas KROX20 levels are even reduced (Domenech-Estevez et al., 2016). 
Interestingly, in the CNS, cholesterol is critical for myelin protein synthesis (Smolders et al., 
2010; Mathews et al., 2014), and mTORC1 was recently identified as a key player in the 
cholesterol-mediated regulation of myelin protein expression (Mathews and Appel, 2016). 
When we made use of tamoxifen-inducible Rab35 knockout in differentiated Schwann cell 
mono-cultures, we could observe a large fraction of cells with abnormally high P0-protein 
expression in vitro (Figure 3-28). P0-signals in these cultures could be reduced to WT-levels 
by Rapamycin application, indicating that mTORC1 hyperactivity is indeed causative. 
Interestingly, Raptor depletion in Schwann cells in vivo results in lower protein levels of P0 
and MBP, but not MAG, suggesting that mTORC1 does not control PNS myelin protein 
synthesis in general but rather the expression of distinct proteins only (Norrmén et al., 2014). 
In contrast, in the CNS, mRNA and protein levels of almost all major myelin proteins are 
downregulated upon Raptor depletion, whereas MBP mRNA levels are less affected (Bercury 
et al., 2014; Lebrun-Julien et al., 2014). From these data, mTORC1 has been suggested to 
control translation but not transcription of MBP (Figlia et al., 2018). Our data, together with 
earlier findings (Norrmén et al., 2014), indicate that P0-protein levels are also regulated by 
mTORC1. Interestingly, the exit of newly synthesized P0-protein from the endoplasmatic 
reticulum is cholesterol-dependent (Saher et al., 2009), providing a mechanism by which 
mTORC1 activation could specifically promote P0-protein synthesis. Thus, inducing 
mTORC1 hyperactivity after KROX20-mediated P0- and MBP-transcription initiation could 
result in a more balanced upregulation of myelin lipid and protein synthesis and thus, to radial 





Rab35-depleted SCs need to be analyzed. In addition, ultrathin sections of sciatic nerves from 
Rab35 cKOSC mice could be analyzed by immunogold labelling for the abundance and 
incorporation of myelin proteins into aberrantly myelinated sheaths in vivo.  
 
 
 Figure 4-1: Regulation of myelin homeostasis by mTORC1 in CNS and PNS. mTORC1 is proposed to 
delay the myelination onset in Schwann cells by S6K-mediated repression of KROX20 transcription and 
inhibition of the cell cycle exit. In the CNS, differentiation of OLs is presumed to be potentiated by 
mTORC1. After onset of myelination, mTORC1 promotes myelin growth by transcriptional upregulation 
of lipid- and cholesterol synthesizing enzymes via SREBPs, and presumably by promoting myelin protein 
synthesis. In the PNS, mTORC1 activity declines in pro-myelinating Schwann cells, and remains at low 
levels in mature myelinating Schwann cells. Modified from (Figlia et al., 2018). 
 
So far, myelin degeneration has not been reported as a frequent morphological feature 
that accompanies focal hypermyelination. However, myelin degeneration in Rab35 cKOSC 
was slightly ameliorated by Rapamycin treatment, indicating a link to mTORC1 
hyperactivation. Re-activation of mTORC1 is observed upon nerve injury and critical for 
MBP  
(P0) 




proper myelin clearance, SC dedifferentiation and re-myelination (Norrmén et al., 2018). In 
turn, abnormally increased mTORC1 activity might induce myelin breakdown and thus, 
myelin degeneration even in the absence of a nerve damage. On the other hand, autophagy is 
required for proper myelin clearance (Gomez-Sanchez et al., 2015). Our data from astrocytic 
cultures and recent studies (De Leo et al., 2016; Minowa-Nozawa et al., 2017) indicate that 
autophagy might be impaired in the absence of Rab35. Thus, defective debris clearance could 
contribute to the progressive abundance of this pathological feature in Rab35 cKOSC sciatic 
nerves.  
Finally, despite of the significant rescue of myelin segment formation ex vivo and P0-
protein levels in vitro by mTORC1 inhibition in Rab35-depleted SCs, aberrant myelination in 
vivo is only partially ameliorated. Tomacula displayed the strongest reduction upon 
Rapamycin treatment, in accordance with the major role of mTORC1 in bulk membrane 
formation (Goebbels et al., 2012; Beirowski et al., 2017; Jiang et al., 2018). Myelin 
degeneration and outfoldings are less efficiently rescued, which might be explained by the 
early onset of the phenotype and the comparably late Rapamycin application. These features, 
but not tomacula, are already observed at P5 with a strikingly high abundance compared to 
Control animals (Figure 3-25j). In contrast, Rapamycin treatment was performed from P12 
on, as earlier application affected the survival of the mice. This problem might be 
circumvented by a 50 % reduction of the Rapamycin dosage, which is reported to be well 
tolerated by young mice already at P3 (Lebrun et al., 2014; Figlia et al., 2017). In addition, 
other processes independent of mTORC1 but regulated by Rab35 and required for the 
maintenance of myelin homeostasis might contribute to the demyelination in Rab35 cKOSC 
animals as further discussed in section 4.4. 
 
4.1.2 Rab35 represses mTORC1 activity independent of growth factor stimulation  
mTORC1 is a conserved and central signaling hub for the switch of cellular anabolism 
and catabolism, controlled by a cohort of extrinsic and intrinsic mechanisms to regulate cell 
growth and survival. In this study, we observed elevated mTORC1 activity upon depletion of 
Rab35 in several cell types. siRNA-mediated knockdown of Rab35 in HEK (Figure 3-13e,f) 
or HeLa cells (Figure 3-21a), or its acute depletion in primary astrocytic cultures (Figures 3-
14a,b; 3-26c,d) or Schwann cells, in vitro (Figure 3-26a,b) as well as in vivo (Figure 3-19a,b), 
resulted in hyperactivation of mTORC1. Rab35 has been implicated in regulation of the 
mTORC1-upstream activator AKT in different tissues. Its absence is reported to cause 





activation in different cancer cell lines (Allaire et al., 2013; Duan et al., 2016; Zheng et al., 
2017; Ye et al., 2018). In contrast, Rab35 is also presumed to facilitate PI3K activity and 
eventually AKT phosphorylation in somatic cancer or HEK cells, as well as upon ROS 
(reactive oxygen species) production in a breast cancer cell line (Wheeler et al., 2015; Deng et 
al., 2016). In these studies, less AKT activation was reported in the absence of Rab35, 
whereas overexpression of the constitutively active mutant Rab35Q67L enhanced AKT 
phosphorylation. In accordance, we observed reduced AKT phosphorylation upon acute 
depletion in Rab35 icKO primary astrocytes in culture (Figure 3-14c,d). Simultaneously, 
these cells display an upregulation in mTORC1 activity. This indicates an additional role of 
Rab35 in the repression of mTORC1, independent of its function in the activation of AKT. 
This hypothesis is corroborated by the fact that downregulation of RTK-mediated PI3K/AKT 
signaling by serum-starvation leads to reduced mTORC1 activity but does not compensate the 
significant hyperactivity in Rab35 icKO compared to control cells (Figure 3-14b). 
Furthermore, elevated mTORC1 activity in vivo, in sciatic nerve tissue of Rab35 icKOSC mice 
is not caused by RTK-overactivation as neither AKT- nor ERK-phosphorylation is increased 
(Figure 3-19c,d). Thus, we conclude that Rab35 represses mTORC1 independent of growth 
factor receptor signaling.  
mTORC1 promotes cell growth on the one hand and represses autophagy on the other 
(Laplante and Sabatini, 2012). In agreement, cultured cells depleted of Rab35 display an 
increased cell area (Figures 3-15a,b; 3-21d). Despite of the established function of mTORC1 
in the transcriptional repression of lysosomal and autophagic biogenesis via TFEB (Settembre 
et al., 2011; Martina et al., 2012), the abundance of lysosomal compartments is not altered in 
Rab35 icKO astrocytic cultures (Figure 3-16e-h). Notably, recent studies revealed, that 
inactivation of mTORC1 does not necessarily result in an increased number of lysosomes, as 
represented by unaltered LAMP-1 and LAMP-2 levels. Instead, enhanced lysosomal function 
by an increased lysosomal pH and TFEB-mediated upregulation of hydrolytic lysosomal 
enzymes was observed (Zhou et al., 2013; Puertollano et al., 2014). Thus, investigating the 
lysosomal functionality could reveal more insight into the effect of mTOR1 hyperactivity on 
protein degradation in our cells. On the other hand, LC3-levels are reduced as expected 
(Figure 3-15c,d). In contrast to the conserved role of mTORC1 in the downregulation of 
autophagy (Hosokawa et al., 2009; Jung et al., 2009), we observed an increased number of 
autophagosomes in the absence of Rab35 (Figure 3-15c-g). This might reflect a block in 
autophagosome maturation or clearance, for instance due to impaired fusion with lysosomes. 
Interestingly, a similar phenotype has been recently observed in Rab35 knockout HeLa cells 




and was assigned to a function of Rab35 in mediating NDP52‐dependent autophagosome 
maturation (Minowa-Nozawa et al., 2017). In addition, the Rab35 effector protein, OCRL, 
has been implicated in autophagosome-lysosome fusion (De Leo et al., 2016). Measuring the 
autophagic flux would reveal if impaired autophagosome maturation or clearance is indeed a 
consequence in Rab35 cKO primary astrocytes. On the other hand, VPS34-complex I -
mediated PI(3)P production is a crucial promoter for autophagosome formation (Vergne et al., 
2009; Jaber et al., 2012; Ronan et al., 2014), and we could observe increased VPS34-
synthesized PI(3)P-levels in the absence of Rab35 (Figures 3-22; 3-27a,b). The complex 
should be at least partially inhibited by mTORC1 activity (Martina et al., 2012; Yuan et al., 
2013), but an impairment in PI(3)P hydrolysis due to a loss of different MTMR phosphatases, 
such as MTMR14, -R3, -R9 and -R8, indeed results in enhanced autophagy initiation (Vergne 
et al., 2009; Taguchi-Atarashi et al., 2010; Cebollero et al., 2012; Zou et al., 2012). It would 
be thus worth to investigate, if the loss of Rab35 increases PI(3)P-levels at autophagosomal 
membranes as well.  
In sum, catabolic pathways are not dramatically downregulated in the absence of 
Rab35 despite of mTORC1 hyperactivity. mTORC1-independent targets of Rab35, as well as 
proteins that mediate the repression of mTORC1 by Rab35 might counteract the effect of 
mTORC1 hyperactivity on autophagy. 
 
 
4.2 Rab35-dependent repression of mTORC1 is mediated by PI(3)P- and 
PI(3,5)P2-hydrolyzing MTMR proteins 
Several reports indicate that mTORC1 recruitment to or activation at late endosomes/ 
lysosomes is mediated by PI(3)P and/ or PI(3,5)P2, independent of AKT or ERK regulation 
(Byfield et al., 2005; Nobukuni et al., 2005; Han et al., 2012; Yoon et al., 2016; Fang et al., 
2001; 2003; Xu et al., 2011; Yoon et al., 2011; Bridges et al., 2012; Jin et al., 2014). By 
genetic manipulations, a set of PI(3)-phosphate kinases have been identified to thereby 
mediate mTORC1 activation, including the PI(3)P-generating enzymes, VPS34 and class II 
PI3K C2α (Jaber et al., 2011; Bridges et al., 2012), and the PI(3,5)P2-synthesizing PIKfyve in 
a complex with Fig4 and Vac14 (Bridges et al., 2012; Jin et al., 2014). In contrast, not much 








4.2.1 MTMR proteins are novel effectors of Rab35 
Active Rab35 specifically interacts with the pseudophosphatases MTMR5 and 
MTMR13 (Figures 3-5; 3-6), and via these also with their complex partner, the active 
phosphatase MTMR2 (Figures 3-9; 3-10). In addition, we identified MTMR1 as a novel 
complex partner of MTMR13 (Figure 3-9), and presumably also MTMR5 (data not shown). 
Rab35 recruits MTMR13 to LAMP-positive late endosomal/ lysosomal (LE/ Lys) membranes 
(Figure 3-8d-f). These compartments display PI(3,5)P2- and PI(3)P-identity, the preferred 
substrates of MTMR2 (Cao et al., 2008) in a complex with MTMR13 (Berger et al. 2006b) or 
MTMR5 (Kim et al., 2003b). Active Rab35 and MTMR13 also colocalized at defined plasma 
membrane sites. This in agreement with the known localization of Rab35 (Li et al., 2014), 
whereas a function of MTMRs at the plasma membrane remains to be investigated. 
Interestingly, lysosomal positioning towards the plasma membrane in response to amino acid 
stimulation is mediated by PI(3)P-binding proteins (Hong et al., 2017). In addition, a plasma 
membrane pool of PI(3)P and PI(3,5)P2 is also reported to mediate mTORC1 activation via 
TSC complex regulation (Bridges et al., 2012; Hirsch et al., 2014; Mohan et al., 2016).  
Furthermore, Rab35-depleted cells display accumulation of PI(3)P, which strongly 
indicates that PI(3)-phosphate regulating enzymes are dysregulated (Figures 3-22; 3-27a,b). 
The only so far known Rab35 effector that regulates PI-metabolism is the 5’-phosphatase 
OCRL. This enzyme preferentially dephosphorylates PI(4,5)P2, which is for instance required 
for the uncoating of clathrin-coated vesicles upon endocytosis, and their eventual fusion with 
endosomes (Cauvin et al., 2016). The subsequent conversion from PI(4)P to endosomal 
PI(3)P is incompletely resolved, but might be realized by class II PI3K C2α-mediated 
generation of PI(3,4)P2 from PI(4)P, which is eventually converted into PI(3)P by INPP4B 
(Posor et al., 2013). Thus, an impaired recruitment of OCRL in the absence of Rab35 would 
thereby not result in the observed accumulation of PI(3)P. In addition, Rab35 icKO Schwann 
cells do not display altered PI(4)P levels (Figure 3-27c,d). Interestingly, overexpression of 
MTMR2 decreases PI(3)P levels in cultured cells (Lorenzo et al., 2006). Thus, we propose 
that the loss of Rab35 impairs the recruitment of the PI(3)P phosphatase complexes 
MTMR13/-R2, MTMR5/-R2, MTMR13/-R1 to lysosomal membranes and thereby causes an 
accumulation of PI(3)P. This hypothesis is corroborated by the finding that PI(3)P levels are 
increased at late endosomal/lysosomal (LE/Lys)-compartments upon depletion of Rab35, 
MTMR2, or both (Figure 3-23). An accumulation of PI(3,5)P2 is also likely, though we could 
not investigate this directly, due to the lack of a functional probe (Hammond et al., 2015). 
Furthermore, we observed reduced MTMR2 levels in Rab35 icKO primary astrocytic cultures 




(Figures 3-17a,b; 3-18b). In turn, sciatic nerve tissue from MTMR2 KO mice also harbor 
reduced Rab35 levels (Figure 3-17c,d). A regulation of these proteins in the translational 
process of each other could explain this finding but a function in protein translation is neither 
reported for Rab35 nor MTMR2 so far. We observed that either loss of Rab35 or MTMR2 in 
HEK cells or primary astrocytes in culture results in increased activity of mTORC1 (Figures 
3-13e,f; 3-18d). Thus, both proteins act in the repression of the core kinase complex. 
Moreover, simultaneous depletion of both proteins partially results in an even more severe 
upregulation of steady state mTORC1 activity. This argues against a genetic compensation by 
the reduction of MTMR2 or Rab35 in the absence of its partner protein. Intriguingly, a 
reduction in MTMR2 protein levels is also observed in MTMR13 KO mice, while MTMR13 
protein levels are reduced in MTMR2 KO mice as well (Ng et al., 2013). In addition, higher 
protein levels than expected from single overexpression of MTMR2 and -R13 are reported 
upon their co-expression in cell cultures (Robinson and Dixon, 2006). The same 
interdependence of protein levels is observed for other MTMR complex-forming members 
(Zou et al., 2009; 2012; Gupta et al., 2013), and likely reflects an increased or decreased 
protein stability in the presence or absence of a complex partner, respectively. Thus, the 
observed interdependence of Rab35 and MTMR2 strongly suggests a functional interaction, 
presumably by complex formation for the repression of mTORC1 activity. This hypothesis is 
corroborated by the finding that overexpression of MTMR2 not only ameliorates mTORC1 
hyperactivation in MTMR2-depleted HEK cells, but also in cells with markedly decreased 
levels of Rab35 upon siRNA-mediated knockdown (Figure 3-20). Furthermore, increased 
mTORC1 activity in the absence of MTMR2 is also not attributed to elevated AKT activation 
(Figures 3-13d; 3-18c). In a recent study, overexpression of MTMR3 has been reported to 
interfere with mTORC1 activation, though independent of its phosphatase activity and by 
direct binding (Hao et al., 2016). If such an interaction is also true for other MTMRs should 
be therefore investigated, for instance in an affinity purification assay. Despite, our data rather 
suggest a lipid-mediated regulation by MTMR2, as mTORC1 hyperactivation is rescued by 
pharmacological interference with PI(3)P synthesis in Rab35 icKO cells (Figure 3-24a,b), and 
in cells additionally depleted of MTMR2 (Figure 3-24c,d). However, lipid-mediated 
regulation of mTORC1 by MTMR2 remains to be ultimately confirmed, for instance by 
showing that overexpression of a phosphatase-deficient MTMR2 mutant does not rescue 
mTORC1 hyperactivation in MTMR2-depleted cells. So far, our findings indicate a sequential 
action of Rab35 and MTMR2 in repressing mTORC1 by PI(3)P- and PI(3,5)P2-hydrolysis at 





4.2.2 Rab35-dependent recruitment of MTMR phosphatase complexes 
Despite of the fact that MTMR2 and its closest homologues MTM1 and MTMR1 
harbor a lipid-binding domain, their association with membranes is only occasionally 
observed upon overexpression, and the localization pattern remains mainly cytosolic 
(Robinson and Dixon, 2006; Cao et al., 2007; 2008). Furthermore, these phosphatases convert 
PI(3)P (Cao et al., 2007; 2008; Ketel et al., 2016; this study), whereas their PH-GRAM 
domain preferentially binds to PI(3,5)P2 and PI(5)P (Berger et al., 2003; Schaletzky et al., 
2003; Tsujita et al., 2004). This indicates their membrane association might be mediated by 
additional factors or other proteins. For instance, constricted conditions such as a 
hypoosmotic shock, which increases PI(3,5)P2 concentration, facilitate MTMR2 membrane 
association (Berger et al., 2003). A report about ERK-mediated MTMR2-dephosphorylation 
and its eventual dissociation from early endosomal membranes (Franklin et al., 2011; 2013) 
contrasts earlier findings of EGF-stimulated MTMR2 translocation to late endosomal 
membranes (Cao et al., 2008). In the latter study, a direct interaction between VPS34 and 
MTM1 or MTMR2, controlled by early endosomal Rab5 or late endosomal Rab7, 
respectively, was proposed to mediate their recruitment (Cao et al., 2007; 2008). However, 
these Rab GTPases activate VPS34 by disrupting the kinase-phosphatase interaction. Thus, 
how MTM1 and MTMR2 bind to the respective PI(3)P-positive membranes remains elusive. 
Interestingly, a recent study reported that Rab11 is activated by an endosomal PI(3)P pool and 
mediates the recruitment of MTM1 (Campa et al., 2018). Here, we propose that Rab35 
recruits MTMR2 and -R1 in a complex with MTMR5 or -R13. This is conceivable, as 
complex formation with these pseudophosphatases by oligomerization through their coiled-
coil regions is known to regulate the membrane association of MTMR2 (Laporte et al., 2002; 
Berger et al., 2003; 2006b; Kim et al., 2002b; 2003b; Robinson and Dixon, 2006). For 
instance, its localization to endomembranes is disrupted when the coiled-coil region is 
mutated (Kim et al., 2002b). In turn, overexpressed MTMR2 translocates from the cytosol to 
punctate, perinuclear puncta when MTMR5 is co-expressed (Kim et al., 2003b). Furthermore, 
the association of MTMR2 with MTMR5 or -R13 results in strikingly increased catalytic 
activity towards PI(3)P and PI(3,5)P2 in vitro (Kim et al., 2003b; Berger et al., 2006b). Thus, 
these pseudophosphatases not only recruit but also stimulate phosphatase activity of MTMR2.  
We propose that membrane association of these pseudophosphatases is regulated by 
recruitment through Rab35, as overexpressed MTMR13 remains mainly cytosolic (Robinson 
and Dixon, 2005) but is translocated by active Rab35 (Figure 3-8d-f). This hypothesis is 
corroborated by the fact that the partial localization of MTMR13 to membrane fractions is 




independent of its two lipid-binding domains, PH or PH-GRAM, whereas the inactive PTP 
domain alone is sufficient (Robinson and Dixon, 2006). Intriguingly, we could map the 
binding site of Rab35 to the PTP domain of MTMR13 (Figure 3-7). Interaction at this site can 
explain the specific binding of Rab35 to these pseudophosphatases, but also raises the 
question if other inactive MTMR members might be recruited as well. In contrast, the inactive 
PTP domain of MTMR13 displays the largest sequence identity with MTMR5 (57,5 %) and 
MTMR2 (30.1 %). Thus, the PTP domains of other MTMR pseudophosphatases have less 
overlap with MTMR13 than MTMR2 and are therefore similarly not expected to bind to 
Rab35. Furthermore, neither our interactor screen in HEK cells (Figure 3-4) nor the screen 
performed with D. melanogaster proteins (Gillingham et al., 2014) indicate comparable 
association of other MTMR pseudophospatases with Rab35. Interestingly, the PTP domain 
displayed a lower binding affinity to Rab35 than full-length MTMR13. Thus, binding of 
Rab35 to the PTP domain could be additionally promoted by other domains of MTMR13 in 
its native conformation. Though, we observed reduced binding of the PTP domain to Rab35 
when expressed in conjunction with the coiled-coil region, steric interference by the latter 
could also be an artefact of the recombinant peptide. In consequence, we propose a model in 
which Rab35 binds to the inactive PTP domain of MTMR13, and presumably also MTMR5. 
The active phosphatases MTMR2 or -R1 hetero-oligomerize with these pseudophosphatases 
via their coiled-coil (CC) regions, and thereby active MTMR complexes can be recruited by 
the small GTPase (Figure 4-2). The hypothesis that these complexes are still active when 
Rab35 is bound remains to be confirmed. For instance, an in vitro phosphatase assay with 
MTMRs, affinity-purified from HEK cell lysates using GST-Rab35^GTPyS as a bait, could 
reveal their functional activity. Alternatively, recombinantly expressed and purified MTMR1 
and -R2 from E. coli can be used. In contrast, the large multi-domain proteins MTMR13 
or -R5 are not soluble in E. coli (data not shown). In addition, localization studies within cells 
were so far limited as endogeneous levels of Rab35 are obviously not sufficient to recruit 
overexpressed MTMR13. Furthermore, the overexpression of all three interacting proteins 
impaired cell morphology and survival (data not shown). Thus, antibodies are required to 
detect their endogeneous localization. Alternatively, if an increased phosphatase activity upon 
co-overexpression of Rab35 with MTMR complexes is responsible for the lethal effect, the 
use of a phosphatase-inactive mutant of MTMR2 might solve this problem.  
Finally, we could not yet reveal how Rab35 is recruited to lysosomal sites. In a recent 
study, overexpression of the long non-coding mRNA HOTAIR increased the co-locolization 





of Rab35 at LAMP-positive late endosomal MVBs during exosome secretion is negatively 
regulated by the GAPs TBC1D10A-C (Hsu et al., 2010). Another candidate could be 
Folliculin, which possesses GEF activity towards Rab35 (Nookala et al., 2012; Zheng et al., 
2017), is identified at lysosomal sites and regulates mTORC1 activity (Baba et al., 2006; 
Hasumi et al., 2009; 2014; Petit et al., 2013; Tsun et al., 2013; Meng and Ferguson, 2018). In 
addition, the Rab35-GEF DENND1A (Connecdenn1) possesses the highest binding affinity 
among all PI-species towards PI(3)P, and insignificantly less to PI(3,5)P2 (Allaire et al., 
2010). Analyzing PI(3)P levels or mTORC1 activation in the absence of these GEFs and 
GAPs in primary Schwann cells could reveal their potential involvement in mediating the 
recruitment and regulation of Rab35 at LE/Lys.  
 
Figure 4-2: Model of interaction between Rab35 and MTMR complexes. Rab35 binds MTMR13, and 
presumably MTMR5 at their inactive PTP domains, and via these, to the active phosphatases MTMR2/ -
R1. CC - coiled-coil region; PTP – phosphotyrosine phosphatase 
 
4.2.3 PI(3)-phosphates in the regulation of Schwann cell myelin homeostasis 
The regulation of PI signaling is strongly correlated to SC myelin homeostasis. Four 
CMT-disease types are caused by loss of function or missense mutations in PI(3)-phosphate 
catabolizing enzymes: CMT4J by Fig4, and CMT4B1, -B2 and -B3 by MTMR2, -R13 and -
R5, respectively (Suter, 2007). In CMT4B1, mostly truncating or missense mutations within 
the highly conserved residues of the catalytic PTP- and the PH-GRAM domain of MTMR2 
are causative (Berger et al., 2012). CMT4J mainly results from mutations in the catalytic SAC 
domain of Fig4, or within its interaction domains with the scaffolding protein Vac14 (Chow 
et al., 2007). While CMT4B is marked by redundant myelin formation, CMT4J patients 
display hypomyelination. The interaction of MTMR2 with Dlg-1 has been recently proposed 
to inhibit the delivery of membrane via vesicular structures at paranodal loops and thereby 
account for the occurrence of myelin outfoldings in CMT4B1 mouse models (Bolis et al., 
2009). Accordingly, depletion of the fusion promoter Sec8 slightly ameliorated myelin 
outfoldings in MTMR2 KO cultures in vitro (Bolis et al., 2009), but inactivation of Dlg-1 in 
MTMR2 KO mice did not alter the phenotype in vivo (Cotter et al., 2010). In addition, how 




the phosphatase activity of MTMR2 could contribute in this mechanism is not revealed. 
Interestingly, heterozygousity of Fig4, which conversely results in reduced PI(3,5)P2 levels 
due to the physical interdependence with PIKfyve (Vaccari et al., 2011), ameliorates the 
phenotype of MTMR2 KO mice in vivo. Also in vitro, the depletion of PIKfyve ameliorates 
myelin abnormalities in MTMR2 KO cultures. These data indicate a striking dependency of 
myelin homeostasis on the phosphatase activity of MTMR2 towards PI(3,5)P2.  
Reminiscent of CMT4B mouse models (Bolino et al., 2004; Robinson et al., 2008; Ng 
et al., 2013), sciatic nerves from Rab35 cKOSC are marked by focal hypermyelination with 
abundant myelin outfoldings (Figure 3-12d-f). In addition, adult mice display a reduction in 
the myelin thickness of large diameter nerve fibers (Figure 3-12h), which is also observed in 
aged MTMR13 KO mice (Ng et al., 2013; Robinson et al., 2008). Moreover, in agreement 
with the identification of Rab35 as an upstream regulator of MTMR2, we observed increased 
PI(3)P levels in Rab35 icKO Schwann cells in culture (Figure 3-27a,b). Furthermore, though 
a positive regulation of AKT (Berger et al., 2011) or negative regulation of ERK (Franklin et 
al., 2011) signaling was presumed from MTMR2 overexpression assays in cell lines, neither 
MTMR2 KO nor -R13 KO mice display altered AKT- or ERK- activation, whereas mTORC1 
activity has not been investigated yet in CMT4B mouse models (Bolino et al., 2016; Ng et al., 
2013). Consistent with the fact, that late endosomal/ lysosomal PI(3)P activates mTORC1 
activity (Byfield et al., 2005; Nobukuni et al., 2005; Jaber et al., 2011), we observed an 
amelioration of mTORC1 hyperactivity in SC mono-cultures upon pharmacological 
interference with the main PI(3)P-synthesizing enzyme VPS34 (Figure 3-26a,b). We could 
not directly probe for PI(3,5)P2 levels (Hammond et al., 2015), but PI(3)P is the only known 
precursor of PI(3,5)P2 and depletion of VPS34 lowers PI(3,5)P2 levels by about 65% (Sbrissa 
et al., 1999; Zolov et al., 2012; Ikonomov et al., 2015). In agreement, we observed a strong 
increase of PI(3)P levels upon pharmacological interference with PIKfyve using Apilimod. 
Despite of that, this condition also rescued the hyperactivation of mTORC1 and, importantly, 
elevated P0-protein levels in Rab35-depleted Schwann cells (Figure 3-28). This suggests that 
PI(3,5)P2 levels, and not PI(3)P, are the main driver for mTORC1 activity in Schwann cells, 
and thus, presumably for myelin regulation.  
Surprisingly, in a recent study, an amelioration of myelin outfoldings in MTMR13 KO 
mice has not been observed upon simultaneous knockout of either VPS34 or PI3KC2ß 
(Robinson et al., 2018). Astonishingly, additive effects in these double knockout mice were 
also not reported, though VPS34 cKOSC animals display a severe hypomyelination in vivo 





compensation of class II and class III PI3K in the absence of each other, similar to the 
observed PI3KC2ß upregulation in the absence of -C2α in HeLa cells and fibroblasts (Tiosano 
et al., 2019). In addition, in contrast to the presented morphometric analysis from 2- and 8-
month-old MTMR13 KO x PI3KC2ß cKOSC animals, adult MTMR13 KO x VPS34 cKOSC 
mice have not been investigated (P3 and P18 only). The authors proposed an 
MTMR2-independent phenotype of MTMR13, which is contrasted by the strong phenocopy 
in MTMR13- and -R2 KO mouse nerves (Bolino et al., 2004; Ng et al., 2013). In addition, 
MTMR2 re-expression in MTMR13 KO SC/ DRG organotypic explants did ameliorate myelin 
outfoldings (Robinson et al., 2018). Our data, together with recent findings (Vaccari et al., 
2011), indicate that an alternative cross breeding of MTMR13 KO animals with Fig4 
heterozygeous mice might be a better strategy to compensate focal hypermyelination. Finally, 
also a reduction in PI(5)P levels due to impaired PI(3,5)P2 dephosphorylation by MTMR2 
could contribute to defective myelin formation. However, its role in myelination and 
membrane trafficking is less well investigated. PI(5)P is a known allosteric activator of the 
PH-GRAM domain (Schaletzki et al., 2003), and can be converted to the PM-lipid PI(4,5)P2 
by type II PI(5)P 4-hydroxy kinase (PI5P 4K) (Rameh et al., 1997; McCartney et al., 2014). 
This might be a crucial step for the fusion of late endosomal/ lysosomal compartments with 
the plasma membrane, for instance during exosome secretion (see section 4.4).  
We identified MTMR1 as a novel active phosphatase that interacts with MTMR13 
(Figure 3-9) and most likely also with MTMR5 (data not shown). Interestingly, the pathology 
and onset of CMT4B1 patients is more severe than displayed in CMT4B2 patients (Pareyson 
et al., 2019). A partial redundancy of MTMR13 and -R5 in the recruitment of MTMR2 in 
Schwann cells is thus highly suggestive. Could MTMR1 likewise compensate the absence of 
the active phosphatase MTMR2? MTMR1 has been recently implicated in muscular atrophy 
(Zanoteli et al., 2005), and its knockdown in HeLa cells partially phenocopies MTM1 
depletion with mislocalized transferrin receptors (Ketel et al., 2016). However, MTMR1 is 
more closely related to MTMR2 than MTM1 with a sequence identity in humans of 69.7 % 
and 58.3 %, respectively. In addition, we could not detect any interaction between MTM1 and 
MTMR13 or -R5. If MTMR1 can functionally compensate the loss of MTMR2 could be 
investigated by analyzing PI(3)P accumulation and mTORC1 activity in the absence of both 
phosphatases in Schwann cells. More insight could be also revealed by comparing the 
modulation of MTMR2 and -R1 phosphatase activity in the presence of MTMR5 or -R13 in 
an in vitro phosphatase assay. Thus, so far, compensation of MTMR1 for -R2 can only be 
speculated and might also be cell type-specific.  




In conclusion, we propose that impaired MTMR complex recruitment leads to an 
accumulation of PI(3,5)P2, which in turn results in dysregulated mTORC1 repression, and 
thus, contributes to myelin abnormalities in Rab35-depleted Schwann cells (Figure 4-3). Our 
data indicate that increased mTORC1 activity might also contribute to the observed focal 
hypermyelination in CMT4B patients. The finding that Rab35 can potentially recruit different 
MTMR complexes can explain why Rab35 cKOSC mice display stronger focal 
hypermyelination including tomacula, which were recently suggested to represent a late form 
of myelin outfoldings (Cai et al., 2002), and an earlier onset of demyelination compared to 
MTMR2 KO mice, in which nerve fiber abnormalities are not observed before P19 (Bolino et 
al., 2004).  
 
Figure 4-3: Proposed model of Rab35-dependent mTORC1 repression in Schwann cells mediated by 
the recruitment of PI(3,5)P2-hydrolyzing MTMR complexes to LE/Lys. PI(3,5)P2, generated by 
PIKfyve from PI(3)P, enables Raptor-binding and thereby promotes mTORC1 recruitment to the late 
endosomal/ lysosomal (LE/Lys) membrane. In turn, active MTMR complexes are recruited to LE/Lys by 
Rab35. MTMR2 (or -R1) mediated dephosphorylation of PI(3,5)P2 facilitates the dissociation of mTORC1 
from LE/Lys and thus, inactivation of the kinase complex. Thereby, sustained mTORC1 activity and 
consequently excessive aberrant myelin growth is repressed. 
 
4.3 Altered myelin homeostasis in Rab35-depleted oligodendrocytes 
In oligodendrocytes, shRNA-mediated depletion of Rab35 has been reported to result 
in impaired secretion of major myelin proteins on the one hand (Hsu et al., 2010), and a gain 
in differentiation and myelination on the other (Miyamoto et al., 2013). We could confirm the 
latter, as acute knockout of Rab35 in primary cultures of differentiated OLs resulted in 
increased in vitro myelin sheet formation and myelin protein abundance (Figure 3-3). Could a 





activation upon OL-specific upregulation of PI3K/AKT or MAPK/ERK signaling leads to 
radial hypermyelination in the CNS (Flores et al., 2008; Narayanan et al., 2009; Goebbels et 
al., 2010; Ishii et al., 2013; Sheean et al., 2014; Furusho et al., 2017), whereas features of 
focal hypermyelination are of lower abundance than in the PNS (Goebbels et al., 2010). This 
difference could reflect the presumed positive effect of mTORC1 activity on myelin induction 
in OLs, though the underlying mechanism is not revealed yet (Figlia et al., 2018; Figure 4-1). 
The early ablation or increased activity of Rheb in OPCs delays or prematures myelination 
onset, respectively (Zou et al., 2014). In addition, Rapamycin treatment delays in vitro 
myelination and downregulates the transcription of myelin lipid synthesizing enzymes and 
major myelin proteins (Tyler et al., 2009; 2011). Though mTORC1 has not yet been 
identified as a direct regulator of myelin protein synthesis, OL-specific Raptor depletion 
results in a reduction of mRNA and protein levels of major myelin proteins as well (Bercury 
et al., 2014; Lebrun-Julien et al., 2014). Similarly, downregulation of the cholesterol 
synthesis in oligodendrocytes results in decreased myelin gene expression in vitro (Smolders 
et al., 2010) and in vivo (Mathews et al., 2014). mTORC1 not only promotes cholesterol 
synthesis but has also been recently identified as a key player in cholesterol-regulated myelin 
protein expression in the CNS (Mathews and Appel, 2016). Thus, promoting myelin lipid 
synthesis as well as protein synthesis in OLs can account for the balanced increase in myelin 
growth and thus, radial hypermyelination in the CNS when mTORC1 activity is elevated. So 
far, we have not investigated mTORC1 activation in Rab35-depleted oligodendrocytes. 
Despite, our data could hint to a similar regulation of mTORC1 by Rab35 in CNS myelinating 
glial cells as in Schwann cells. First, as indicated from above-mentioned studies, a loss of 
mTORC1 repression can indeed result in hypermyelination as observed in vitro in Rab35 
icKO OL cultures. Second, these cells also accumulate PI(3)P (Figure 3-22c,d), suggesting an 
important role of Rab35 in PI(3)-phosphate conversion in oligodendrocytes as well. In 
addition, this regulation might also be mediated by MTMR complexes in OLs, as short-term 
depletion of MTMR2 phenocopies the loss of Rab35 in form of elevated myelin protein levels 
(Figure 3-11). MTMR2 is also expressed in other CNS cells such as neurons (Lee et al., 2010) 
and astrocytes (this study). Despite of that, defects of the central nervous system have not 
been reported so far in CMT4B1, but CMT4B3 patients only (Alazami et al., 2014; Romani et 
al., 2016; Manole et al., 2017). One explanation for that discrepancy could be a functional 
compensation of MTMR2 loss in OLs in vivo, for instance by MTMR1. Thus, Rab35 might 
also regulate MTMR complexes and mTORC1 activity in OLs.  




Rab35 is reported to recruit the ARF6-GAP ACAP2 and thereby represses ARF6 
activity and eventually OL differentiation (Miyamoto et al., 2013). How ARF6 finally 
promotes the latter remains enigmatic. Alternatively, elevated mTORC1 activity could be the 
underlying cause. A gain in differentiation might even directly contribute to the observed in 
vitro hypermyelination in our cultures, though our setting did not allow us to analyze this in 
Rab35 icKO cultures directly. Mono-cultures of Rab35-depleted OPCs displayed markedly 
reduced proliferation and increased cell death, and thus, were not sufficiently confluent for a 
comprehensive OL analysis upon early tamoxifen application (Figure 3-2a-c). The defects in 
proliferation might result from altered recycling and signaling of the main receptor for OPC 
proliferation, PDGFRα, as suggested from HEK cell experiments (Wheeler et al., 2015). 
Interestingly, increased apoptosis of OPCs is also reported upon elevated mTORC1 activity in 
conditional TSC1 knockout mice (Jiang et al., 2016). However, this could also result from 
mTORC1-independent regulation by TSC1 (Figlia et al., 2017). Interestingly, lower 
proliferation rates accompanied by increased apoptotic cell death have been observed for SC 
precursors depleted of MTMR2 in mono-cultures (Chojnowski et al., 2007), though this effect 
was never reported upon co-culturing with neurons (Bolis et al., 2009). Thus, our data could 
rather reflect the hypersensitivity of OPCs in mono-cultures, than predicting a great loss of 
Rab35-depleted OPCs in vivo.  
Rab35 is presumed to mediate docking of MVBs to the plasma membrane and thus to 
promote the secretion of exosomes in oligodendrocytes (Hsu et al., 2010). In the absence of 
the small GTPase, impaired exosome secretion is observed in vitro, accompanied by 
intracellular accumulation of PLP in LAMP-positive compartments. A function of Rab35 in 
the secretion of exosomes is also reported from non-myelinating cells (Novo et al., 2018; 
Yang et al., 2019). Intriguingly, the accumulation of MAG in LAMP-positive compartments 
is observed in cultured oligodendrocytes from Fig4-/- mice as well, which display reduced 
PI(3,5)P2 levels (Mironova et al, 2016). Thus, defects in MVB fusion with the plasma 
membrane in the absence of Rab35 could be caused by dysregulateded PI(3)-phosphate 
conversion. However, the consequence of impaired exosome release on myelin formation in 
Rab35-depleted oligodendrocytes was not investigated so far (Hsu et al., 2010). Recent 
publications indicate a crucial requirement of MAG- and PLP-release by LE/Lys in the 
formation of myelin sheaths (Simmons and Trajkovic, 2006; Winterstein et al., 2008; 
Mironova et al., 2016). Accordingly, PLP-containing MVBs located to non-compacted 
myelin regions, in paranodal loops and cytoplasmic channels, the presumed sites of myelin 





directly address this question by purification and thus, analysis of secreted exosomes. 
However, Rab35 icKO oligodendrocytes form myelin sheets in vitro, even in excess, and 
without obvious intracellular accumulation of myelin proteins (Figure 3-3). Thus, how 
impaired exosome secretion in the absence of Rab35 can contribute to the observed gain of 
myelin formation in vitro (Miyamoto et al., 2013; this study) remains elusive at this point. 
In consequence, Rab35 is strongly implicated in myelin homeostasis of the CNS and 
our data might indicate that the regulation of PI(3)-phosphates and mTORC1 contributes to 
the observed effects upon Rab35 loss in vitro. However, in vivo analysis of CNS myelination 
in OL-specific Rab35 knockout animals will reveal its physiological requirement. If myelin 
proteins are indeed accumulated intracellularly in vivo, could be investigated then by 
purification of the myelin exosomal fraction from these brains with subsequent analysis by 
mass spectrometry.  
 
4.4 Rab35-dependent mechanisms which might contribute to the control of 
myelin homeostasis 
Rapamycin treatment rescued myelination defects in the absence of Rab35 ex vivo and 
in vitro. However, impaired PNS myelin homeostasis in vivo is only partially ameliorated by 
mTORC1 inhibition. As already mentioned, this can be attributed to the treatment timing on 
the one hand. On the other, it could also indicate that other processes downstream of Rab35 
and independent of mTORC1 contribute to PNS myelin homeostasis. 
Rab35 is implicated in the regulation of the actin cytoskeleton via its effector protein 
fascin, the GEF DENND1C, as well as CDC42 and Rac1, in the formation of actin-rich 
protrusions during phagocytosis, filopodium and lamellipodium formation, as well as in 
neurite outgrowth (Shim et al., 2010; Chevallier et al., 2009). The regulation of the actin 
cytoskeleton is important in SC-mediated radial sorting of axons, and the axonal 
ensheathment by OLs and SCs (Bacon et al., 2007; Benninger et al., 2007; Nodari et al., 
2007; Chernousov et al. 2008). Despite, Rab35 cKOSC nerves did not display an obvious 
impairment or delay of axonal sorting and ensheathment. Alternatively, a loss of OCRL 
recruitment by Rab35 could contribute to aberrant myelination. PI(4,5)P2 is the major PI in 
the plasma membrane (Deshmukh et al., 1980) as well as in myelin layers, in which MBP 
binds to this lipid (Musse et al., 2006). Interestingly, a myelination defect in the white matter 
was observed by MRI (magnetic resonance imaging) in some Lowe-Oculo-Cerebro-Renal 
syndrome patients, caused by mutations in OCRL (Carvalho-Neto et al., 2009). This could 
implicate Rab35 in CNS myelination in vivo through regulation of OCRL as well.  




In addition, the interaction between Rab35 and MTMR complexes could also regulate 
other mechanisms besides mTORC1 repression. Rab35 is involved in the recycling of 
different transmembrane receptors (Jean et al., 2012; Xhabija et al., 2011). In accordance, our 
screen for Rab35-associated proteins revealed a couple of receptors, including ErbB2 (Suppl-
table 1). Interestingly, MTMR2 is involved in the recycling of AMPA receptors in spines (Lee 
et al., 2010). Moreover, Schwann cell-specific knockout of VPS34, which causes severe 
hypomyelination in vivo, results in altered ErbB2/B3 recycling (Logan et al., 2017). In 
addition, both, Rab35 and MTMR2 have been linked to the degradation of EGFR receptors 
(Allaire et al., 2013; Cao et al., 2008; Duan et al., 2016; Zheng et al., 2017; Ye et al., 2018). 
ErbB2/B3 and EGFR (ErbB1) are closely related, internalized upon ligand binding and 
degraded in lysosomes. In contrast, we did not detect any gross changes in endomembrane 
organelles, including LE/Lys (Figure 3-16). However, loss of the PI(3)P- or PI(3,5)P2-
synthesizing enzymes, VPS34 or PIKfyve, but not of PI(3)-phosphatases have been reported 
to cause enlarged endosomal or lysosomal compartments (Bonangelino et al., 2002; 
Ikonomov et al., 2003; Dong et al., 2010; Vaccari et al., 2011; Carpentier et al., 2013; 
Munson et al., 2015; Jaber et al., 2012; 2016). In agreement, altered endosomal or lysosomal 
morphology is not observed upon MTMR2 or -R13 depletion in Schwann cells or MEF cells 
(Ng et al., 2013). A recent review proposes that ErbB receptor recycling could link the 
function of several CMT-associated proteins (Lee et al., 2017). In contrast, neither ERK nor 
AKT activation downstream of ErbB receptors is altered in MTMR2 KO or Rab35 cKOSC 
sciatic nerves (Bolino et al., 2016; this study). Nevertheless, the potential involvement of 
Rab35 in ErbBR-recycling could be more directly addressed, for instance by the use of 
fluorescently labelled NRG1-III, or by analyzing the levels of phosphorylated, and thus 
activated receptors vs. total levels in Rab35 cKO Schwann cells. 
Finally, Rab35 might also function in exosome secretion in Schwann cells. Vesicular 
structures have been observed at cytoplasmic sites of the myelin sheath (Court et al. 2008; 
2011a; Sotelo et al. 2013) and cytoplasmic paranodal loops are the presumed sites of 
membrane addition as well as the origin of focal hypermyelinaton (Berthold and Nilsson, 
2002; Bolino et al., 2004; Goebbels et al., 2012). In a recent study the proteome of Schwann 
cell-derived exosomes has been analyzed. In contrast to OL-derived exosomes, myelin 
proteins were not identified (Wei et al., 2019). However, cholesterol is released by exosome 
secretion as well, presumably for disposal (Canfran-Duque et al., 2013). Thus, impaired 
cholesterol disposal together with mTORC1-mediated elevated cholesterol synthesis might 





PI(3,5)P2 but also elevated mTORC1 activity is linked to impaired exosome secretion in 
MEFs, HEK and HeLa cells (Zou et al., 2018). In turn, rapamycin application or serum-
starvation results in increased exosome release. Moreover, the loss of ARF6 causes 
hypomyelination of the PNS in vivo, and is accompanied by reduced mTORC1-, though also, 
MAPK/ERK- and PI3K/AKT- activation (Torii et al., 2015). Notably, ARF6 has never been 
linked to PI(3,5)P2 conversion, but was recently implicated in the regulation of mTORC1 
activity at lysosomal sites by activating PLD (Knizhnik et al., 2012). Furthermore, ARF6 is 
linked to MVB/exosome biogenesis by controlling the internalization of ILVs through its 
effector PLD2 (Ghossoub et al., 2014). ARF6 acts also upstream of Rab35 by activating the 
Rab35-GAP TC1D10B (Chesneau et al., 2012). Thus, the mutual regulation between Rab35 
and ARF6 might function (mTORC1-dependent) in PNS myelination as well. ARF6 could 
link mTORC1 activation to exosome biogenesis, whereas Rab35 could couple mTORC1 
inactivation via PI(3,5)P2 dephosphorylation to exosome secretion. Exosomes are usually 
isolated from high-confluent cultures, and thus, the low yield of Schwann cells that are 
achieved from mouse nerves, limited the investigation of SC-derived exosomes from 
genetically modified mice so far. A recently published protocol circumvents these problems 
(Shojapour et al., 2018). Here, exosomes are purified from a high yield of primary Schwann 
cells obtained through the degeneration of nerves from adult mice prior to SC isolation. This 
method could enable the analysis of SC-derived exosomes from Rab35 cKOSC mice. 
 
4.5 The role of Rab35 in SV recycling  
Rab35 is linked to the facilitation of synaptic vesicle recycling on an endosomal route 
in D. melanogaster (Uytterhoeven et al., 2011). In the absence of its putative GAP Skywalker 
in fly NMJs, an increased abundance of endosomal compartments is reported to result from 
the upregulation of active Rab35. An accompanied elevation in SV protein degradation is 
presumed to lead to the observed increase in neurotransmitter release from these synapses. In 
contrast, in the absence of Rab35 we could not observe reduced formation of endosomal-like 
compartments in synapses of mammalian primary neurons (Figure S1i,j). In addition, SV 
endocytosis/ acidification of synaptotagmin1-pHluorin in these Rab35 icKO neuronal cultures 
is unaffected (Figure S1f-h). Furthermore, surface and total protein pools of the SV proteins 
synaptotagmin1 and synaptophysin are not altered upon Rab35 depletion (Figure S1a-e). In 
parallel to our study, Waites and colleagues have investigated a potential function of Rab35 in 
the degradation of SV proteins in mammalian synapses (Sheehan et al., 2016; Vaz-Silva et 
al., 2018). In that study, elevated degradation of SV2 and VAMP2 upon neuronal activity or 




overexpression of Rab35 has been observed. In turn, the depletion of Rab35 by shRNA-
mediated knockdown led to decreased degradation (Sheehan et al., 2016). The authors 
proposed a function of Rab35 in the endosomal sorting of distinct SV proteins for degradation 
into late endosomal MVBs. If and how degradation of SV proteins, of which only a subset is 
observed to depend on neuronal activity or Rab35 (Sheehan et al., 2016), is achieved on the 
one hand, and impacts the recycling kinetics of SVs at mammalian synapses on the other, 
remains to be clarified. Our data show, that acute long-term depletion of Rab35 does not 
result in an overt defect in mammalian SV recycling in vitro. However, we cannot exclude a 
genetic compensation which is frequently observed in response to gene knockouts (El-
Brolosy and Stainier, 2017). For instance, in D. melanogaster, Rab10 also controls PI(4,5)P2 
and ACAP-mediated ARF-6 regulation (Shi et al., 2012). In addition, overlapping roles with 
Rab35 in the endosomal sorting of endocytosed cargo are displayed by Rab4, Rab5 and 
Rab11 (Pavlos et al., 2010; Pavlos and Jahn, 2011). 
Would altered SV recycling be expected due to the loss of lipid-regulated mTORC1 
repression in the absence of Rab35? mTORC1 and PI(3,5)P2-regulating enzymes are indeed 
implicated in synaptic functions, but so far, at postsynaptic compartments only. Presynaptic 
inactivity induces AMPA receptor-mediated mTORC1 activation at the postsynapse. This 
initiates presynaptic compensation by mTORC1-dependent translation of BDNF (brain-
derived neurotrophic factor) (Henry et al., 2018). MTMR2 is reported to function in the 
endocytic internalization of the AMPA receptor subunit GluA2 at postsynapses (Lee et al., 
2010). In addition, Vac14 or Fig4 depletion results in increased surface levels of GluA2 
(Zhang et al., 2012; McCartney et al., 2014). Thus, a disturbance of synaptic plasticity might 
be an expectable outcome upon loss of Rab35. However, the application of inhibitors for 
AMPA and NMDA receptors in our system did not allow us to detect feedback loop-mediated 
effects from postsynaptic sites. In sum, we did not observe a direct effect of acute Rab35 












4.6 Future directions  
This work unveils Rab35 as a novel regulator of myelin homeostasis in the PNS and a 
recruiter of MTMR lipid phosphatase complexes that dephosphorylate PI(3)P and PI(3,5)P2 at 
late endosomal/ lysosomal membranes to suppress mTORC1 activity. This regulation might 
be required to tightly adapt the activity of the essential kinase complex to the availability of 
nutrients and axonal signals, and thus, contributes to Schwann cell survival and myelination 
adjustment to axonal parameters. These findings provide a deeper insight into a mechanism 
that might underlie common pathologies in demyelinating diseases but also raise new 
questions for future research.  
Our data as well as recent studies implicate Rab35 in the control of oligodendrocytic 
myelin formation as well. If this regulation is also mediated by Rab35-dependent repression 
of mTORC1 activity should be further investigated. Furthermore, the sequential action of 
Rab35, PI(3)-phosphate regulation and mTORC1 activity could be implicated in controlling 
exosome secretion in OLs. Interestingly, PI(3)P and PI(3,5)P2 synthesis at late endosomes/ 
MVBs is required for both, the fusion with lysosomes but also for exosome secretion (Cao et 
al., 2007; 2008; Mironova et al, 2016). How the fate of LE/Lys is determined to either of 
these endomembrane trafficking routes is still elusive. Nevertheless, how impaired secretion 
of major myelin proteins in the absence of Rab35 impacts myelin formation remains to be 
investigated and complicates a prediction of how loss of Rab35 will affect CNS myelination 
in vivo. According to our data, hypermyelination can be well expected.  
Furthermore, despite of decades since the pathological features of focal 
hypermyelination have been first observed in demyelinating diseases (Madrid and Bradley 
1975), the underlying molecular mechanisms that lead to their formation remain elusive. 
Similarly, how upregulated mTORC1 activity can induce these features is not resolved yet 
(Goebbels et al., 2012; Beirowski et al., 2017). Interestingly, tomacula and myelin 
outfoldings are also observed upon genetic defects in major myelin proteins (Sander et al., 
2000). As discussed, Rab35, PI(3)-phosphate lipid-conversion and mTORC1 might be linked 
at the level of cholesterol and myelin protein secretion as well. Thus, in addition to a 
transcriptional upregulation of myelin lipid synthesis by hyperactive mTORC1 in adult 
animals, impaired membrane addition, imbalanced myelin protein levels and/ or incorporation 
into nascent sheaths could account for the formation of aberrant myelin structures in Rab35 
cKOSC animals. In accordance, the lack of myelin-residing proteins has been suggested to 
disrupt paranodal junctions and thereby contribute to focal hypermyelination (Guo et al., 




2014; Hu et al., 2016). Thus, the analysis of structural components within these regions might 
another conceivable approach in Rab35 cKOSC organotypic explants.  
We could observe an accumulation of PI(3)P as well as increased mTORC1 activity in the 
absence of Rab35, in agreement with the reported activation of mTORC1 by PI(3)-phosphates 
in different cell types. Thus, Rab35-dependent repression of mTORC1 activity by recruiting 
MTMR lipid phosphatase complexes might be an ubiquitous mechanism. Our data reveal a 
crucial involvement of PI(3,5)P2 in mTORC1 activation in Schwann cells. However, in other 
cell types mTORC1 activation might be dominated by PI(3)P, hydrolyzed by MTMR2 as 
well. Thus, why do MTMR2 and MTMR13 mutations almost exclusively affect Schwann 
cells? A possible explanation could be the association of active MTMR phosphatases with 
different pseudophosphatases in distinct tissues, such as MTMR5 and -R13 with MTMR2, 
which modulate their specificity towards PI(3)-phosphates. Vice versa, the loss or impairment 
of MTMR2 could be tissue-dependent compensated by another active MTMR phosphatase. 
Interestingly, overexpression of MTMR2 in myoblasts, which is usually expressed in these 
cells but presumably at low levels, can even rescue muscle defects in MTM1 KO animals 
(Raess et al., 2017). Our data reveal that pseudophosphatase complex partners of MTMR2 
also associate with MTMR1. Thus, Rab35 can potentially control at least four different 
complexes. A cell type-specific redundancy of MTMR complexes could therefor account for 
varying sensitivities to the loss of distinct MTMR proteins. This might well explain the more 
severe focal hypermyelination in Rab35 cKOSC sciatic nerves compared to CMT4B-mouse 
models. Similarly, CMT4B2 results in a milder phenotype than CMT4B1 (Pareyson et al., 
2019), presumably due to the functional replacement of MTMR13 by MTMR5. However, if 
and in which context MTMR1 can substitute MTMR2 still needs to be investigated, in vitro 
and in vivo. 
Finally, our findings implicate that mTORC1 activity might be dysregulated in 
CMT4B patients. Though this hypothesis remains to be confirmed, it is corroborated by the 
rescue effect of Niaspan: The downregulation of NRG-ErbBR and thus, AKT signaling in 
MTMR2 KO nerve fibers ameliorates myelin outfoldings (Bolino et al., 2016). Nevertheless, 
Niaspan might also exert additional effects on several targets downstream of NRG-ErbBR. 
This could be circumvented by the potential use of Rapamycin and thus the direct tackling of 
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6.1 List of Abbreviations 
Ø diameter 
4E-BP1 eIF 4E-binding protein 1 
α (y-α-x) “anti”: antibody, raised in species y and targets protein x  
aa amino acid 
ACAP2 Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 
ADAM17 A disintegrin and metalloproteinase domain 17 
AKT Ak strain transforming 1 
AKT(CA) constitutively active AKT (“DD” - T308D and S473D) 
AMP adenosine monophosphate 
AMPA(R) α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (receptor) 
AMPK AMP-activated protein kinase 
AP action potential 
APS ammoniumpersulfat 
APV DL-2-Amino-5-phosphonopentanoic acid 
Ara-C cytosine β-D-arabinofuranoside 
ARF-6 ADP-ribosylation factor 6 
ATG autophagy related 
ATP adenosine triphosphate 
BACE β-site of APP cleaving enzyme 
BDNF brain-derived neurotrophic factor 
bioAMP biotinoyl-5’-AMP 
BioID proximity-dependent biotin identification 
BirA(*) protein biotin ligase from E. coli (promiscuous mutant) 
BLB biopsy lysis buffer 
bp base pair 
BrdU bromodeoxyuridine 
BSA bovine serum albumin 
BSL1 Griffonia (Bandeiraea) Simplicifolia lectin 1  
CA constitutively active 
CADM cell adhesion molecule 
CAG CMV early enhancer element 
CAM cell adhesion molecules 
cAMP cyclic adenosine monophosphate 
CC coiled-coil 
CCP clathrin-coated pit 
CCV clathrin-coated vesicle 
Cdc42 cell division cycle 42 
CdK cycline dependent kinase 
C. elegans Caenorhabditis elegans 
ch chicken 
c-Jun leucine-zipper zinc-finger transcription factor 
cKOSC Schwann cell-specific conditional knockout 
CMT Charcot-Marie-Tooth 
CMV cytomegalovirus 
CNPase 2′,3′-cyclic nucleotide 3′-phosphodiesterase 
CNS central nervous system 
CNTF ciliary neurotrophic factor 
CNQX 6-cyano-7-nitroquinoxaline-2,3-dione  





CreER Chimera of Cre recombinase and LBD-ERTM 
CRTC2 cAMP response element-binding protein (CREB) regulated transcription coactivator2 
Ctrl control 
Da dalton [g/mol] 
DAB 3,3′-diaminobenzidine tetrahydrochloride 
DAPI 4',6-Diamidino-2-phenylindol 
DENN differentially expressed in neoplastic versus normal cells 
DEPTOR DEP domain containing mTOR-interacting protein 
Dhh Desert hedge hoc 
DIV day(s) in vitro 
dk donkey 
Dlg-1  discs large homolog 1 
D. melanogaster Drosophila melanogaster 
DMEM Dulbecco's modified Eagle medium 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
DNase deoxyribonuclease 
dNTP 2´-desoxynucleoside-5´-triphosphates 
D-PBS                             
(+/- Ca2+/Mg2+) 
Dulbecco’s Phosphate-Buffered Saline                                                                                              
(with/ without calcium and magnesium ions) 
DPSS diode pumped solid state 
DRG Dorsal root ganglion 
DSM DMEM-Sato based growth medium 
E(number) embryonic day number x 
EBSS Earle’s balanced salt solution 
ECL enhanced chemiluminescence 
E. coli Escherichia coli 
EDTA ethylene diamine tetraacetic acid 
EEA1 early endosomal antigen 1 
EF endotoxin-free 
eGFP enhanced green fluorescent protein 
eGFP-2xFYVE 
(Hrs) 
eGFP-tagged tandem version of the PI(3)P binding FYVE domain of Hrs 
EGFR epidermal growth factor receptor 
EGTA ethylene glycol-bis(ß-aminoethyl ether)-N,N,N'N'-tetraacetic acid 
eIF eukaryotic translation initiation factor  
ELV endosomal-like vacuole 
ERK extracellular signal–regulated kinase 
ESCRT endosomal sorting complexes required for transport 
F0 initial fluorescence intensity 
F-actin filamenteous actin 
FastAP alkaline phosphatase 
FBS fetal bovine serum 
FGF2 fibroblast growth factor 2 
Fig. (Sx) figure (supplementary figure number x) 
FKBP12 FK506 binding protein 12 kDa 
FL full-length 
Fl „floxed“ = loxP sites inserted 
Fmax Peak fluorescence intensity 
fw forward 
FYVE  Fab1, YOTB, Vac1, EEA1  
GalC galactocerebroside 




GAP GTPase-activating protein 
GC guanine-cytosine 
GDI Rab-GDP dissociation inhibitor 
GDNF glial cell line-derived neurotrophic factor 
GDP guanosine nucleotide diphosphate 
GEF guanine nucleotide exchange factor 
GFP green fluorescent protein 
GLUT4 glucose transporter 4 
gp guinea pig 
GRAM glycosyltransferase, Rab-like GTPase activator and myotubularin 
Grb growth factor receptor bound protein 
GST glutathione sepharose tag 
gt goat 
GTP (yS) guanosine triphosphate (non-hydrolyzable) 
GTPase GTP hydrolase  
h hour(s) 
HBS HEPES buffered saline 
HBSS Hanks' balanced salt solution 
HCl hydrochloride 
HEK human embryonic kidney cells strain 293T 
HEPES 4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid  
HNPP Hereditary Neuropathy with liability to pressure palsies 
HOS high-ovomucoid solution 
HRP horseradish peroxidase 
HS horse serum 
HSC70 heat shock cognate 70 
hu human 
ICC immunocytochemistry 
icKO tamoxifen-inducible conditional knockout 
Ig immunoglobulin 
IGF1 insulin-like growth factor 1 
IHC immunohistochemistry 
ILV intraluminal vesicle  
INPP4B Inositol polyphosphate-4-phosphatase type II 
IPTG isopropyl β-D-1-thiogalactopyranosid 
JNK c-Jun N-terminal kinase 
KD knockdown 
kDa kilodalton 
KI knock in 
KO knockout 
Kv voltage-gated potassium channels 
L-15 Leibovitz’s L-15 medium 
LAGeSo Landesamt für Gesundheit und Soziales 
LAMP(-1/2) lysosomal-associated membrane protein 1 
LB(-agar/-medium) lysogeny broth 
LBD-ERTM ligand binding domain of estrogen receptor (tamoxifen-responsive) 
LC3 microtubule-associated protein 1 light chain 3 
LC3-I cytosolic LC3 
LC3-II phosphatidylethanolamine-conjugated LC3 at autophagosomal membranes 
LC-MS/MS liquid chromatography - tandem mass spectrometry 
LE/Lys late endosomal/ lysosomal compartment 





LKB1 liver kinase B1 
LOS low-ovomucoid solution 
MAG myelin-associated glycoprotein 
MAPK mitogen-activated protein kinase 
MBP myelin basic protein 
mCCM  mammalian cell culturing medium 
MEF mouse embryonic fibroblast 
MEK MAPK/ERK kinase 
MEK(CA) Constitutively active MEK (S218D; S222D) 
MEM minimum essential medium  
MICAL1 molecules interacting with casL 1 
min minute(s) 
MOG myelin oligodendrocyte glycoprotein 
MOI multiplicity of infection 
ms mouse 
MS mass spectrometry 
mRNA messenger RNA 
mSin1 mammalian stress-activated protein kinase-interacting protein 1 
MTM(R) myotubularin-related lipid phosphatase 
mTOR mechanistic target of rapamycin 
mTORC mTOR complex 
MVB multi vesicular body 
myc myelocytomatose 
NA numerical aperture 
NaOH sodium hydroxide 
Nav voltage-gated sodium channel 
NBA neurobasal medium A 
N-CAM nerve CAM 
NCV nerve conduction velocity 
NDP52 nuclear dot protein 52 kDa 
NDS normal donkey serum 
NFAT nuclear factor of activated T cells 
NF-L/M Neurofilament- low/ medium molecular weight 
NG2 neural glial antigen 2 
NGS normal goat serum 
NMDA(R) N-methyl-D-aspartate (receptor) 
NMJ neuromuscular junction 
norm. normalized 
Notch neurogenic locus notch homolog protein 
NRG1(-III) neuregulin1 (type III) 
n.s. not significant 
NT-3 neurotrophin-3 
OCRL oculocerebrorenal syndrome of Lowe 
OL(s) oligodendrocyte(s) 
OPC(s) oligodendrocyte precursor cell(s) 
p-(S/T/Y x)y phosphorylated protein y (at Serine/Threonine/ Tyrosine number x) 
P0 myelin protein 0 
P(number) postnatal day number x 
PA phosphatic acid 
PBS phosphate buffered saline 
PBS-T PBS with 0.05 % (v/v) TWEEN-20 
PC phosphatidylcholine 




PCR polymerase chain reaction 
PDGF platelet-derived growth factor 
PDGFR platelet-derived growth factor receptor 
PDK1 3-phosphoinositide-dependent kinase 1 
PDL poly-D-lysine hydrobromide 
PDZ PSD-95/Dlg-1/ZO1 
PFA paraformaldehyde 
PH pleckstrin homology 
pH potential hydrogen 









PI3K/(C2) phosphatidylinositol 3-kinase class I/ class II 
PI5P 4K type II PI(5)P 4-hydroxy kinases 
PiB PIPES-based buffer 
PIC mammalian protease inhibitor cocktail 
PIKfyve PI(3)-phosphate 5-kinase type III, FYVE finger-containing 
PIPES piperazine-N,N'-bis-2-ethanesulfonic acid 
PLC phospholipase C 
PLD Phoshpolipase D 
PLL poly-L-lysine hydrobromide 
PLP proteolipid protein 
PM plasma membrane 
PMP peripheral myelin protein 
PMSF phenylmethylsulfonyl fluoride  
PNS peripheral nervous system 
POI protein of interest 
POU Pit-Oct-Unc 
PRAS40 proline-rich Akt substrate of 40 kDa 
P/S penicillin/ streptomycin  
PTEN dual protein and lipid phosphatase and tensin homolog on chromosome 10 
PTP(i) phosphotyrosine phosphatase (inactive) 
Rab Ras-related in brain  
Rab35Fl/+ mice with heterozygously „floxed“ Rab35 gene/ one allele with loxP site insertion 
Rab35Fl/Fl mice with homozygously „floxed“ Rab35 gene/ both alleles with loxP site insertion 
Rab35^GTPys/GDP nucleotide-loaded Rab35 (with GTPys or GDP) 
Rac1 Ras-related C3 botulinum toxin substrate 1 
Rag Ras-related GTPases 
Rapa Rapamycin 
Raptor regulatory-associated protein of mTOR 
Ras rat sarcoma 
rb rabbit 
REDD1 regulated in DNA damage and development 1 
rev reverse 
Rheb Ras homolog enriched in brain  





Rictor Raptor-independent companion of mTOR 
RNA ribonucleic acid 
RNase ribonuclease 
ROI region of interest 
rpm rounds per minute  
RT room temperature 
RTK receptor tyrosine kinase 
S6 40s ribosomal protein S6 
S6K p70 S6 Kinase 1 
Sbf SET-binding factor 
SC(s) Schwann cell(s) 
scr scrambled (non-targeting [negative control] si/shRNA) 
SD standard deviation 
SDS(-PAGE) sodiumdodecylsulfate (- polyacrylamide gel electrophoresis) 
SEM standard error of the mean 
SF surface 
shRNA small hairpin RNA 
siRNA small interfering RNA 
SLI(s) Schmidt-Lantermann-incisure(s) 
SN sciatic nerve (N. sciaticus) 
Sox SRY (sex determining region Y)-box 
SREBP sterol regulatory element-binding protein 
Suppl. supplementary 
SV(s) synaptic vesicle(s) 
SV2 synaptic vesicle protein 2 
Syph synaptophysin 
Syt1 synaptotagmin1 
Syt1-pH chimera of synaptotagmin1 and pHluorin 
τ endocytic time constant 
T3 thyroid hormone triiodothyronine 
table Sx supplementary table number x 




TBS TRIS-buffered saline 
TE TRIS-EDTA 
TEMED N,N,N',N'-Tetramethylethylenediamin 
TES N-tris(hydroxymethyl)methyl-2-aminoethane sulfonic acid 
TFEB transcription factor EB 
TfR transferrin receptor 
TGFβ transforming growth factor ß 
TLB tail lysis buffer 
TMX tamoxifen ((Z)-4-hydroxytamoxifen) 
TNB tail neutralization buffer 
TRIS Tris-(hydroxymethyl)-aminomethan  
TSC tuberous sclerosis complex 
TWEEN polyethyleneglycolsorbitanmonolaurate 
ULK1/Atg13/FIP200 
unc-51-like kinase 1/mammalian autophagy-related gene 13/focal adhesion kinase 
family-interacting protein of 200kDa 
UV ultraviolet 
Vac vacuole-related protein  




VAMP vesicle associated membrane protein 
Veh vehicle 
VPS vacuolar protein sorting 
VSV-G vesicular stomatits virus G protein 
v/v volume per volume 
WT  wild type 
w/v weight per volume 
x g multiplicity of acceleration of gravity 
XLCNM X-linked centronuclear myopathy 







6.2.1 Mass spectrometry results of the Rab35-BioID 
Table S1: Proteins, selectively enriched in Rab35-BioID samples. bold – linked to Rab35 by literature 
Gene  Protein 
ABCC1 Multidrug resistance-associated protein 1 
ABCC5 Multidrug resistance-associated protein 5 
ADCY9 Adenylate cyclase type 9 
AGPAT9 Glycerol-3-phosphate acyltransferase 3 
AKT2 RAC-beta serine/threonine-protein kinase 
ALCAM CD166 antigen 
ANKS6 Ankyrin repeat and SAM domain-containing protein 6 
ATP6AP2 Renin receptor 
ATP7A Copper-transporting ATPase 1 
ATP7B Copper-transporting ATPase 2;WND/140 kDa 
BASP1 Brain acid soluble protein 1 
CAMLG Calcium signal-modulating cyclophilin ligand 
CCDC8 Coiled-coil domain-containing protein 8 
CDC42EP1 Cdc42 effector protein 1 
CDC42EP4 Cdc42 effector protein 4 
CHM Rab proteins geranylgeranyltransferase component A 1 
CHMP6 Charged multivesicular body protein 6 
COL1A1 Collagen alpha-1(I) chain 
CXADR Coxsackievirus and adenovirus receptor 
DAG1 Dystroglycan; Alpha-dystroglycan; Beta-dystroglycan 
DENND5B DENN domain-containing protein 5B 
DENR Density-regulated protein 
DHRS7 Dehydrogenase/reductase SDR family member 7 
DOCK8 Dedicator of cytokinesis protein 8 




EGFR Epidermal growth factor receptor 
EPHA2 Ephrin type-A receptor 2 
EPHA7 Ephrin type-A receptor 7 
ERBB2 Receptor tyrosine-protein kinase erbB-2 
EWSR1 RNA-binding protein EWS 
FAM171B Protein FAM171B 
FAM207A Protein FAM207A 
FLOT2 Flotillin-2 
FLRT3 Leucine-rich repeat transmembrane protein FLRT3 
FLVCR1 Feline leukemia virus subgroup C receptor-related protein 1 
GTF2B Transcription initiation factor IIB 




GULP1 PTB domain-containing engulfment adapter protein 1 
HM13 Minor histocompatibility antigen H13 
HMGCR 3-hydroxy-3-methylglutaryl-coenzyme A reductase 
HMOX2 Heme oxygenase 2 
IFNGR1 Interferon gamma receptor 1 
IGF1R Insulin-like growth factor 1 receptor 
IGHA1; IGHA2 Ig alpha-1 chain C region;Ig alpha-2 chain C region 
IGSF3 Immunoglobulin superfamily member 3 
INSR Insulin receptor 
ITGA6 Integrin alpha-6 
ITGB1 Integrin beta-1 
JAM3 Junctional adhesion molecule C 
KIAA0319L Dyslexia-associated protein KIAA0319-like protein 
KIAA0355 Uncharacterized protein KIAA0355 
KIRREL Kin of IRRE-like protein 1 
KLRG2 Killer cell lectin-like receptor subfamily G member 2 
LNPEP Leucyl-cystinyl aminopeptidase, pregnancy serum form 
LPHN2 Latrophilin-2 
LRP2 Low-density lipoprotein receptor-related protein 2 
MARCKSL1 MARCKS-related protein 
MCAM Cell surface glycoprotein MUC18 
MINA 
Bifunctional lysine-specific demethylase and histidyl-hydroxylase 
MINA 
MINK1 Misshapen-like kinase 1 
MPP6 MAGUK p55 subfamily member 6 
MPZL1 Myelin protein zero-like protein 1 
MYBBP1A Myb-binding protein 1A 
NCAM1 Neural cell adhesion molecule 1 
NDC1 Nucleoporin NDC1 







PHF6 PHD finger protein 6 
PHLDB2 Pleckstrin homology-like domain family B member 2 
PIK3R2 Phosphatidylinositol 3-kinase regulatory subunit beta 
PIP5K1C Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma 
PLXNA1 Plexin-A1 
PREB Prolactin regulatory element-binding protein 
PTK7 Inactive tyrosine-protein kinase 7 
PTPLAD1 
Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] 
dehydratase 3 




PVRL3 Poliovirus receptor-related protein 3 
RAB23 Ras-related protein Rab-23 
RALBP1 RalA-binding protein 1 
RCC1 Regulator of chromosome condensation 
RELL1 RELT-like protein 1 
ROBO1 Roundabout homolog 1 
ROR2 Tyrosine-protein kinase transmembrane receptor ROR2 
RPL18 60S ribosomal protein L18 
RPS19 40S ribosomal protein S19 
RRAGC; 
RRAGD 
Ras-related GTP-binding protein C; 
Ras-related GTP-binding protein D 
SAFB; SAFB2 Scaffold attachment factor B1; Scaffold attachment factor B2 
SBF2 Myotubularin-related protein 13 




SLC12A7 Solute carrier family 12 member 7 
SLC19A1 Folate transporter 1 
SLC1A3 Excitatory amino acid transporter 1 
SLC20A1 Sodium-dependent phosphate transporter 1 
SLC20A2 Sodium-dependent phosphate transporter 2 
SLC25A22; SLC25A18 Mitochondrial glutamate carrier 1+ 2 
SLC27A4 Long-chain fatty acid transport protein 4 
SLC29A1 Equilibrative nucleoside transporter 1 
SLC30A1 Zinc transporter 1 
SLC38A1 Sodium-coupled neutral amino acid transporter 1 
SLC38A2 Sodium-coupled neutral amino acid transporter 2 
SLC39A10 Zinc transporter ZIP10 
SLC39A14 Zinc transporter ZIP14 
SLC39A6 Zinc transporter ZIP6 
SLC4A2 Anion exchange protein 2 
SLC6A8 Sodium- and chloride-dependent creatine transporter 1 
SLC7A2 Low affinity cationic amino acid transporter 2 
SLC7A5 Large neutral amino acids transporter small subunit 1 
SLC9A3R2 Na(+)/H(+) exchange regulatory cofactor NHE-RF2 
SNAP47 Synaptosomal-associated protein 47 
SNX30 Sorting nexin-30 
SPTLC1 Serine palmitoyltransferase 1 
SRC Proto-oncogene tyrosine-protein kinase Src 
SSR1 Translocon-associated protein subunit alpha 
STBD1 Starch-binding domain-containing protein 1 
STEAP3 Metalloreductase STEAP3 
STIM2 Stromal interaction molecule 2 
STK11IP Serine/threonine-protein kinase 11-interacting protein 
STX18 Syntaxin-18 







SUSD5 Sushi domain-containing protein 5 
SYTL4 Synaptotagmin-like protein 4 
TADA3 Transcriptional adapter 3 
TAPT1 Transmembrane anterior posterior transformation protein 1 homolog 
TBC1D13 TBC1 domain family member 13 
TC2N Tandem C2 domains nuclear protein 
TLDC1 TLD domain-containing protein 1 
TMEM2 Transmembrane protein 2 
TMX1 Thioredoxin-related transmembrane protein 1 
TRUB1 Probable tRNA pseudouridine synthase 1 
TULP3 Tubby-related protein 3 
UBXN6 UBX domain-containing protein 6 
UNC5B Netrin receptor UNC5B 
UNC5C Netrin receptor UNC5C 
VANGL1 Vang-like protein 1 
VAT1 Synaptic vesicle membrane protein VAT-1 homolog 
ZDHHC5 Palmitoyltransferase ZDHHC5 
 
 
Table S2: Proteins, more than fivefold enriched (LFQ-intensity BirA*Rab35/BirA*) in Rab35-BioID 
samples in n = 2 independent experiments. Enrichment: mean ± SD; bold -– linked to Rab35 by literature 
Rank Gene  Protein 
Fold 
enrichment 
1 RAB35 Ras-related protein Rab-35 745.72 ± 347.31 
2 TFRC Transferrin receptor protein 1 45.86 ± 48.09 
3 SLC3A2 4F2 cell-surface antigen heavy chain 44.72 ± 35.72 
4 LSR Lipolysis-stimulated lipoprotein receptor 36.04 ± 11.34 
5 SLC12A2 Solute carrier family 12 member 2 36.00 ± 5.00 
6 STX12 Syntaxin-12 35.95 ± 38.94 
7 CACHD1 VWFA and cache domain-containing protein 1 34.44 ± 39.70 
8 SBF1 Myotubularin-related protein 5 28.92 ± 1.45 
9 CHML Rab proteins geranylgeranyltransferase component A 2 23.35 ± 16.53 
10 SLC1A5 Neutral amino acid transporter B(0) 22.19 ± 5.44 
11 CNNM3 Metal transporter CNNM3 21.10 ± 18.18 
12 ATP2B1 Plasma membrane calcium-transporting ATPase 1 13.35 ± 4.94 
13 UACA 
Uveal autoantigen with coiled-coil domains and ankyrin 
repeats 
10.90 ± 6.91 
14 IGF2R Cation-independent mannose-6-phosphate receptor 8.17 ± 1.84 
15 SLC4A7 Sodium bicarbonate cotransporter 3 7.01 ± 1.09 




Vesicle-associated membrane protein 2 




6.2.2 SV recycling in Rab35 icKO primary neuronal cultures  
 
 




Figure S1: No major alterations in the synaptic vesicle recycling of Rab35 icKO primary neuronal 
cultures. Primary cultures of hippocampal neurons were prepared from tamoxifen-inducible Rab35 
icKO (Rab35Fl/Fl x CreER) and WT (Rab35Fl/Fl) animals and cultured in the presence of 0.4 µM tamoxifen 
until DIV14. (a-e) Surface levels of two major transmembrane synaptic vesicle (SV) proteins are not 
altered. Cells were fixed and immunolabelled for the plasma membrane-residing surface (SF) pool of 
SV proteins, under non-permeabilizing conditions using antibodies targeting their luminal domain. Total 
protein levels were revealed by subsequent immunolabelling with an antibody recognizing the 
corresponding cytoplasmic domain under permeabilizing conditions. Immunostaining for synapsin was 
performed to mark synaptic areas. No significant changes were observed for any protein pool in Rab35 
icKO compared to WT synapses. (a) Representative confocal images of synaptotagmin1 (Syt1) surface 
(SF; red) and total levels (green). Synapses are depicted by synapsin (magenta); Scale bars: 10 µm. (b) 
Quantification of surface over total Syt1 mean intensities in synapsin-positive areas, in Rab35 icKO 
normalized to WT cells (=1); (mean ± SEM; n = 3 independent experiments; one sample two-tailed 
student’s t-test with a theoretical mean of 1; p = 0.3899). (c) Quantification of synapsin mean intensities 
in Rab35 icKO normalized to WT cells (100 %), reveals no change upon loss of Rab35; (mean ± SEM; 
n = 3 independent experiments; one sample two-tailed student’s t-test with a theoretical mean of 100; p 
= 0.4781). (d) Representative confocal images of synaptophysin (Syph) surface (SF; red), total levels 
(green) and synapsin (magenta). Scale bars: 10 µm. (e) Quantification of surface over total 
synaptophysin mean intensities in synapsin-positive areas, in Rab35 icKO normalized to WT cells (= 
1); (mean ± SEM; n = 3 independent experiments; one sample two-tailed student’s t-test with a 
theoretical mean of 1; p = 0.5515). (f-h) Synaptic vesicle recycling of synaptotagmin1-pHluorin is 
unaltered in Rab35 icKO neurons. Primary hippocampal cultures were transfected at DIV7 with a 
plasmid encoding for synaptotagmin1-pHluorin (Syt1-pH) under control of a synapsin-promoter. 
Live-cell imaging according to a pHluorin-based assay (Miesenböck et al., 1998) was performed at 
DIV14. Neuronal activity in the cultures was elicited by electrical field stimulation with 200 action 
potentials (AP) at 5 Hz and SV recycling kinetics were analyzed from n = 5 independent experiments. 
(f) Relative fluorescence intensity course (ΔF/ΔFmax) of Syt1-pH over time of Rab35 WT and icKO 
cells, used to calculate the endocytic decay. (g) Quantification of the endocytic decay, depicted by the 
decay time constant (τ), revealed no significant change of endocytic uptake/ re-acidification in Rab35 
icKO neurons; (two-tailed paired student’s t-test; p = 0.1079). (h) Quantification of the relative peak 
fluorescence intensity upon stimulation (Fmax/F0) depicted normalized to WT cells (mean = 100 %). The 
amplitude of peak fluorescence is unaltered in Rab35 icKO neurons; (two-tailed paired student’s t-test; 
p = 0.4240). (i, j) Rab35 depletion does not alter the number of endocytical-derived synaptic or 
endosome-like vesicles in synapses. Primary neuronal cultures were chemically stimulated with 80 mM 
potassium chloride for 1 min in the presence of horse-radish peroxidase (HRP) in order to label newly 
endocytosed vesicles. Cells were fixed 5 min post-stimulation. HRP was visualized by 3,3'-
diaminobenzidine (DAB)-mediated chromogenic detection and the number of HRP-positive synaptic 
vesicles (SVs) and endosome-like vesicles (ELVs) in presynapses was ultrastructurally analysed by 
electron microscopy (EM), performed by Dr. Dmytro Puchkov (FMP, Berlin). (i) Representative 
ultrastructural images of Rab35 WT and icKO synapses. Arrows indicate HRP-containing organelles in 
presynapses. PSD – postsynaptic density; Scale bar: 300 µm. (j) Quantification of the number of 
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